<html>
<body>
<H2>

<FONT COLOR=A70716 SIZE=-1>INVITED REVIEW</FONT><BR>



Whole body glucose metabolism

</H2>



	
		
			


<STRONG>
<NOWRAP>
Kenneth 
Zierler
</NOWRAP>
</STRONG>
<P>
Endocrine and Metabolism Division, Department of Medicine, and
Department of Physiology, The Johns Hopkins University School of
Medicine, Baltimore, Maryland 21287-4904
<P>


		
	






    
	
	    
	
	    
		
    
	
	    
	
    
	
	    
	
    
	
	    
	
    
	
	    
	
    
	
	    
	
    
	
	    
	
    
	
	    
	
    
    
	
	    
	
    





	








	

<a name = "abs"><!-- comment for mosaic --></a>



<BR CLEAR=ALL>
<A NAME="Abstract"><!-- null --></A>
<TABLE WIDTH=100% BGCOLOR=E1E1E1 CELLPADDING=0 CELLSPACING=0>
<TR>
<TD ALIGN=LEFT VALIGN=MIDDLE WIDTH=5% BGCOLOR=FFFFFF>&nbsp;<IMG WIDTH=10 HEIGHT=21 HSPACE=5 ALT="" SRC="/icons/toc/rarrow.gif"></TD>
<TH ALIGN=LEFT VALIGN=MIDDLE WIDTH=95%><FONT SIZE=+2>&nbsp;&nbsp;ABSTRACT</FONT></TH>
</TR>
</TABLE>

<TABLE ALIGN=RIGHT CELLPADDING=5 BORDER NOWRAP><R>
<TH ALIGN=LEFT>
<FONT SIZE=-1>



<A HREF="#Top"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">Top</A>


<BR><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/dot.gif"><FONT COLOR=46
4C53>Abstract</FONT>


<BR>
<A HREF="#SEC1"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/darrow.gif">SCOPE OF THE REVIEW</A>


<BR>
<A HREF="#SEC2"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/darrow.gif">METHODS FOR STUDYING GLUCOSE...</A>


<BR>
<A HREF="#SEC3"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/darrow.gif">GLUCOSE DISTRIBUTION AND...</A>


<BR>
<A HREF="#SEC4"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/darrow.gif">GLUCOSE TRANSPORTERS:...</A>


<BR>
<A HREF="#SEC5"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/darrow.gif">RELATION OF GLUCOSE METABOLISM...</A>


<BR>
<A HREF="#SEC6"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/darrow.gif">EXERCISE</A>


<BR>
<A HREF="#SEC7"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/darrow.gif">HYPOXIA</A>


<BR>
<A HREF="#SEC8"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/darrow.gif">SUMMARY AND PROJECTION</A>


<BR>
<A HREF="#References"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/darrow.gif">References</A>
</FONT></TH>
</TR></TABLE>


<P>This review describes major factors that, singly
or together, influence the concentration and distribution of
<font size=-1>D</font>-glucose in<SUP> </SUP>mammals,
particularly in humans, with emphasis on rest, physical<SUP> </SUP>activity, and
alimentation. It identifies areas of uncertainty:<SUP> </SUP>distribution and
concentrations of glucose in interstitial fluid,<SUP> </SUP>kinetics and mechanism
of transcapillary glucose transport, kinetics<SUP> </SUP>and mechanism of glucose
transport via its transporters into cells,<SUP> </SUP>detailed mechanisms by which
hormones, exercise, and hypoxia affect<SUP> </SUP>glucose movement across cell
membranes, whether translocation<SUP> </SUP>of glucose transporters to the cell
membrane accounts completely,<SUP> </SUP>or even mainly, for insulin-stimulated
glucose uptake, whether<SUP> </SUP>exercise stimulates release of a circulating
insulinomimetic factor,<SUP> </SUP>and the relation between muscle glucose uptake
and muscle blood<SUP> </SUP>flow. The review points out that there is no
compartment of glucose<SUP> </SUP>in the body at which all glucose is at the same
concentration,<SUP> </SUP>and that models of glucose metabolism, including effects
of insulin<SUP> </SUP>on glucose metabolism based on assumptions of concentration
homogeneity,<SUP> </SUP>cannot be entirely correct. A fresh approach to modeling
is<SUP> </SUP>needed.
</P>




<P>
distribution; uptake; output; blood flow; alimentation; exercise; anoxia; hormonal control; fatty acids
</P>






<TXT>
<A NAME="SEC0"><!-- comment for mosaic --></A>


    
    
    

    
    
    

    
    
    

    
    
    

    
    
    

    
    
    

    
    
    

    
    
    

    
    
    

    
    
    

    
    
    





<BR CLEAR=ALL>
<A NAME="SEC1"><!-- null --></A>
<TABLE WIDTH=100% BGCOLOR=E1E1E1 CELLPADDING=0 CELLSPACING=0>
<TR>
<TD ALIGN=LEFT VALIGN=MIDDLE WIDTH=5% BGCOLOR=FFFFFF>&nbsp;<IMG WIDTH=10 HEIGHT=21 HSPACE=5 ALT="" SRC="/icons/toc/rarrow.gif"></TD>
<TH ALIGN=LEFT VALIGN=MIDDLE WIDTH=95%><FONT SIZE=+2>&nbsp;&nbsp;SCOPE OF THE REVIEW</FONT></TH>
</TR>
</TABLE>

<TABLE ALIGN=RIGHT CELLPADDING=5 BORDER NOWRAP><R>
<TH ALIGN=LEFT>
<FONT SIZE=-1>



<A HREF="#Top"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">Top</A>


<BR>
<A HREF="#Abstract"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">Abstract</A>


<BR><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/dot.gif"><FONT COLOR=46
4C53>SCOPE OF THE REVIEW</FONT>


<BR>
<A HREF="#SEC2"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/darrow.gif">METHODS FOR STUDYING GLUCOSE...</A>


<BR>
<A HREF="#SEC3"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/darrow.gif">GLUCOSE DISTRIBUTION AND...</A>


<BR>
<A HREF="#SEC4"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/darrow.gif">GLUCOSE TRANSPORTERS:...</A>


<BR>
<A HREF="#SEC5"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/darrow.gif">RELATION OF GLUCOSE METABOLISM...</A>


<BR>
<A HREF="#SEC6"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/darrow.gif">EXERCISE</A>


<BR>
<A HREF="#SEC7"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/darrow.gif">HYPOXIA</A>


<BR>
<A HREF="#SEC8"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/darrow.gif">SUMMARY AND PROJECTION</A>


<BR>
<A HREF="#References"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/darrow.gif">References</A>
</FONT></TH>
</TR></TABLE>


    
    <P><font size=-1>D</font>-glucose is the transport form
of carbohydrate, an important fuel for stoking metabolic engines in all
mammalian cells. It<SUP> </SUP>is the major substrate for neuronal
O<SUB>2</SUB> consumption (<A HREF="#B104">104</A>). However,<SUP> </SUP>it
is not the major fuel for either the beating heart (<A HREF="#B17">17</A>) or<SUP> </SUP>skeletal
muscle, at rest (<A HREF="#B3">3</A>) or with mild to moderate exercise<SUP> </SUP>(<A HREF="#B54">54</A>, <A HREF="#B136">136</A>); free
fatty acids (FFA) are. Respiratory quotient<SUP> </SUP>(RQ&nbsp;=&nbsp;expired
CO<SUB>2</SUB>/inspired
O<SUB>2</SUB>) of healthy young adult men
and<SUP> </SUP>women at rest in the basal state is ~0.76, implying that
carbohydrate<SUP> </SUP>supplies less than about one-third and fat more than about
two-thirds<SUP> </SUP>of the nonprotein substrate metabolized by the whole body
(<A HREF="#B27">27</A>).
    </P>
    

    
    <P>The purpose of this review is to bring together information about major
factors that influence the concentration and distribution<SUP> </SUP>of
<font size=-1>D</font>-glucose. It is limited to
mammalian glucose metabolism, with<SUP> </SUP>emphasis on humans, and to the
influence of three states: rest,<SUP> </SUP>physical activity (including effects
of hypoxia), and alimentation<SUP> </SUP>(including effects of fat and plasma FFA
concentration). The review<SUP> </SUP>does not consider intermediary metabolism
except insofar as it<SUP> </SUP>is necessary for transfer of glucose from
interstitial fluid into<SUP> </SUP>cells and for endogenous glucose production.
Unless the context<SUP> </SUP>requires specification of the optical isomer,
"glucose" will refer<SUP> </SUP>only to
<font size=-1>D</font>-glucose, and the descriptive
"mammalian" will be assumed<SUP> </SUP>for all references to bodily
processes, unless stated<SUP> </SUP>otherwise.
    </P>
    




<BR CLEAR=ALL>
<A NAME="SEC2"><!-- null --></A>
<TABLE WIDTH=100% BGCOLOR=E1E1E1 CELLPADDING=0 CELLSPACING=0>
<TR>
<TD ALIGN=LEFT VALIGN=MIDDLE WIDTH=5% BGCOLOR=FFFFFF>&nbsp;<IMG WIDTH=10 HEIGHT=21 HSPACE=5 ALT="" SRC="/icons/toc/rarrow.gif"></TD>
<TH ALIGN=LEFT VALIGN=MIDDLE WIDTH=95%><FONT SIZE=+2>&nbsp;&nbsp;METHODS FOR STUDYING GLUCOSE  METABOLISM IN VIVO</FONT></TH>
</TR>
</TABLE>

<TABLE ALIGN=RIGHT CELLPADDING=5 BORDER NOWRAP><R>
<TH ALIGN=LEFT>
<FONT SIZE=-1>



<A HREF="#Top"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">Top</A>


<BR>
<A HREF="#Abstract"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">Abstract</A>


<BR>
<A HREF="#SEC1"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">SCOPE OF THE REVIEW</A>


<BR><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/dot.gif"><FONT COLOR=46
4C53>METHODS FOR STUDYING GLUCOSE...</FONT>


<BR>
<A HREF="#SEC3"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/darrow.gif">GLUCOSE DISTRIBUTION AND...</A>


<BR>
<A HREF="#SEC4"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/darrow.gif">GLUCOSE TRANSPORTERS:...</A>


<BR>
<A HREF="#SEC5"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/darrow.gif">RELATION OF GLUCOSE METABOLISM...</A>


<BR>
<A HREF="#SEC6"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/darrow.gif">EXERCISE</A>


<BR>
<A HREF="#SEC7"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/darrow.gif">HYPOXIA</A>


<BR>
<A HREF="#SEC8"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/darrow.gif">SUMMARY AND PROJECTION</A>


<BR>
<A HREF="#References"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/darrow.gif">References</A>
</FONT></TH>
</TR></TABLE>


    
    <P>Two methods are gold standards. Although they supply only limited
information, they have the advantage of being reliable when<SUP> </SUP>carried out
with due care. They are easily understood and clearly<SUP> </SUP>based on
steady-state balance studies. <I>1</I>)
Estimation of glucose<SUP> </SUP>uptake by a single organ or region of the body is
accomplished<SUP> </SUP>by an input-output method, first described and used by
Chauveau<SUP> </SUP>(<A HREF="#B22">22</A>), although often called the Fick principle. Input to the<SUP> </SUP>organ or tissue is the product of blood (or plasma) flow and arterial<SUP> </SUP>concentration of the substance of interest, such as glucose. Output<SUP> </SUP>from the organ or tissue is the product of blood flow and venous<SUP> </SUP>concentration. Net uptake or output of the substance of interest<SUP> </SUP>is,
then, the product of blood flow and arteriovenous (a-v) concentration<SUP> </SUP>difference. Such methods are valid only in a steady state in which<SUP> </SUP>flow
and concentrations are constant, although uptake can be measured<SUP> </SUP>from
integrated a-v differences during transition between two<SUP> </SUP>steady states
of glucose concentrations, but not during changes<SUP> </SUP>in blood flow (<A HREF="#B133">133</A>).
One of the powerful advantages of this method<SUP> </SUP>when applied to studies
of metabolism of forearm skeletal muscle<SUP> </SUP>and adipose tissue lies in the
possibility of controlling elements<SUP> </SUP>in the composition of inflowing
blood by close arterial infusion.<SUP> </SUP>Forearm blood flow at rest, with
circulation to the hand excluded,<SUP> </SUP>is of the order of 1% of cardiac
output. This makes it possible<SUP> </SUP>to introduce hormones or other potent
agents by constant infusion<SUP> </SUP>into the brachial artery in locally
effective concentrations,<SUP> </SUP>and yet any of the agent that escapes into
forearm venous blood<SUP> </SUP>is diluted ~100-fold in the central circulation
so that its circulating<SUP> </SUP>concentration outside the forearm is impotent
to stimulate unwanted<SUP> </SUP>responses and counterregulatory mechanisms that
would otherwise<SUP> </SUP>confound interpretation of the data. Similarly,
substrates such<SUP> </SUP>as glucose can be introduced by close arterial infusion
into the<SUP> </SUP>brachial artery so as to produce local forearm hyperglycemia
to<SUP> </SUP>an extent that might, for example, double normal blood glucose<SUP> </SUP>concentration, and yet the general circulating glucose concentration<SUP> </SUP>is
increased by only 1%, at most, a concentration too small to<SUP> </SUP>evoke
counterregulatory responses. <I>2</I>)
Total body glucose uptake,<SUP> </SUP>under conditions in which there is no
endogenous glucose production,<SUP> </SUP>is estimated by the Andres glucose clamp
method (<A HREF="#B4">4</A>). When glucose<SUP> </SUP>uptake is constant, total body glucose uptake
must equal the amount<SUP> </SUP>of glucose, corrected for urinary loss, that must
be infused to<SUP> </SUP>maintain constant blood glucose concentration, once the
entire<SUP> </SUP>volume of extracellular glucose distribution has been
accommodated.<SUP> </SUP>Endogenous glucose production can be shut off by
somatostatin,<SUP> </SUP>by insulin, or by sufficient hyperglycemia. If there is
endogenous<SUP> </SUP>glucose production, one seeks to estimate it by the decrease
in<SUP> </SUP>plasma glucose specific activity when a tracer amount of
radiolabeled<SUP> </SUP>glucose is added to the infusion. Translation of that
decrease<SUP> </SUP>in specific activity into a quantitative statement about
endogenous<SUP> </SUP>glucose production requires further assumptions that may or
may<SUP> </SUP>not be valid. <I>Methods
1</I>&nbsp;and
<I>2</I>&nbsp;have often been used<SUP> </SUP>together.
    </P>
    

    
    <P>In efforts to find methods for in vivo study of glucose metabolism that
are either less demanding or have potential to supply<SUP> </SUP>information
unattainable by steady-state input-output or glucose<SUP> </SUP>clamp methods, a
great deal of work has been spent in proposing<SUP> </SUP>and using models. These
models, or their equivalent representation<SUP> </SUP>in the form of equations,
have more parameters than can be measured,<SUP> </SUP>or than are measured
directly. They cannot be solved, therefore,<SUP> </SUP>without additional
assumptions, as, for example, that total body<SUP> </SUP>glucose is distributed in
a small number of compartments, in each<SUP> </SUP>of which there are no glucose
concentration gradients, and that<SUP> </SUP>there is a single transfer rate into
and a single rate out of<SUP> </SUP>each compartment. These are therefore called
lumped parameter<SUP> </SUP>models and are usually referred to as compartmental
analysis.<SUP> </SUP>As we shall see, the assumptions are inaccurate. This does
not<SUP> </SUP>necessarily invalidate use of such a model, but it must be
demonstrated<SUP> </SUP>for each model and for each experimental condition in
which it<SUP> </SUP>is used that the inherent inaccuracies are negligible for its<SUP> </SUP>specific use, not a trivial task. For details and examples of<SUP> </SUP>models,
see, for example, major contributions by Bergman (<A HREF="#B14">14</A>,<SUP> </SUP><A HREF="#B15">15</A>), Berman (<A HREF="#B62">62</A>),
Cobelli (<A HREF="#B6">6</A>, <A HREF="#B14">14</A>, <A HREF="#B15">15</A>), and a review<SUP> </SUP>by Radziuk (<A HREF="#B97">97</A>), who uses
compartmental analysis as an element<SUP> </SUP>in a broader approach. Space
limitation prevents detailed assessment<SUP> </SUP>of lumped parameter<SUP> </SUP>models.
    </P>
    

    
    <P>An interesting and influential lumped parameter model, introduced by
Bergman and Cobelli and colleagues (<A HREF="#B14">14</A>), is the "minimal<SUP> </SUP>model,"
designed to interpret data from a frequently sampled glucose<SUP> </SUP>tolerance
test. The model claims to yield a measure of sensitivity<SUP> </SUP>of the whole
body to insulin with respect to glucose uptake and<SUP> </SUP>a measure of the
rate of glucose uptake stimulated by increased<SUP> </SUP>circulating glucose and
independent of insulin action (a process<SUP> </SUP>called "glucose
effectiveness"). Although results of the analyses<SUP> </SUP>compared favorably
with results obtained in glucose clamp experiments<SUP> </SUP>under certain
conditions, they do not do so under all conditions.<SUP> </SUP>Selection of the
minimal model was the result of tests for best<SUP> </SUP>fit to data
of seven candidate models. The model selected assumes<SUP> </SUP>two properties
known to be contrary to biological fact: first,<SUP> </SUP>it assumes that glucose
uptake is a linear function of circulating<SUP> </SUP>blood glucose concentration
and that the slope of that relationship<SUP> </SUP>is an index of insulin
sensitivity (when, as we shall see, glucose<SUP> </SUP>uptake by cells occurs only
via saturable cell-surface glucose<SUP> </SUP>transporters, so that the
relationship cannot be linear, and there<SUP> </SUP>is therefore no single,
constant slope); and, second, it claims<SUP> </SUP>that extrapolation of the
best-fit straight line back to intersect<SUP> </SUP>the glucose uptake axis
measures insulin-independent glucose uptake<SUP> </SUP>(when, of course, there
cannot be any glucose uptake if blood<SUP> </SUP>glucose concentration is zero).
One of the problems with the process<SUP> </SUP>by which the decision to accept
the model was made is that the<SUP> </SUP>seven models tested failed to include a
Michaelis-Menten model<SUP> </SUP>in which the parameters could be sensitive to
insulin, a model<SUP> </SUP>long used in studies of insulin action on glucose
uptake by isolated<SUP> </SUP>cells and tissues. A Michaelis-Menten model is an
oversimplification,<SUP> </SUP>but at least it avoids the two erroneous
assumptions (although<SUP> </SUP>not the lumped parameter assumption) of the
minimal model pointed<SUP> </SUP>out<SUP> </SUP>above.
    </P>
    

    
    <P>We shall see that there are no anatomic regions in the body in which
the concentration of glucose is everywhere the same,<SUP> </SUP>not even
circulating blood plasma. Therefore, strictly speaking<SUP> </SUP>there are no
compartments, in the sense in which the word is used<SUP> </SUP>to mean some
volume in which there are no glucose chemical potential<SUP> </SUP>gradients,
although there may be conditions that are of a scale<SUP> </SUP>at which the real
chemical potential gradients can be ignored.<SUP> </SUP>My own policy is to seek
to avoid compartmental models on the<SUP> </SUP>grounds that they are likely to
yield misleading results, that<SUP> </SUP>they require assumptions that are likely
to be untrue, that there<SUP> </SUP>is often no independent test of validity of
the results, and that<SUP> </SUP>they are often not needed; one may be able to
obtain a useful<SUP> </SUP>and desirable answer by a different approach that makes
no unwarranted<SUP> </SUP>assumptions. Elements of a possible alternative to
compartmental<SUP> </SUP>analysis lumped parameter models are suggested by Mari
(<A HREF="#B82">82</A>),<SUP> </SUP>in which the circulatory system plays a primary role in glucose<SUP> </SUP>distribution, and its role is equated to the density function<SUP> </SUP>of
transit time of glucose through the system. In part, this approach<SUP> </SUP>was
anticipated by experiments in which the paired-tracer dilution<SUP> </SUP>method
was applied to the perfused rat hindlimb (<A HREF="#B60">60</A>).
    </P>
    




<BR CLEAR=ALL>
<A NAME="SEC3"><!-- null --></A>
<TABLE WIDTH=100% BGCOLOR=E1E1E1 CELLPADDING=0 CELLSPACING=0>
<TR>
<TD ALIGN=LEFT VALIGN=MIDDLE WIDTH=5% BGCOLOR=FFFFFF>&nbsp;<IMG WIDTH=10 HEIGHT=21 HSPACE=5 ALT="" SRC="/icons/toc/rarrow.gif"></TD>
<TH ALIGN=LEFT VALIGN=MIDDLE WIDTH=95%><FONT SIZE=+2>&nbsp;&nbsp;GLUCOSE DISTRIBUTION AND CONCENTRATIONS</FONT></TH>
</TR>
</TABLE>

<TABLE ALIGN=RIGHT CELLPADDING=5 BORDER NOWRAP><R>
<TH ALIGN=LEFT>
<FONT SIZE=-1>



<A HREF="#Top"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">Top</A>


<BR>
<A HREF="#Abstract"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">Abstract</A>


<BR>
<A HREF="#SEC1"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">SCOPE OF THE REVIEW</A>


<BR>
<A HREF="#SEC2"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">METHODS FOR STUDYING GLUCOSE...</A>


<BR><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/dot.gif"><FONT COLOR=46
4C53>GLUCOSE DISTRIBUTION AND...</FONT>


<BR>
<A HREF="#SEC4"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/darrow.gif">GLUCOSE TRANSPORTERS:...</A>


<BR>
<A HREF="#SEC5"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/darrow.gif">RELATION OF GLUCOSE METABOLISM...</A>


<BR>
<A HREF="#SEC6"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/darrow.gif">EXERCISE</A>


<BR>
<A HREF="#SEC7"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/darrow.gif">HYPOXIA</A>


<BR>
<A HREF="#SEC8"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/darrow.gif">SUMMARY AND PROJECTION</A>


<BR>
<A HREF="#References"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/darrow.gif">References</A>
</FONT></TH>
</TR></TABLE>


    


<P><I>Glucose Concentrations Throughout the Body</I>
</P>


    


<P><I>Erythrocytes.</I>


    
    Fetal and neonatal erythrocytes of all mammalian species are highly
permeable to glucose; in them glucose concentrations in<SUP> </SUP>red blood cell
water are about the same as those in plasma water.<SUP> </SUP>In all mammals
studied except for porpoise, rhesus monkey, and<SUP> </SUP>human, red blood cell
glucose content decreases at about the same<SUP> </SUP>time as fetal hemoglobin
decreases (<A HREF="#B1">1</A>). The ratio of red cell<SUP> </SUP>water glucose to plasma water
glucose varies widely among mammals,<SUP> </SUP>from near zero (in swine) to near
unity (in primates and porpoise),<SUP> </SUP>with many species at ~0.5 (<A HREF="#B47">47</A>).
Therefore, whole blood glucose<SUP> </SUP>concentration underestimates plasma
water glucose concentration,<SUP> </SUP>which is the glucose concentration of
interest as the driving<SUP> </SUP>force for movement into interstitial water. In
adult humans, glucose<SUP> </SUP>concentration in plasma water is nearly the same
as in red blood<SUP> </SUP>cell water over a wide range of blood glucose
concentration, until<SUP> </SUP>plasma glucose concentration becomes extremely
high when erythrocyte<SUP> </SUP>glucose transporters are saturated (<A HREF="#B84">84</A>).
    </P>
    

    
    Jaquez (<A HREF="#B63">63</A>) points out that glucose enters human red blood cells at a
rate that exceeds its red blood cell utilization by<SUP> </SUP>a thousandfold.
Whatever else its function may be, erythrocyte<SUP> </SUP>glucose does serve as
buffer to damp the amplitude of variations<SUP> </SUP>in plasma water glucose
concentration. Even in those species in<SUP> </SUP>which glucose concentration in
red blood cell water is substantially<SUP> </SUP>less than in plasma, erythrocytes
serve to buffer plasma glucose.<SUP> </SUP>In rats, red blood cells take up
glucose when there is hyperglycemia<SUP> </SUP>and store most of it as glycogen.
When there is hypoglycemia,<SUP> </SUP>and under the influence of a <IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">-adrenergic
agonist, red blood cell<SUP> </SUP>glycogen is dissimilated to glucose and moves
into plasma (<A HREF="#B52">52</A>).<SUP> </SUP>In this context, erythrocytes have been dubbed
"circulating<SUP> </SUP>hepatocytes."
    </P>
    


    

    


<P><I>Transcapillary exchange and interstitial fluid.</I>


    
    With the possible exception of blood capillary endothelial cells, no
<font size=-1>D</font>-glucose molecule crosses a
plasma membrane except via<SUP> </SUP>a
<font size=-1>D</font>-glucose-specific transporter.
There is no <font size=-1>L</font>-glucose
transporter,<SUP> </SUP>so <font size=-1>L</font>-glucose is
excluded from cells and cannot cross the blood-brain<SUP> </SUP>barrier (<A HREF="#B53">53</A>).
However, both <font size=-1>D</font>-glucose and
<font size=-1>L</font>-glucose move back<SUP> </SUP>and forth
between blood plasma and interstitial fluid (<A HREF="#B126">126</A>).<SUP> </SUP>We don't know
whether the route of glucose across capillaries<SUP> </SUP>is transcellular or
paracellular or both. It is because
<font size=-1>L</font>-glucose<SUP> </SUP>is distributed in
interstitial fluid (except for brain), despite<SUP> </SUP>the fact that there is
no known <font size=-1>L</font>-glucose transporter,
that we<SUP> </SUP>suspect strongly that
<font size=-1>D</font>-glucose does not require a
transporter<SUP> </SUP>to move between blood plasma and interstitial fluid.
Although<SUP> </SUP>details of <font size=-1>D</font>-glucose
movement across capillaries are unknown,<SUP> </SUP>the process is usually treated
as diffusion, driven only by a<SUP> </SUP>glucose concentration gradient across
capillaries, but it may<SUP> </SUP>be more<SUP> </SUP>complicated.
    </P>
    

    
    Glucose is not distributed instantly across capillaries into
interstitial fluid. When glucose is injected intravenously so<SUP> </SUP>as to
produce arterial blood plasma hyperosmolality, the initial<SUP> </SUP>response is
net water movement from interstitial fluid into plasma;<SUP> </SUP>water crosses
capillaries faster than glucose. Glucose concentration<SUP> </SUP>in relatively
large bodies of interstitial water (including lymph,<SUP> </SUP>transudates, and
edema fluid) is approximately the same as in<SUP> </SUP>arterial plasma water
(<A HREF="#B55">55</A>). However, glucose concentration in<SUP> </SUP>interstitial fluid must be less
than that in arterial plasma water<SUP> </SUP>for glucose to diffuse out of blood
plasma. The gradient need<SUP> </SUP>not be<SUP> </SUP>steep.
    </P>
    

    
    Glucose concentration in subcutaneous interstitial fluid has been
assessed by several methods: cotton wick, microdialysis,<SUP> </SUP>microfiltration, needle-type glucose sensors, and equilibration<SUP> </SUP>with
microfiltration. Reported values of the ratio of interstitial<SUP> </SUP>to venous
glucose range from ~0.4 (<A HREF="#B104">104</A>) to &gt;1, a value inconsistent<SUP> </SUP>with
diffusion from blood into interstitial fluid, and therefore<SUP> </SUP>suspect
(<A HREF="#B94">94</A>). In a study comparing three methods, Schmidt et<SUP> </SUP>al. (<A HREF="#B106">106</A>) found
that all gave a ratio of ~0.45. The mean of 0.45<SUP>&nbsp;</SUP>is thought to
reflect gradients in glucose concentration; the<SUP> </SUP>field detected by the
sensor includes a volume ranging from interstitial<SUP> </SUP>face of a capillary,
where glucose concentration is likely close<SUP> </SUP>to that of arterial plasma
water, to adipocyte or myocyte, where<SUP> </SUP>interstitial glucose
concentration need be only just larger than<SUP> </SUP>that of free glucose in the
cell (near zero) to enter the cell<SUP> </SUP>via a glucose transporter. If these
observations are not artifacts,<SUP> </SUP>it is erroneous to treat total
extracellular fluid as though it<SUP> </SUP>were characterized by only a single
glucose concentration. However,<SUP> </SUP>others report, with microdialysis of
perfused rat limbs, that<SUP> </SUP>interstitial glucose concentration is about
the same as that in<SUP> </SUP>blood (<A HREF="#B43">43</A>). As one expects, when insulin was added
to the perfusate,<SUP> </SUP>interstitial glucose concentration in skeletal muscle
fell to<SUP> </SUP>a greater extent than did blood glucose (<A HREF="#B43">43</A>). Obviously, when<SUP> </SUP>muscle glucose uptake is increased, a fall in interstitial glucose<SUP> </SUP>concentration must precede that in blood. There is also a report<SUP> </SUP>of
interstitial glucose concentrations, by microdialysis in normal<SUP> </SUP>young
adults, measured separately in muscle and in fat tissue<SUP> </SUP>interstitium
under euglycemic and hypoglycemic hyperinsulinemic<SUP> </SUP>glucose clamp. The
two interstitial fluid glucose concentrations<SUP> </SUP>were the same throughout.
With euglycemia, the ratio of interstitial<SUP> </SUP>to plasma glucose was ~0.7
but dropped to ~0.34 during hypoglycemia;<SUP> </SUP>both the absolute and
relative decreases in glucose concentration<SUP> </SUP>in interstitial fluid were
greater than in plasma, emphasizing<SUP> </SUP>that extracellular fluid cannot be
treated as having no gradients<SUP> </SUP>in glucose concentration (<A HREF="#B79">79</A>).
    </P>
    


    

    


<P><I>Heterogeneity of venous and interstitial glucose concentrations.</I>


    
    It is common to speak of a "rapidly equilibrated"
<font size=-1>D</font>-glucose space, which consists
of extracellular fluid plus red blood cell<SUP> </SUP>water, ~20% of body
weight, as though at any instant there is<SUP> </SUP>only one glucose
concentration throughout it. However, glucose<SUP> </SUP>is not distributed
instantaneously throughout its rapidly equilibrated<SUP> </SUP>volume. Time is
required for glucose molecules to reach systemic<SUP> </SUP>capillaries when
introduced either into hepatic or renal venous<SUP> </SUP>circulation by
endogenous glucose production or into portal venous<SUP> </SUP>circulation by
intestinal absorption or when administered intravenously.<SUP> </SUP>Because
tissues remove glucose from arterial blood, venous glucose<SUP> </SUP>concentrations are less than arterial, except that hepatic venous<SUP> </SUP>glucose concentration may exceed arterial during periods in which<SUP> </SUP>the
liver is adding glucose to the circulation. Venous glucose<SUP> </SUP>concentrations are not all the same; they depend on arterial flow<SUP> </SUP>rate
and the rate of glucose uptake by the tissue drained by the<SUP> </SUP>vein in
question. In normal young men and women, mean arterial<SUP> </SUP>blood glucose
concentration in the basal state was 5.0&nbsp;&#177;&nbsp;0.05<SUP>&nbsp;</SUP>mM; forearm
arterial-deep venous concentration difference was<SUP> </SUP>0.14&nbsp;&#177;&nbsp;0.017&nbsp;mM,
and forearm arterial-superficial venous concentration<SUP> </SUP>difference was
0.19&nbsp;&#177;&nbsp;0.027&nbsp;mM (<A HREF="#B9">9</A>). These are basal state glucose<SUP> </SUP>extraction
fractions of only 3&nbsp;and 4%, from which we may conclude<SUP> </SUP>that for some
restricted purposes it may be acceptable to treat<SUP> </SUP>blood plasma glucose
concentration as being the same everywhere<SUP> </SUP>in a well-defined basal
state. However, in response to a maximum<SUP> </SUP>dose of insulin, forearm
arterial-deep venous glucose concentration<SUP> </SUP>difference increased to 1.36&nbsp;mM, an extraction fraction of 27%,<SUP> </SUP>9&nbsp;times greater than in the basal
state (<A HREF="#B2">2</A>). It is, therefore,<SUP> </SUP>not accurate to speak of blood glucose
concentration as though<SUP> </SUP>at any instant under any circumstance it is
everywhere in blood<SUP> </SUP>the same under all<SUP> </SUP>conditions.
    </P>
    


    

    


<P><I>Intracellular glucose.</I>


    
    It has not been easy to determine whether there is free glucose, as
opposed to its phosphorylated products, in most cells,<SUP> </SUP>particularly in
skeletal muscle. The difficulty is that one seeks<SUP> </SUP>to measure a small
difference, if any, between total glucose in<SUP> </SUP>the sample and
extracellular glucose. Most evidence points to<SUP> </SUP>the likelihood that,
over the range of normal blood glucose concentration,<SUP> </SUP>if there is any
free glucose in skeletal muscle cells it is below<SUP> </SUP>the resolving power
of our methods. For example, in rats under<SUP> </SUP>glucose clamp at various
glycemic levels, no free glucose was<SUP> </SUP>detected in skeletal muscle but
was present in liver, its concentration<SUP> </SUP>varying directly with serum
glucose (<A HREF="#B130">130</A>). Katz et al. (<A HREF="#B65">65</A>)<SUP> </SUP>concluded that there is no free
intracellular glucose in biopsied<SUP> </SUP>human quadriceps femoris muscle, but
their conclusion is uncertain<SUP> </SUP>because it was based on an assumption
that extracellular glucose<SUP> </SUP>concentration is the same as that in plasma
(so that intracellular<SUP> </SUP>glucose tended to be underestimated, although
perhaps only negligibly)<SUP> </SUP>and on an arguable assumption that
extracellular water is 300<SUP>&nbsp;</SUP>ml/kg dry weight of muscle, perhaps an
underestimate (so that<SUP> </SUP>intracellular glucose tended to be
overestimated). That there<SUP> </SUP>is very little or no free intracellular
glucose in skeletal muscle<SUP> </SUP>at normal plasma glucose concentrations
implies that glucose is<SUP> </SUP>phosphorylated in muscle about as rapidly as it
is translocated<SUP> </SUP>into the<SUP> </SUP>cell.
    </P>
    


    


    

    


<P><I>Daily Range of Blood Glucose Concentration</I>
</P>


    
    At any moment, the change in concentration of glucose in any small
volume element of blood plasma depends on the rate at which<SUP> </SUP>glucose is
introduced into circulating blood, the rate at which<SUP> </SUP>it is distributed
throughout the blood circulation, the rate at<SUP> </SUP>which it is apportioned
between red blood cells and plasma, and<SUP> </SUP>the rate at which it is removed
from circulation. The limiting<SUP> </SUP>event on rate of glucose removal from
the circulation is its rate<SUP> </SUP>of entry into cells. The rate of glucose
entry into cells may<SUP> </SUP>be limited by transmembrane transport or by
glucose phosphorylation.<SUP> </SUP>All of these factors are changing throughout
the day in relation<SUP> </SUP>to meals, physical activity, emotional state, and
stage of<SUP> </SUP>development.
    </P>
    

    
    <P>Arterial blood plasma glucose concentration is not tightly controlled.
In normal healthy young adults, during the course of<SUP> </SUP>a day's activity,
arterial blood glucose concentration may vary<SUP> </SUP>from a low of a little
more than 3&nbsp;to a high of 9&nbsp;mM (<A HREF="#B111">111</A>). The<SUP> </SUP>highs and lows of blood
glucose concentration are affected by<SUP> </SUP>dietary carbohydrate and fat, by
blood plasma levels of FFA, by<SUP> </SUP>muscle exercise, by local hypoxia, and
by families of<SUP> </SUP>hormones.
    </P>
    


    




<BR CLEAR=ALL>
<A NAME="SEC4"><!-- null --></A>
<TABLE WIDTH=100% BGCOLOR=E1E1E1 CELLPADDING=0 CELLSPACING=0>
<TR>
<TD ALIGN=LEFT VALIGN=MIDDLE WIDTH=5% BGCOLOR=FFFFFF>&nbsp;<IMG WIDTH=10 HEIGHT=21 HSPACE=5 ALT="" SRC="/icons/toc/rarrow.gif"></TD>
<TH ALIGN=LEFT VALIGN=MIDDLE WIDTH=95%><FONT SIZE=+2>&nbsp;&nbsp;GLUCOSE TRANSPORTERS: CATEGORIES  AND DISTRIBUTION</FONT></TH>
</TR>
</TABLE>

<TABLE ALIGN=RIGHT CELLPADDING=5 BORDER NOWRAP><R>
<TH ALIGN=LEFT>
<FONT SIZE=-1>



<A HREF="#Top"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">Top</A>


<BR>
<A HREF="#Abstract"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">Abstract</A>


<BR>
<A HREF="#SEC1"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">SCOPE OF THE REVIEW</A>


<BR>
<A HREF="#SEC2"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">METHODS FOR STUDYING GLUCOSE...</A>


<BR>
<A HREF="#SEC3"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">GLUCOSE DISTRIBUTION AND...</A>


<BR><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/dot.gif"><FONT COLOR=46
4C53>GLUCOSE TRANSPORTERS:...</FONT>


<BR>
<A HREF="#SEC5"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/darrow.gif">RELATION OF GLUCOSE METABOLISM...</A>


<BR>
<A HREF="#SEC6"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/darrow.gif">EXERCISE</A>


<BR>
<A HREF="#SEC7"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/darrow.gif">HYPOXIA</A>


<BR>
<A HREF="#SEC8"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/darrow.gif">SUMMARY AND PROJECTION</A>


<BR>
<A HREF="#References"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/darrow.gif">References</A>
</FONT></TH>
</TR></TABLE>


    
    <P>There are two broad categories of glucose transporters:
Na<SUP>+</SUP> dependent (SGLT) and
Na<SUP>+</SUP> independent (GLUT). There are
several reviews of SGLT (<A HREF="#B124">124</A>)<SUP> </SUP>and GLUT (<A HREF="#B87">87</A>, <A HREF="#B91">91</A>) to which readers are
referred, and which<SUP> </SUP>serve as references in this section for material
not specifically<SUP> </SUP>referenced.
    </P>
    

    


<P><I>Na<SUP>+</SUP> Dependent
(SGLT)</I>
</P>


    
    By a mechanism not understood, SGLT glucose transport is coupled to
downhill Na<SUP>+</SUP> transport, which is
thought to confer sufficient energy on the<SUP> </SUP>system to permit glucose to
cross the cell membrane against its<SUP> </SUP>concentration gradient. When loss
of glucose from isolated intestinal<SUP> </SUP>epithelial cells is prevented by
blocking GLUTs in the basolateral<SUP> </SUP>membrane, the cell can concentrate
glucose, taken up via its SGLT,<SUP> </SUP>by ~30-fold (<A HREF="#B70">70</A>). SGLTs are limited
to some epithelial cells;<SUP> </SUP>our concern in this review is mainly with
SGLT in the brush border<SUP> </SUP>of intestinal and proximal renal tubular cells
and in cytoplasmic<SUP> </SUP>vesicles close to or attached to the brush-border
plasma membrane,<SUP> </SUP>at least of small intestine<SUP> </SUP>enterocytes.
    </P>
    


    

    


<P><I>Na<SUP>+</SUP>
Independent (GLUT)</I>
</P>


    
    In contrast to the limited distribution of SGLT, GLUTs are distributed
widely among nearly all cells, although with varying<SUP> </SUP>density. Net
movement of glucose across a cell membrane via GLUT<SUP> </SUP>is in the direction
of a glucose concentration gradient. Because<SUP> </SUP>movement down a chemical
potential gradient suggests diffusion,<SUP> </SUP>but the rate at which glucose
travels from one side of the membrane<SUP> </SUP>to the other is faster than can
be explained by diffusion of a<SUP> </SUP>molecule of its size and hydrophilicity
across unit area of a<SUP> </SUP>plasma membrane, the process is called
facilitated diffusion.<SUP> </SUP>This may be a misnomer. GLUTs are not simply
pipes through the<SUP> </SUP>plasma membrane through which random molecular
movement of glucose<SUP> </SUP>in aqueous solution drives glucose concentrations
in two bulk<SUP> </SUP>aqueous phases toward equality, a process that defines
"diffusion."<SUP> </SUP>As is thought the case for ion channels, there may
be energy barriers<SUP> </SUP>in GLUTs that glucose molecules must overcome in
connection with<SUP> </SUP>one or more association-dissociation<SUP> </SUP>steps.
    </P>
    

    
    <P>There are six functional GLUT isoforms, of which five transport
primarily <font size=-1>D</font>-glucose: GLUT-1,
GLUT-2, GLUT-3, GLUT-4, and GLUT-7.<SUP> </SUP>All GLUTs have considerable
homology but vary in their affinity<SUP> </SUP>for glucose. To reach cytoplasm of
neurones in the brain, glucose<SUP> </SUP>has to cross two barriers: the choroid
plexus blood-brain barrier<SUP> </SUP>via GLUT-1 and the neuronal plasma membrane
via GLUT-3. GLUT-1<SUP> </SUP>is the most widely distributed, serving many cell
types alone<SUP> </SUP>or in company with another isoform. It is in pancreatic
<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">-cells<SUP> </SUP>in humans, whereas GLUT-2 serves that role in rodents (<A HREF="#B34">34</A>),<SUP> </SUP>illustrating the fact that we cannot necessarily extrapolate from<SUP> </SUP>one
species to another. GLUT-2 is also the major GLUT for intestinal<SUP> </SUP>absorption and renal reabsorption and for releasing glucose from<SUP> </SUP>and
translocating it into hepatocytes. GLUT-4 is the major GLUT<SUP> </SUP>in those
cells that respond to insulin by an increase in glucose<SUP> </SUP>uptake. In
adipocytes and muscle cells, most GLUT-4 is located<SUP> </SUP>in the wall of
intracellular vesicles in the basal state, with<SUP> </SUP>only a little in the
cell surface plasma membrane. In skeletal<SUP> </SUP>muscle there may be nearly
none in the plasma membrane in the<SUP> </SUP>basal state. GLUT-7 has been
localized to hepatocyte endoplasmic<SUP> </SUP>reticulum; it is conjectured that
GLUT-7 may serve to transport<SUP> </SUP>newly produced glucose out of endoplasmic
reticulum lumen into<SUP> </SUP>cytoplasm, from which it leaves the cell for the
bloodstream by<SUP> </SUP>way of GLUT-2 (<A HREF="#B119">119</A>).
    </P>
    

    
    <P>GLUT isoforms vary in their transport efficiency. Numerical values for
the Michaelis constant,
<I>K</I><SUB>m</SUB>, have been
estimated for<SUP> </SUP>the four GLUT isoforms found in cell surface membranes.
They fall<SUP> </SUP>into three groups. It is not known to what extent GLUT
<I>K</I><SUB>m</SUB> in purified<SUP> </SUP>or
semipurified systems accurately reflects the affinity between<SUP> </SUP>the GLUT
isoform and glucose in situ. Nevertheless, we may get<SUP> </SUP>an idea about
relative values: the lowest
<I>K</I><SUB>m</SUB> is 1-5
mM, for GLUT-3,<SUP> </SUP>the brain GLUT, consistent with the observation that
increased<SUP> </SUP>glucose concentration in blood perfusing the brain does not
increase<SUP> </SUP>brain glucose uptake; the highest
<I>K</I><SUB>m</SUB> is 20-40
mM, for GLUT-2,<SUP> </SUP>which may have to deal with intracellular glucose
concentrations<SUP> </SUP>in enterocytes, renal tubular cells, and hepatocytes
that are<SUP> </SUP>higher than plasma levels; GLUT-1 and GLUT-4
<I>K</I><SUB>m</SUB> falls within
the<SUP> </SUP>middle-to-upper range of normal blood glucose concentration. These<SUP> </SUP>numerical <I>K</I><SUB>m</SUB>
values should be taken with reservation; it is not<SUP> </SUP>clear that the
kinetics of glucose transport via GLUT obey the<SUP> </SUP>Michaelis-Menten
assumptions in<SUP> </SUP>detail.
    </P>
    


    

    


<P><I>SGLT and GLUT Cooperation and Mobilization</I>
</P>


    
    SGLT and GLUT-2 work in series in small intestinal enterocytes and in
the renal proximal tubule. In both cases, SGLT is on<SUP> </SUP>the brush-border
luminal membrane, where it absorbs glucose from<SUP> </SUP>gut contents or from
renal glomerular filtrate; absorbed glucose<SUP> </SUP>travels somehow through
cytoplasm to the basolateral membrane,<SUP> </SUP>through which it travels via
GLUT-2 to interstitial fluid and<SUP> </SUP>the portal vein in the gut and to the
renal vein in the<SUP> </SUP>kidney.
    </P>
    

    
    <P>Enterocyte SGLT occurs not only in the brush-border membrane but also
in, or in the membrane of, intracellular vesicles. These<SUP> </SUP>vesicles fuse
with the brush-border membrane to increase surface<SUP> </SUP>SGLT, which
subsequently cycles back to the cell interior (<A HREF="#B129">129</A>).<SUP> </SUP>Similarly, in
adipocytes and cardiac and skeletal muscle, GLUTs<SUP> </SUP>are found laced in
the wall of intracellular vesicles. Under circumstances<SUP> </SUP>to be described
later, these vesicles are mobilized to fuse with<SUP> </SUP>the cell surface
membrane, increasing plasma membrane GLUT density<SUP> </SUP>(<A HREF="#B29">29</A>, <A HREF="#B114">114</A>).
Subsequently, cell surface GLUT returns to the cell<SUP> </SUP>interior via
endocytosis. In adipocytes, the intracellular GLUTs<SUP> </SUP>are both GLUT-1 and
GLUT-4, and both are recruited to the cell<SUP> </SUP>membrane (<A HREF="#B137">137</A>). In skeletal
muscle, the predominant sarcolemma<SUP> </SUP>GLUT in the basal state is GLUT-1.
The smaller amount of GLUT-4<SUP> </SUP>in the basal state is overwhelmingly (<A HREF="#B38">38</A>)
or exclusively in<SUP> </SUP>the wall of the transverse tubule (T tubule) (<A HREF="#B42">42</A>).
The intracellular<SUP> </SUP>GLUT is exclusively GLUT-4, or nearly so, and, in
response to<SUP> </SUP>stimuli that mobilize the intracellular vesicles to fuse
with<SUP> </SUP>cell membrane, they appear to dock only, or at least mainly, with<SUP> </SUP>T tubules (<A HREF="#B42">42</A>, <A HREF="#B81">81</A>). There are quantitative differences in<SUP> </SUP>these
responses among muscle fibers (<A HREF="#B48">48</A>). Except for adipocytes<SUP> </SUP>and cardiac
and skeletal muscle, GLUTs have been identified only<SUP> </SUP>in the cell
surface plasma<SUP> </SUP>membranes.
    </P>
    


    




<BR CLEAR=ALL>
<A NAME="SEC5"><!-- null --></A>
<TABLE WIDTH=100% BGCOLOR=E1E1E1 CELLPADDING=0 CELLSPACING=0>
<TR>
<TD ALIGN=LEFT VALIGN=MIDDLE WIDTH=5% BGCOLOR=FFFFFF>&nbsp;<IMG WIDTH=10 HEIGHT=21 HSPACE=5 ALT="" SRC="/icons/toc/rarrow.gif"></TD>
<TH ALIGN=LEFT VALIGN=MIDDLE WIDTH=95%><FONT SIZE=+2>&nbsp;&nbsp;RELATION OF GLUCOSE METABOLISM  TO ALIMENTATION</FONT></TH>
</TR>
</TABLE>

<TABLE ALIGN=RIGHT CELLPADDING=5 BORDER NOWRAP><R>
<TH ALIGN=LEFT>
<FONT SIZE=-1>



<A HREF="#Top"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">Top</A>


<BR>
<A HREF="#Abstract"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">Abstract</A>


<BR>
<A HREF="#SEC1"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">SCOPE OF THE REVIEW</A>


<BR>
<A HREF="#SEC2"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">METHODS FOR STUDYING GLUCOSE...</A>


<BR>
<A HREF="#SEC3"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">GLUCOSE DISTRIBUTION AND...</A>


<BR>
<A HREF="#SEC4"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">GLUCOSE TRANSPORTERS:...</A>


<BR><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/dot.gif"><FONT COLOR=46
4C53>RELATION OF GLUCOSE METABOLISM...</FONT>


<BR>
<A HREF="#SEC6"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/darrow.gif">EXERCISE</A>


<BR>
<A HREF="#SEC7"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/darrow.gif">HYPOXIA</A>


<BR>
<A HREF="#SEC8"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/darrow.gif">SUMMARY AND PROJECTION</A>


<BR>
<A HREF="#References"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/darrow.gif">References</A>
</FONT></TH>
</TR></TABLE>


    


<P><I>The Food and Famine Hypothesis</I>
</P>


    
    The food and famine hypothesis considers effects of meals and periods
between meals on blood glucose concentration and glucose<SUP> </SUP>uptake and
output as determined by various combinations of hormones<SUP> </SUP>throughout the
day (<A HREF="#B96">96</A>). The hypothesis treats three periods:<SUP> </SUP>prandial and immediate
postprandial, delayed postprandial, and<SUP> </SUP>remote postprandial, which
evolves into the basal state or postabsorptive<SUP> </SUP>period. These periods
are characterized by nearly reciprocal relations<SUP> </SUP>between blood plasma
concentrations of, on the one hand, insulin,<SUP> </SUP>the major stimulator of
glucose uptake, and, on the other hand,<SUP> </SUP>growth hormone (GH),
<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">-adrenergic agonists, and glucagon. GH opposes<SUP> </SUP>insulin-stimulated
glucose uptake. Glucagon and <IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">-adrenergic agonists<SUP> </SUP>stimulate glucose
production via glycogenolysis and<SUP> </SUP>gluconeogenesis.
    </P>
    

    
    <P>Exposure to insulin, which dominates in the prandial and immediate
postprandial period, encourages storage of carbohydrate<SUP> </SUP>and fat and
reduces or prevents hepatic glucose production. Exposure<SUP> </SUP>to GH plus
insulin in the delayed postprandial period encourages<SUP> </SUP>protein
synthesis. At the same time, because the antilipolytic<SUP> </SUP>effect of
insulin prevails over the lipolytic effect of GH, antilipolysis<SUP> </SUP>continues. In a series of reports, Froesch's laboratory has added<SUP> </SUP>a
role for insulin-like growth factor I (IGF-I) (summarized in<SUP> </SUP>Ref. <A HREF="#B85">85</A>).
Exposure to GH and IGF-I, with basal concentrations<SUP> </SUP>of insulin, in the
remote postprandial period encourages mobilization<SUP> </SUP>and peripheral
oxidation of fat and retards translocation of glucose<SUP> </SUP>into muscle and
adipose tissue. IGF-I has an "insulin-sparing"<SUP> </SUP>effect. The
combination of insulin and IGF-I infusions during<SUP> </SUP>a euglycemic clamp
caused greater whole body glucose uptake than<SUP> </SUP>insulin alone. Whereas GH
reduces the glucose uptake response<SUP> </SUP>to insulin, IGF-I increases it.
IGF-I diminishes the GH inhibition<SUP> </SUP>of insulin effect on glucose uptake.
On the other hand, IGF-I,<SUP> </SUP>like GH, is lipolytic, and IGF-I enhances GH
in its prevention<SUP> </SUP>of protein catabolism. Exposure to increasing
concentrations of<SUP> </SUP><IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">-adrenergic agonists and glucagon in the
intermediate and late<SUP> </SUP>postprandial period causes glycogenolysis and<SUP> </SUP>gluconeogenesis.
    </P>
    

    
    <P>Dallman et al. (<A HREF="#B30">30</A>) considered interactions between insulin and
corticosteroids, via the hypothalamic-pituitary-adrenal<SUP> </SUP>axis, in
response to fed and fasting cycles. Corticosteroids may<SUP> </SUP>be either
synergistic with or antagonistic to insulin-stimulated<SUP> </SUP>glucose uptake,
in a concentration-dependent manner. Dallman's<SUP> </SUP>review should be
consulted for analysis and summary of the complex<SUP> </SUP>interplay.
    </P>
    


    

    


<P><I>The Basal State and Remote Postprandial Period</I>
</P>


    


<P><I>Distribution of glucose uptake and output.</I>


    
    The basal state is simply a quite late postprandial period, or early
starvation, in which quasi-stability is maintained for<SUP> </SUP>some properties.
In the basal state in humans, insulin and GH<SUP> </SUP>blood levels are at or
near their lowest concentration of the<SUP> </SUP>24-h period, insulin at
5-10 U/ml (~30-60 pM) and GH at ~5 ng/ml<SUP> </SUP>(<A HREF="#B30">30</A>, <A HREF="#B59">59</A>).
    </P>
    

    
    There is a slow decline of blood glucose concentration, by less than
1%/h in the basal state (<A HREF="#B3">3</A>, <A HREF="#B59">59</A>), so that total body<SUP> </SUP>glucose uptake
must exceed total body glucose production in the<SUP> </SUP>basal state. We can
construct only an incomplete balance sheet<SUP> </SUP>for basal glucose uptake and
production in humans. Endogenous<SUP> </SUP>glucose production (by glycogenolysis
and gluconeogenesis; all<SUP> </SUP>data in
mmol &#183;&nbsp;min<SUP><IMG SRC="/math/12pt/normal/scr/minus.gif" ALIGN=BASELINE ALT="-">1</SUP> &#183;&nbsp;1.73&nbsp;m<SUP>2</SUP>&nbsp;body
surface<SUP><IMG SRC="/math/12pt/normal/scr/minus.gif" ALIGN=BASELINE ALT="-">1</SUP>) by the
splanchnic bed would be 0.62&nbsp;(<A HREF="#B89">89</A>), by the kidney 0.07,<SUP>&nbsp;</SUP>and total
production 0.69&nbsp;(<A HREF="#B113">113</A>). Glucose uptake by brain would<SUP> </SUP>be 0.43&nbsp;(<A HREF="#B104">104</A>), by
skeletal muscle 0.12&nbsp;(<A HREF="#B3">3</A>), by heart 0.08<SUP>&nbsp;</SUP>(<A HREF="#B116">116</A>), and the total by these
three tissues 0.63,&nbsp;or ~90% of<SUP> </SUP>reported glucose
production. Not available are data for other<SUP> </SUP>tissues,
particularly skin and adipose tissue, large masses of<SUP> </SUP>tissue, which,
along with cumulative uncertainties about the calculations<SUP> </SUP>reported,
must make total uptake slightly exceed total basal<SUP> </SUP>production.
    </P>
    


    

    


<P><I>Fate of glucose.</I>


    
    If all glucose taken up were oxidized completely to
CO<SUB>2</SUB> and
H<SUB>2</SUB>O (which it is not), the total
glucose uptake could account<SUP> </SUP>for only 35% of the observed
O<SUB>2</SUB> uptake. This predicts a total<SUP> </SUP>body RQ of 0.8.&nbsp;The actual RQ is lower, ~0.76, because glucose<SUP> </SUP>is not
oxidized<SUP> </SUP>completely.
    </P>
    

    
    Brain glucose uptake, if oxidized completely, can account for more than
(~125% of) the observed O<SUB>2</SUB>
uptake (<A HREF="#B101">101</A>), which suggests<SUP> </SUP>that some glucose is not oxidized
completely in the brain. Although<SUP> </SUP>adult brain depends entirely on
glucose oxidation in the basal<SUP> </SUP>state, that is not true for the embryo.
Embryonic brain oxidizes<SUP> </SUP>ketones, not glucose, because it lacks, or
poorly expresses, GLUT-1,<SUP> </SUP>which is necessary for glucose to cross the
choroid plexus. In<SUP> </SUP>the rabbit, brain GLUT-1 is upregulated through
<I>days 14-70</I> (<A HREF="#B39">39</A>).
    </P>
    

    
    Oxidation of glucose uptake by the beating heart accounts for only 35%
of observed O<SUB>2</SUB> uptake (<A HREF="#B116">116</A>).
Unlike skeletal muscle,<SUP> </SUP>the heart takes up lactate and can use it as
substrate for oxidation.<SUP> </SUP>This still leaves most of the
O<SUB>2</SUB> uptake to be accounted for by<SUP> </SUP>FFA (<A HREF="#B17">17</A>).
    </P>
    

    
    Between 40&nbsp;and 60% of observed forearm muscle glucose uptake in the
basal state is accounted for by lactate production (<A HREF="#B3">3</A>).<SUP> </SUP>This implies
that, at any instant, some 40% or more of forearm<SUP> </SUP>muscle fibers are
not perfused, but presumably no fiber is unperfused<SUP> </SUP>for long. That is,
blood circulation to resting muscle, ~3-4
ml<SUP> </SUP>&#183;&nbsp;min<SUP><IMG SRC="/math/12pt/normal/scr/minus.gif" ALIGN=BASELINE ALT="-">1</SUP> &#183;&nbsp;100&nbsp;ml forearm volume<SUP><IMG SRC="/math/12pt/normal/scr/minus.gif" ALIGN=BASELINE ALT="-">1</SUP>, is
small and limited, so that it is economically distributed<SUP> </SUP>among forearm
muscle fibers, now perfusing one group of fibers<SUP> </SUP>and later another
group. (Lactate, derived from skeletal muscle<SUP> </SUP>anaerobic glycolysis,
released into the circulation, is used as<SUP> </SUP>a substrate for myocardial
O<SUB>2</SUB> consumption and for hepatic
glycogen<SUP> </SUP>synthesis.) When glucose uptake is corrected for lactate
production,<SUP> </SUP>the remaining forearm muscle glucose uptake accounts for
only<SUP> </SUP>~16% of forearm muscle O<SUB>2</SUB>
uptake. This value predicts a forearm<SUP> </SUP>muscle RQ of 0.74.&nbsp;The observed
RQ was 0.76&nbsp;&#177;&nbsp;0.02.&nbsp;The remaining<SUP> </SUP>84% of forearm
O<SUB>2</SUB> uptake in the basal state is
accounted for by<SUP> </SUP>FFA extracted from blood (<A HREF="#B8">8</A>). This calculation means
that little<SUP> </SUP>or none of the glucose taken up by muscle in the basal
state is<SUP> </SUP>stored as glycogen (<A HREF="#B3">3</A>), a fact demonstrated by nuclear
magnetic<SUP> </SUP>resonance spectroscopy (<A HREF="#B107">107</A>).
    </P>
    


    

    


<P><I>Difference between in vivo and in vitro muscle glucose uptake.</I>


    
    Glucose uptake by the forearm in the basal state is only ~0.5
&#181;mol &#183;&nbsp;min<SUP><IMG SRC="/math/12pt/normal/scr/minus.gif" ALIGN=BASELINE ALT="-">1</SUP> &#183;&nbsp;100&nbsp;ml of forearm<SUP><IMG SRC="/math/12pt/normal/scr/minus.gif" ALIGN=BASELINE ALT="-">1</SUP>, or an
estimated 390&nbsp;nmol &#183;&nbsp;h<SUP><IMG SRC="/math/12pt/normal/scr/minus.gif" ALIGN=BASELINE ALT="-">1</SUP> &#183;&nbsp;g
forearm muscle<SUP><IMG SRC="/math/12pt/normal/scr/minus.gif" ALIGN=BASELINE ALT="-">1</SUP> (<A HREF="#B2">2</A>).
Excised rat hemidiaphragm muscle takes up glucose at<SUP> </SUP>a rate <IMG SRC="/math/12pt/normal/ge.gif" ALIGN=BASELINE ALT="&gt;= ">50 times
greater than that (<A HREF="#B134">134</A>), and excised rat epitrochlearis<SUP> </SUP>muscle takes up
glucose at ~20 times the rate of the human forearm<SUP> </SUP>(<A HREF="#B21">21</A>). Skeletal
muscle responds to hypoxia and to contraction<SUP> </SUP>by rapid increase in the
number of GLUTs on its surface. Because<SUP> </SUP>skeletal muscle contracts the
instant its nerve is cut and because<SUP> </SUP>there is apt to be a period of
hypoxia during dissection, it is<SUP> </SUP>possible, even likely, that estimates
of GLUT density in excised<SUP> </SUP>muscle in the "basal" state are
actually higher than true basal,<SUP> </SUP>owing to the insults of dissection
with consequent translocation<SUP> </SUP>of GLUT to the surface membrane. We shall
see, later, that the<SUP> </SUP>stimuli of contraction and, possibly, hypoxia
during preparation<SUP> </SUP>of muscle for in vitro experiments are probably
submaximal, because<SUP> </SUP>in vitro muscle does increase glucose uptake in
response to either<SUP> </SUP>electrical stimulation or hypoxia (<A HREF="#B7">7</A>, <A HREF="#B35">35</A>). When this
excised<SUP> </SUP>muscle is then exposed to insulin at concentrations that elicit<SUP> </SUP>a maximum response, total cell surface membrane GLUT may or may<SUP> </SUP>not
increase by as much absolute amount as it does in normally<SUP> </SUP>perfused
muscle, but the ratio of glucose uptake with to that<SUP> </SUP>without insulin
will be smaller than in in situ perfused preparations<SUP> </SUP>owing to the
abnormally high basal value. Kern et al. (<A HREF="#B67">67</A>) demonstrated<SUP> </SUP>this
phenomenon by comparison of glucose uptake in excised strips<SUP> </SUP>of rat
skeletal muscles with that by the same muscles subjected<SUP> </SUP>only to
anesthesia and hindlimb perfusion. Basal transport was<SUP> </SUP>lower and
maximum transport in response to insulin was higher<SUP> </SUP>in perfused
muscles, so that the glucose uptake ratio in response<SUP> </SUP>to insulin was
much higher in perfused than in excised muscles<SUP> </SUP>(15&nbsp;vs. 2.5&nbsp;in soleus;
9.8&nbsp;vs. 2.3&nbsp;in extensor digitorum longus).<SUP> </SUP>Some investigators are now
preincubating excised skeletal muscle<SUP> </SUP>for 30&nbsp;min or longer, during
which time it is hypothesized that<SUP> </SUP>the abnormally high density of
plasma membrane GLUT (in response<SUP> </SUP>to the stimuli of anesthesia and
excision) is reduced to normal,<SUP> </SUP>perhaps by recycling of surface GLUT.
Glucose transport measurements<SUP> </SUP>after preincubation are then lower and
approach those of muscle<SUP> </SUP>in<SUP> </SUP>situ.
    </P>
    


    


    

    


<P><I>Prandial State</I>
</P>


    


<P><I>Glucose absorption.</I>


    
    Readers are referred to reviews for further details (<A HREF="#B41">41</A>, <A HREF="#B59">59</A>, <A HREF="#B64">64</A>, <A HREF="#B93">93</A>).
Glucose in the gut is absorbed mainly in the<SUP> </SUP>jejunum and ileum, by two
routes: transcellular and paracellular.<SUP> </SUP>The paracellular route is
across the tight junction between enterocytes,<SUP> </SUP>into lateral clefts
between cells. The transcellular route was<SUP> </SUP>described above, via SGLT
and GLUT-2. An increase in dietary carbohydrate<SUP> </SUP>increases glucose
absorption from small intestinal segments via<SUP> </SUP>an unknown path that
leads to an increase in the number of SGLT<SUP> </SUP>in the brush-border membrane
(<A HREF="#B40">40</A>, <A HREF="#B64">64</A>). It is inferred that<SUP> </SUP>SGLT-1, by successive exo- and
endocytosis, cycles between the<SUP> </SUP>interior and the plasma membrane.
Little is known yet about this<SUP> </SUP>cycling process (<A HREF="#B41">41</A>). High concentration
of glucose in the gut<SUP> </SUP>lumen also increases paracellular glucose
transport by an unknown<SUP> </SUP>mechanism, possibly by a cascade of signals
from brush-border<SUP> </SUP>SGLT, which may be the only available glucose sensor
(<A HREF="#B93">93</A>).
    </P>
    

    
    Translocation through GLUT-2 in the basolateral membrane is increased
by hyperglycemia within 30&nbsp;min by an unknown mechanism<SUP> </SUP>(<A HREF="#B24">24</A>). Increase
in glucose transport exceeds the increase in<SUP> </SUP>number of GLUTs, so that
it was suggested that the intrinsic transport<SUP> </SUP>activity of GLUT was
increased as well as the GLUT number. There<SUP> </SUP>is also a slow increase in
basolateral GLUT number after ~3 days<SUP> </SUP>in response to increased
dietary carbohydrate (<A HREF="#B23">23</A>), probably<SUP> </SUP>due to increased message and
synthesis, combined with slow migration<SUP> </SUP>of enterocyte from the crypt.
Paths for stimulating this GLUT<SUP> </SUP>response are<SUP> </SUP>unknown.
    </P>
    


    

    


<P><I>Effect of prandial hyperglycemia: insulin-dependent and -independent
glucose uptake.</I>


    
    Glucose absorption generates the familiar prandial blood glucose curve.
The rapidity of rise in blood glucose concentration<SUP> </SUP>and the height of
its maximum concentration depend on the rate<SUP> </SUP>at which the stomach
empties its contents, because most glucose<SUP> </SUP>absorption occurs in the
jejunum and ileum. The rate of gastric<SUP> </SUP>emptying is well controlled.
Teleologically, it makes sense that<SUP> </SUP>hypoglycemia actually accelerates
gastric emptying and hyperglycemia<SUP> </SUP>retards it. Two peptides decrease
the rate of gastric emptying:<SUP> </SUP>glucagon-like polypeptide-1 (GLP-1) (123,&nbsp;and for review 37) and<SUP> </SUP>amylin (<A HREF="#B127">127</A>). It is suggested that the effect of
GLP-1 on gastric<SUP> </SUP>emptying is mediated via vagal afferents (<A HREF="#B61">61</A>). Amylin
is a peptide<SUP> </SUP>hormone, cosecreted with insulin from pancreatic
<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">-cells. Its<SUP> </SUP>mode of action is not<SUP> </SUP>known.
    </P>
    

    
    Hyperglycemia declines as glucose is transferred from interstitial
fluid into cells. Baron et al. (<A HREF="#B11">11</A>) and, later, Bergman<SUP> </SUP>[Best et
al. (<A HREF="#B16">16</A>)] emphasized that there are two components<SUP> </SUP>to this
increased glucose uptake, an insulin-dependent and an<SUP> </SUP>insulin-independent component. It is not simple to establish the<SUP> </SUP>relative contribution of the two components, and there is some<SUP> </SUP>disagreement about the quantitative estimates. Bergman calls the<SUP> </SUP>process of insulin-independent glucose uptake glucose effectiveness,<SUP> </SUP>but a more fitting designation is "GLUT effectiveness," for the<SUP> </SUP>following<SUP> </SUP>reason.
    </P>
    

    
    Increased glucose uptake has to occur with hyperglycemia, without
intervention of hormones, simply because the glucose concentration<SUP> </SUP>gradient from interstitial fluid to cytoplasm is greater, and<SUP> </SUP>increased
facilitated diffusion must occur via all GLUTs that<SUP> </SUP>are not saturated,
unless hexokinase is limiting. The two tissues<SUP> </SUP>that do not increase
glucose uptake in response only to increased<SUP> </SUP>glucose delivery are brain
and, in humans, skeletal muscle (<A HREF="#B5">5</A>).<SUP> </SUP>Brain does not respond to
hyperglycemia because its GLUT-3 has<SUP> </SUP>so small a
<I>K</I><SUB>m</SUB> value that it
is saturated at euglycemic levels.<SUP> </SUP>In situ, muscles of the forearm in
humans do not increase glucose<SUP> </SUP>uptake when the local (but not systemic)
forearm arterial blood<SUP> </SUP>glucose level is raised to a steady value of
10-15 mM, presumably<SUP> </SUP>because GLUT density in the basal state is so
small (<A HREF="#B5">5</A>). In<SUP> </SUP><font size=-1>METHODS FOR STUDYING GLUCOSE METABOLISM</font>
<font size=-1>IN VIVO</font>, I wrote that<SUP> </SUP>a powerful asset of the forearm
input-output technique lies in<SUP> </SUP>use of constant infusion into the
brachial artery to produce effective<SUP> </SUP>local forearm concentrations of
the injected material, which are<SUP> </SUP>then rendered impotent to have
systemic effects because the infusate<SUP> </SUP>is diluted by ~100-fold when
venous effluent from the forearm<SUP> </SUP>mixes with blood in the central
circulation. I have been able<SUP> </SUP>to locate only one report, an abstract,
in which this technique<SUP> </SUP>was used to inquire into the effect of a purely
local limb hyperglycemic<SUP> </SUP>input (<A HREF="#B5">5</A>). In six healthy young adult men,
brachial arterial<SUP> </SUP>glucose concentration was increased by ~50, 100,&nbsp;and 200% above<SUP> </SUP>normal by continuous infusion into the brachial artery.
There<SUP> </SUP>was no effect on forearm blood flow (hand excluded from
circulation)<SUP> </SUP>or on glucose a-v concentration difference in blood
draining forearm<SUP> </SUP>muscle; that is, there was no effect on forearm muscle
glucose<SUP> </SUP>uptake, indicating that forearm muscle plasma membrane GLUTs
were<SUP> </SUP>saturated at least at and above the normal blood glucose
concentration.<SUP> </SUP>There are a number of reports from which authors have
concluded<SUP> </SUP>that human skeletal muscle in situ does increase glucose
uptake<SUP> </SUP>in response to increased glucose delivery, and these authors
have<SUP> </SUP>suggested that this is a mass action effect of
glucose. However,<SUP> </SUP>in all these reports, the observations
were carried out under<SUP> </SUP>hyperglycemic clamp conditions; that is, the
entire body was perfused<SUP> </SUP>with abnormally high glucose concentration.
Therefore, no conclusion<SUP> </SUP>can be drawn from this sort of experiment as
to whether the increased<SUP> </SUP>glucose uptake, either by the whole body or by
input-output measurement<SUP> </SUP>of leg glucose uptake, was due to a local
mass-action effect of<SUP> </SUP>hyperglycemia on glucose uptake. This criticism
is true even for<SUP> </SUP>those experiments in which the hyperglycemic glucose
clamp study<SUP> </SUP>used somatostatin to block pancreatic <IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">-cell insulin
release (<A HREF="#B16">16</A>).<SUP> </SUP>Increased glucose uptake in humans in response to
systemic hyperglycemia<SUP> </SUP>has two causes. One is the increased glucose
concentration gradient<SUP> </SUP>available for facilitated diffusion via GLUT in
tissues other<SUP> </SUP>than brain. The other may be explained by a report that,
in rat<SUP> </SUP>skeletal muscle, glucose uptake increases with glucose infusion<SUP> </SUP>and systemic hyperglycemia even when insulin concentration is<SUP> </SUP>maintained constant. This increased glucose uptake is associated<SUP> </SUP>with
an approximate doubling of muscle plasma membrane GLUT-4;<SUP> </SUP>that is, it
appears that hyperglycemia in the rat can initiate<SUP> </SUP>signals, apart from
insulin, to translocate GLUT-4 to the muscle<SUP> </SUP>plasma membrane (<A HREF="#B44">44</A>). The
hyperglycemic signal to increase muscle<SUP> </SUP>surface GLUT therefore appears
to be systemic and not<SUP> </SUP>local.
    </P>
    

    
    The first stimuli for insulin release from pancreatic <IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">-cells are a
family of peptides, incretins, related in their amino<SUP> </SUP>acid sequences,
that include glucose-dependent insulinotropic<SUP> </SUP>polypeptide, GLP-1,
glucagon, vasoactive intestinal peptide, and<SUP> </SUP>pituitary adenylate
cyclase-activating peptide. Of these, perhaps<SUP> </SUP>the most potent is GLP-1
(<A HREF="#B121">121</A>). Incretins are released into the<SUP> </SUP>circulation in response to food,
primarily carbohydrate and long-chain<SUP> </SUP>fatty acids, in the gut. With
absorption of glucose and ensuing<SUP> </SUP>hyperglycemia, more insulin is
released, beginning at ~8 mM blood<SUP> </SUP>glucose and increasing as blood
glucose concentration increases<SUP> </SUP>up to a maximum, reached within
30-60 min, from which it falls<SUP> </SUP>with a second, smaller peak, often
obscured by fusion with the<SUP> </SUP>downlimb of the first surge of insulin.
Plasma insulin concentration<SUP> </SUP>then continues to fall to the upper range
of normal basal and<SUP> </SUP>then falls slowly during the intermediate and late
postprandial<SUP> </SUP>period. During the rising and peak portions of the blood
insulin<SUP> </SUP>concentration curve, blood levels of GH decrease, even to
immeasurably<SUP> </SUP>small concentrations. GH, glucagon, <IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">-adrenergic
agonists, and<SUP> </SUP>cortisol are released into the circulation at some point
on the<SUP> </SUP>downlimb of falling blood glucose concentration, reported to be<SUP> </SUP>~1.6 mM below the subject's basal level, that is, 3.3&nbsp;mM or less<SUP> </SUP>(<A HREF="#B31">31</A>). These agents act to prevent or reverse insulin-induced<SUP> </SUP>hypoglycemia (for review see Ref. <A HREF="#B28">28</A>). Of these agents the most<SUP> </SUP>important is glucagon, which stimulates endogenous glucose production.<SUP> </SUP>The incretin GLP-1 has multiple roles; not only does it stimulate<SUP> </SUP>insulin release, but it also inhibits glucagon release, thereby<SUP> </SUP>tending
to delay hepatic<SUP> </SUP>glycogenolysis.
    </P>
    

    
    When hyperinsulinemia becomes sufficiently high, the insulin-receptor
complex in adipocytes and in cardiac and skeletal muscle<SUP> </SUP>initiates a
transduction chain that results in translocation of<SUP> </SUP>intracellular
vesicles to fuse with the plasma membrane. Laced<SUP> </SUP>in the walls of these
vesicles are GLUTs, GLUT-1 and GLUT-4 in<SUP> </SUP>adipocytes, but almost
exclusively GLUT-4 in skeletal muscle (for<SUP> </SUP>reviews see
Refs. <A HREF="#B73">73</A> and <A HREF="#B75">75</A>). All studies in which insulin-stimulated<SUP> </SUP>increases in
glucose uptake and insulin-stimulated increase in<SUP> </SUP>cell surface GLUT
have both been measured find that the relative<SUP> </SUP>increase in glucose
uptake exceeds that of plasma membrane GLUT.<SUP> </SUP>In particular, the
increase in plasma membrane GLUT-1 has always<SUP> </SUP>been reported to be
substantially less than the proportionate<SUP> </SUP>increase in glucose uptake.
When plasma membrane GLUTs were assessed<SUP> </SUP>by first subjecting the cells
to subcellular fractionation by<SUP> </SUP>density gradient centrifugation,
insulin-induced increase in plasma<SUP> </SUP>membrane GLUT-4 was always, and
usually substantially, less than<SUP> </SUP>the proportionate increase in glucose
uptake. With availability<SUP> </SUP>of an impermeant bismannose photolabeling
method (<A HREF="#B25">25</A>), it became<SUP> </SUP>unnecessary to subject cells to subcellular
fractionation, and<SUP> </SUP>reported values of insulin-induced increases in
plasma membrane<SUP> </SUP>GLUT-4 in a few, but not most, studies were reported as
~80% of<SUP> </SUP>the degree of increase in glucose uptake by rat adipocytes
(<A HREF="#B57">57</A>,<SUP> </SUP><A HREF="#B77">77</A>) and by 3T3-L1 adipose-like cells (<A HREF="#B20">20</A>). There are no reports<SUP> </SUP>that the increase in plasma membrane GLUT-4 is proportionately<SUP> </SUP>greater
than that of glucose<SUP> </SUP>uptake.
    </P>
    

    
    It is shown by a model-free analysis of a system in which
<font size=-1>D</font>-glucose cannot enter a cell
except via a GLUT and in which it<SUP> </SUP>must enter the cell only by either
GLUT-1 or GLUT-4, that if the<SUP> </SUP>increase in plasma membrane GLUT-1
induced by insulin is proportionately<SUP> </SUP>less than that of glucose uptake,
which is in fact the case in<SUP> </SUP>all reports, then the increase in plasma
membrane GLUT-4 must<SUP> </SUP>be greater than that of glucose uptake, unless
insulin also increases<SUP> </SUP>the intrinsic activity of one or both GLUT
isoforms to transport<SUP> </SUP>glucose (<A HREF="#B131">131</A>). Analysis of available reports in
which plasma<SUP> </SUP>membrane densities of both GLUT isoforms and glucose
uptake were<SUP> </SUP>measured led to an estimate that the relative increase in
GLUT-4<SUP> </SUP>would have to have been about 4&nbsp;times greater than actually
observed<SUP> </SUP>if insulin increased glucose uptake only by translocating
glucose<SUP> </SUP>to the cell surface, and that insulin-stimulated increase in
plasma<SUP> </SUP>membrane GLUT intrinsic activity accounted for at least one-half<SUP> </SUP>of the observed increase in glucose uptake (<A HREF="#B131">131</A>). This suggests<SUP> </SUP>the
possibility that GLUTs, at least GLUT-4 and possibly GLUT-1,<SUP> </SUP>in the
plasma membrane exist in at least two stable configurations,<SUP> </SUP>and that,
similar to gated ion channels, they can undergo change<SUP> </SUP>of state from
one configuration to another, in which their ability<SUP> </SUP>to transport
glucose is increased in response to insulin and perhaps<SUP> </SUP>to other<SUP> </SUP>stimuli.
    </P>
    

    
    In humans under glucose clamp experiments, 75% of estimated whole body
insulin-mediated glucose uptake during euglycemia is<SUP> </SUP>into skeletal
muscle, and 95% is during hyperglycemia (<A HREF="#B11">11</A>).
    </P>
    

    
    The question of whether insulin, under physiological conditions,
increases blood flow to skeletal muscle, and whether this<SUP> </SUP>increased
flow is an additional cause of increased glucose uptake,<SUP> </SUP>is
controversial. Blood flow of resting skeletal muscle is relatively<SUP> </SUP>small and distributed heterogeneously so that some regions are<SUP> </SUP>metabolizing anaerobically, producing lactate to account for about<SUP> </SUP>one-half the muscle glucose uptake (<A HREF="#B3">3</A>). It is conjectured that<SUP> </SUP>although
about one-half the muscle fibers are not perfused at<SUP> </SUP>rest,
survival of fibers requires that no fiber is underperfused<SUP> </SUP>for long, at
most only a few minutes. We envision skeletal muscle<SUP> </SUP>circulation as
continuously redistributed among resting fibers,<SUP> </SUP>so that there are
scanning waves of alternating vasoconstriction<SUP> </SUP>and dilatation (<A HREF="#B3">3</A>). We
suppose that this parsimonious blood<SUP> </SUP>flow to resting muscle is a device
for minimizing resting cardiac<SUP> </SUP>output and the work of the heart. There
is similar, but less extreme,<SUP> </SUP>distribution of blood flow to the
myocardium. Unlike the case<SUP> </SUP>for skeletal muscle, heterogeneity of
coronary flow to the normal<SUP> </SUP>beating heart can be relatively stable, for
as long as a day.<SUP> </SUP>Deussen (<A HREF="#B33">33</A>) studied heterogeneity of blood flow and
of glucose<SUP> </SUP>uptake in the dog heart and concluded that variations in
local<SUP> </SUP>blood flow cannot explain the differences in local glucose<SUP> </SUP>uptake.
    </P>
    

    
    Insulin stimulates nitric oxide (NO) synthase in vascular endothelium
(<A HREF="#B105">105</A>, <A HREF="#B112">112</A>) and therefore is capable of vasodilating.<SUP> </SUP>Baron and his
colleagues (for review of publications from their<SUP> </SUP>laboratory see Refs.
<A HREF="#B11">11</A> and <A HREF="#B12">12</A>) have a series of reports that<SUP> </SUP>insulin, administered by
continuous intravenous infusion for hours,<SUP> </SUP>increases leg blood flow.
Laakso et al. (<A HREF="#B77">77</A>) obtained insulin-leg<SUP> </SUP>blood flow dose-response curves
and reported that, in normal young<SUP> </SUP>men, the maximum effect, an ~70%
increase in leg blood flow, occurred<SUP> </SUP>at a systemic circulating serum
insulin concentration of ~600<SUP> </SUP>pM (100&nbsp;mU/ml). Half-maximum response
occurred at ~300 pM (50<SUP>&nbsp;</SUP>mU/ml).
    </P>
    

    
    It has been questioned whether this mechanism for increasing blood flow
to an arm or a leg is physiological, for the following<SUP> </SUP>reasons:
<I>1</I>) The effect of insulin on blood
flow is remarkably<SUP> </SUP>slow. In a euglycemic hyperinsulinemic clamp study
in which serum<SUP> </SUP>insulin concentration was held at ~530 pM, leg blood
flow had<SUP> </SUP>not quite reached its full response after 4&nbsp;h (<A HREF="#B77">77</A>).
Insulin-induced<SUP> </SUP>increase in limb blood flow has been confirmed when
insulin is<SUP> </SUP>administered intravenously, usually in hyperinsulinemic
glucose<SUP> </SUP>clamp studies, but only after <I>hours
4-6</I> (<A HREF="#B125">125</A>). This delay suggests<SUP> </SUP>two grounds for
concern about the physiological significance of<SUP> </SUP>the observation. First,
at no time during the course of a day<SUP> </SUP>is there normal hyperinsulinemia
for a period as long as 4&nbsp;h;<SUP> </SUP>prandial hyperinsulinemia is transient; it
reaches a peak in about<SUP> </SUP>half an hour or so after a glucose meal, the
peak is sustained<SUP> </SUP>for perhaps 15&nbsp;min, and the total duration of
prandial hyperinsulinemia<SUP> </SUP>is <IMG SRC="/math/12pt/normal/le.gif" ALIGN=MIDDLE ALT="&lt;= ">2 h, most of it below insulin levels
found to affect blood<SUP> </SUP>flow when administered by close arterial
injection. Interpolation<SUP> </SUP>of the data of Laakso et al. (<A HREF="#B77">77</A>) suggests
that maximum transient<SUP> </SUP>prandial hyperinsulinemia would be expected to
increase limb blood<SUP> </SUP>flow, if at all, by &lt;10% in the time available
for an effect,<SUP> </SUP>a value unlikely to be demonstrable by present methods.
Second,<SUP> </SUP>if the mechanism by which insulin increases blood flow to an
arm<SUP> </SUP>or a leg is stimulation of NO synthase in endothelium of limb<SUP> </SUP>vasculature, why is there such a delay? Other vasoactive agents<SUP> </SUP>administered intra-arterially act almost immediately and can produce<SUP> </SUP>much greater increase in local blood flow, for example, infusion<SUP> </SUP>of
adenosine into a brachial artery (<A HREF="#B89">89</A>) and infusion of sodium<SUP> </SUP>nitroprusside (<A HREF="#B90">90</A>). Although it has been demonstrated that
administration<SUP> </SUP>of <I>N</I>-monomethyl-<font size=-1>L</font>-arginine, a
competitive inhibitor of NO synthase,<SUP> </SUP>prevents increased blood flow
otherwise seen with intravenous<SUP> </SUP>insulin after several hours, the delay
of limb vasodilator response<SUP> </SUP>to sustained intravenous insulin suggests
that insulin sets in<SUP> </SUP>motion some systemic response that leads to
increased limb blood<SUP> </SUP>flow under these artificial conditions; that is,
the increased<SUP> </SUP>limb blood flow in the presence of several hours of
intravenous<SUP> </SUP>insulin infusion is unlikely to be attributable to a direct
action<SUP> </SUP>of insulin on resistance vessels in the limb.
<I>2</I>) The second kind<SUP> </SUP>of observation
that questions the physiological verisimilitude<SUP> </SUP>of reported limb
vasodilatation in response to several hours of<SUP> </SUP>intravenous insulin is
that, when insulin is administered by close<SUP> </SUP>intra-arterial infusion,
there is either no vasodilatation at<SUP> </SUP>a small dose of insulin or a
relatively small increase, ~20%,<SUP> </SUP>in blood flow after several hours
of a large dose (see Refs. <A HREF="#B115">115</A><SUP> </SUP>and <A HREF="#B125">125</A> for additional references).
Reexamination of our data<SUP> </SUP>on insulin effect on brachial arterial blood
flow fails to show<SUP> </SUP>an effect of insulin, although a 10%, and in some
instances even<SUP> </SUP>a 20%, change in blood flow could not be detected (<A HREF="#B2">2</A>,
<A HREF="#B135">135</A>).<SUP> </SUP>We infused insulin at constant rate into a brachial artery for<SUP> </SUP>only 26&nbsp;min, less time than has been necessary to demonstrate<SUP> </SUP>insulin-induced increased blood flow, but with that infusion,<SUP> </SUP>forearm
glucose uptake increased by 14-fold. When increased limb<SUP> </SUP>blood flow has
been observed to accompany longer intra-arterial<SUP> </SUP>infusions of insulin,
unfortunately in none of the experiments<SUP> </SUP>has the recirculating insulin
concentration been measured. Because<SUP> </SUP>only 10-20% of
intra-arterial insulin is extracted by forearm<SUP> </SUP>tissues, recirculating
insulin concentration could become significantly<SUP> </SUP>high after several
hours, so that it is possible that, even when<SUP> </SUP>intra-arterial insulin
infusion does lead to increased flow, the<SUP> </SUP>vasodilator may have been
produced in response to systemic, rather<SUP> </SUP>than local, hyperinsulinemia.
Again, if limb muscle vasodilatation<SUP> </SUP>in response to insulin is caused
by NO synthesized by muscle vascular<SUP> </SUP>endothelium, why is there no, or
only slight, vasodilatation in<SUP> </SUP>response to intra-arterial<SUP> </SUP>infusion?
    </P>
    

    
    This is a review of glucose metabolism, not of insulin actions. Our
concern here is only to address the question of whether<SUP> </SUP>an increase in
blood flow can be responsible for increased local<SUP> </SUP>glucose uptake.
Yki-Jarvinen and Utriainen (<A HREF="#B125">125</A>) point out that<SUP> </SUP>there is increased
forearm glucose uptake in response to intra-arterial<SUP> </SUP>insulin infusion
within minutes, whereas, they say, a vasodilating<SUP> </SUP>response to
intravenous insulin requires some 4-6 h. Furthermore,<SUP> </SUP>the
responses are disproportionate: more than a 10-fold increase<SUP> </SUP>in glucose
uptake for, at most, a doubling of blood flow. Limb<SUP> </SUP>blood flow can be
increased by other means, for example by intra-arterial<SUP> </SUP>infusion of
adenosine (<A HREF="#B89">89</A>) or of sodium nitroprusside (<A HREF="#B90">90</A>),<SUP> </SUP>with no effect on
glucose uptake. However, Baron (<A HREF="#B10">10</A>) proposes<SUP> </SUP>that there is
nonnutritive blood flow to skeletal muscle, functional<SUP> </SUP>arteriovenous
shunts, and that insulin vasodilates potentially<SUP> </SUP>nutritive arterioles,
thereby recruiting capillary beds and increasing<SUP> </SUP>capillary surface
through which glucose can diffuse into interstitial<SUP> </SUP>fluid. Baron's
conjecture has received some experimental support<SUP> </SUP>by Vicini et al.
(<A HREF="#B118">118</A>), who used positron emission tomography<SUP> </SUP>(PET) to estimate regional
blood flow distribution in the leg<SUP> </SUP>before and during euglycemic,
hyperinsulinemic clamp. They conclude<SUP> </SUP>that, although they could not
detect an insulin effect on the<SUP> </SUP>relative dispersion of blood flow, the
data suggested that insulin<SUP> </SUP>vasodilated fewer perfused areas to a
greater degree. A similar<SUP> </SUP>technique was used by Raitakari et al. (<A HREF="#B98">98</A>)
and by Utriainen<SUP> </SUP>et al. (<A HREF="#B117">117</A>). The latter group asked if the degree of
glucose<SUP> </SUP>uptake in small regions of femoral muscle correlated with the<SUP> </SUP>blood flow to the region. Analysis of PET in the basal state showed<SUP> </SUP>no
colocalization of the flow marker
[<SUP>15</SUP>O]H<SUB>2</SUB>O
and the glucose marker
[<SUP>18</SUP>F]-2-deoxy-<font size=-1>D</font>-glucose
([<SUP>18</SUP>F]2-DG), both
given by intravenous infusion. When insulin was<SUP> </SUP>given intravenously for
60&nbsp;min, there was a 30% increase in blood<SUP> </SUP>flow, increased
heterogeneity (a larger standard deviation about<SUP> </SUP>the mean flow), but
about the same coefficient of variance as<SUP> </SUP>in the basal state, and
regions of increased flow colocalized<SUP> </SUP>with regions of increased glucose
uptake. This colocalization<SUP> </SUP>is not surprising. I referred earlier to
evidence that GLUTs in<SUP> </SUP>forearm muscle do not increase
glucose uptake in response to glucose<SUP> </SUP>load created by increasing the
local forearm blood glucose concentration,<SUP> </SUP>and that this implies that
skeletal muscle surface GLUTs in the<SUP> </SUP>basal state are in such low
concentration that they are saturated<SUP> </SUP>at normal blood glucose
concentration (<A HREF="#B5">5</A>). If this is correct,<SUP> </SUP>then an increase in glucose
delivery caused by increasing local<SUP> </SUP>blood flow to muscle should not
increase glucose uptake, unless<SUP> </SUP>the increased blood flow were to
regions not previously perfused.<SUP> </SUP>We assume, then, that when forearm
intra-arterial infusion of<SUP> </SUP>vasodilators, such as adenosine and sodium
nitroprusside, increases<SUP> </SUP>blood flow but does not increase glucose
uptake, there has not<SUP> </SUP>been increased flow to previously underperfused
regions, and that<SUP> </SUP>when intravenous insulin ultimately causes increased
muscle blood<SUP> </SUP>flow and increased glucose uptake, in addition to
insulin's recruitment<SUP> </SUP>of GLUTs to the muscle surface (which long
precedes increased<SUP> </SUP>blood flow), there may now be improved perfusion of
previously<SUP> </SUP>underperfused regions in which muscle surface GLUTs had not
previously<SUP> </SUP>been<SUP> </SUP>saturated.
    </P>
    

    
    Although an increase in limb blood flow in response to intravenous
insulin has been correlated with insulin-stimulated glucose<SUP> </SUP>uptake, the
time course of the two responses is different. With<SUP> </SUP>a hyperinsulinemic
clamp, increased glucose uptake is at half-maximum<SUP> </SUP>in ~40 min;
increased limb blood flow is at half-maximum in ~100<SUP> </SUP>min (<A HREF="#B77">77</A>). This
sizable difference in time course makes it unlikely<SUP> </SUP>that increased
blood flow, even under these artificial conditions,<SUP> </SUP>had any role in
increased glucose uptake. Utriainen et al. (<A HREF="#B117">117</A>)<SUP> </SUP>studied a group of
normal men and a group of men with non-insulin-dependent<SUP> </SUP>diabetes
mellitus (NIDDM) who were resistant to insulin with respect<SUP> </SUP>to glucose
uptake. Mean blood flow and the dispersion of blood<SUP> </SUP>flow, both in the
basal state and in response to hyperinsulinemic<SUP> </SUP>clamp, were the same in
the two groups, although glucose uptake<SUP> </SUP>by the diabetic group in
response to insulin was subnormal. It<SUP> </SUP>can be concluded that, at least
in this group of diabetic patients,<SUP> </SUP>the increase in limb blood flow and
its distribution in response<SUP> </SUP>to systemic insulin were insufficient to
cause increased glucose<SUP> </SUP>uptake.
    </P>
    

    
    In summary, although circumstances can be established in which insulin
increases blood flow to skeletal muscle, these circumstances<SUP> </SUP>are not
physiological. Insulin infused intra-arterially for sufficiently<SUP> </SUP>long
to increase forearm glucose uptake does not increase forearm<SUP> </SUP>blood
flow, or produces only a small increase. Furthermore,
insulin-stimulated<SUP> </SUP>glucose uptake occurs more rapidly than the increase
in blood<SUP> </SUP>flow. Critical experiments are still needed to settle the
question<SUP> </SUP>of the role, if any, of insulin-stimulated vasodilatation. If<SUP> </SUP>our concept of the distribution of muscle blood flow is correct,<SUP> </SUP>waves
of asynchronous vasoconstriction, alternating with vasodilatation,<SUP> </SUP>scan
muscle so that at any instant about one-half the muscle fibers<SUP> </SUP>are
forced to metabolize anaerobically. What we may need is an<SUP> </SUP>instrument
not yet invented, a cinematic PET, to inform us about<SUP> </SUP>blood flow
distribution and glucose uptake distribution as functions<SUP> </SUP>of<SUP> </SUP>time.
    </P>
    

    
    Although there is evidence that insulin stimulates NO synthesis in
endothelial cells, and that this NO may vasodilate and<SUP> </SUP>increase blood
flow, there are reports that NO can have effects<SUP> </SUP>on glucose uptake
independent of blood flow. Excised rat skeletal<SUP> </SUP>muscle was exposed to
either a maximum concentration of insulin<SUP> </SUP>or to electrical stimulation
to contraction. A NO synthase inhibitor<SUP> </SUP>decreased basal and
exercise-stimulated glucose uptake but had<SUP> </SUP>no effect on
insulin-stimulated glucose uptake. Addition of the<SUP> </SUP>NO donor, Na
nitroprusside, increased basal glucose uptake; this<SUP> </SUP>effect was additive
to the effects of submaximal and maximal insulin<SUP> </SUP>concentrations (<A HREF="#B8">8</A>). In
a related report, two NO donors increased<SUP> </SUP>basal glucose uptake of
excised rat soleus muscle. This effect<SUP> </SUP>was additive to and independent
of insulin concentration-dependent<SUP> </SUP>increase in glucose uptake (<A HREF="#B128">128</A>).
These reports support the conjecture<SUP> </SUP>that insulin and exercise act on
separate GLUT pools. It is further<SUP> </SUP>suggested that NO might be produced
by skeletal muscle during<SUP> </SUP>contraction, and perhaps also during hypoxia,
which (see below)<SUP> </SUP>seems to draw on the same GLUT pool as<SUP> </SUP>contraction.
    </P>
    

    
    When insulin concentration is high and glucagon and epinephrine
concentrations are low, hepatic and renal glycogenolysis and<SUP> </SUP>gluconeogenesis cease. Whereas in the basal state little or none<SUP> </SUP>of
skeletal muscle glucose uptake can be accounted for by glycogen<SUP> </SUP>deposition, in response to insulin <IMG SRC="/math/12pt/normal/ge.gif" ALIGN=BASELINE ALT="&gt;= ">70% of glucose uptake is
accounted<SUP> </SUP>for by an increase in muscle glycogen (<A HREF="#B2">2</A>, <A HREF="#B107">107</A>).
    </P>
    


    

    


<P><I>Insulin stimulates much greater multiples of increase in skeletal
muscle glucose uptake in the intact subject than in excised muscle or
its membrane fractions.</I>


    
    As stated earlier in <I>Difference between in vivo and in vitro muscle
glucose uptake,</I> basal glucose uptake in excised muscle<SUP> </SUP>is much
greater, probably artifactually, than in normally perfused<SUP> </SUP>muscle in
situ. It is not surprising, then, to find that in excised<SUP> </SUP>skeletal
muscle preparations (<A HREF="#B120">120</A>, <A HREF="#B132">132</A>) or plasma membrane vesicles<SUP> </SUP>from
skeletal muscle (<A HREF="#B48">48</A>), insulin increases glucose uptake<SUP> </SUP>by only about 2-&nbsp;to 3-fold compared with a 5-fold (<A HREF="#B74">74</A>) to 15-fold<SUP> </SUP>(<A HREF="#B67">67</A>) increase in
glucose uptake in perfused hindlimb muscles<SUP> </SUP>of the rat, anesthetized
and exposed to a surgical procedure,<SUP> </SUP>and compared with an ~15-fold
increase by forearm muscles of a<SUP> </SUP>human in response to constant
intrabrachial artery insulin infusion<SUP> </SUP>(<A HREF="#B135">135</A>). These observations
emphasize the fallacy of relying on<SUP> </SUP>multiples of increase to compare
effectiveness of various<SUP> </SUP>agents.
    </P>
    


    

    


<P><I>Role of fatty acids in modifying glucose metabolism.</I>


    
    <font size=-1>ON GLUCOSE UPTAKE. </font>On the basis of their observation that
FFA decreased carbohydrate (CHO) oxidation in rat diaphragm and<SUP> </SUP>perfused heart, Randle et al. (<A HREF="#B99">99</A>) proposed, in 1963,&nbsp;that circulating<SUP> </SUP>FFA led to increased FFA uptake, increased FFA metabolism with<SUP> </SUP>increased production of acetyl-CoA and citrate, followed by the<SUP> </SUP>known
acetyl-CoA inhibition of pyruvate dehydrogenase, which decreases<SUP> </SUP>glucose oxidation, and the known citrate inhibition of
phosphofructokinase,<SUP> </SUP>thereby blocking glycolysis (<A HREF="#B99">99</A>). This process was
considered<SUP> </SUP>to proceed independently of any hormonal control. It has
been<SUP> </SUP>confirmed repeatedly that an increase in plasma FFA increases<SUP> </SUP>fat
oxidation and decreases CHO oxidation and that this occurs<SUP> </SUP>in
proportion to the plasma concentration of FFA over its physiological<SUP> </SUP>concentration range (<A HREF="#B18">18</A>). However, there is disagreement as<SUP> </SUP>to whether
the Randle cycle is the underlying mechanism. It is<SUP> </SUP>generally agreed
that, in the presence of high plasma FFA, insulin-stimulated<SUP> </SUP>glucose
uptake is reduced. Resistance to insulin in patients with<SUP> </SUP>NIDDM has
been associated with high plasma FFA concentration (<A HREF="#B51">51</A>).<SUP> </SUP>Mechanisms
underlying this insulin resistance are unknown. In<SUP> </SUP>rats on a high-fat
diet, plasma insulin concentration was higher<SUP> </SUP>than in rats fed a
high-CHO diet, presumably a reactive hyperinsulinemia<SUP> </SUP>in response to
peripheral resistance to insulin. GLUT-2 and glucokinase<SUP> </SUP>mRNA levels in
pancreas from high fat-fed rats were only one-half<SUP> </SUP>as great as in high
CHO-fed rats, suggesting the possibility that<SUP> </SUP>hyperglycemic signaling
to insulin release from <IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">-cells may be<SUP> </SUP>impaired in high fat-fed rats
(<A HREF="#B68">68</A>). Skeletal muscle from rats<SUP> </SUP>on a high-fat diet translocated as much
GLUT-4 to the plasma membrane<SUP> </SUP>but transported less glucose than rats on
a high-CHO diet, suggesting<SUP> </SUP>that the effect was on the hypothetical
activation of surface<SUP> </SUP>membrane GLUT rather than on its transport (<A HREF="#B103">103</A>).
Most recently,<SUP> </SUP>from hyperinsulinemic-euglycemic studies in conscious
rats infused<SUP> </SUP>with fatty acids, data appear to confirm that the Randle
glucose-fatty<SUP> </SUP>acid cycle is the predominant underlying mechanism for
FFA interference<SUP> </SUP>with insulin-stimulated glucose uptake (<A HREF="#B69">69</A>). In a
related study,<SUP> </SUP>fatty acids were infused into rats to maintain 24-h
elevation<SUP> </SUP>of plasma FFA. Under euglycemic-hyperinsulinemic clamp, there<SUP> </SUP>was less glucose uptake in the high-FFA group in response to insulin<SUP> </SUP>by
an unidentified mechanism (<A HREF="#B80">80</A>).
    </P>
    

    
    Perhaps the most compelling support of Randle's hypothesis (<A HREF="#B66">66</A>) in
humans comes from input-output studies of legs in healthy<SUP> </SUP>young adults,
coupled with analyses of biopsied muscle and euglycemic<SUP> </SUP>insulin clamps.
When FFA serum was kept constant during hyperinsulinemia<SUP> </SUP>by FFA
replacement, compared with findings when insulin was permitted<SUP> </SUP>to
reduce FFA levels, there was less glucose uptake, less glycogen<SUP> </SUP>stored
(i.e., reduced glycogen synthase activity), reduced leg<SUP> </SUP>respiratory
quotient, and reduced muscle pyruvate dehydrogenase<SUP> </SUP>activity, all in
line with Randle's<SUP> </SUP>hypothesis.
    </P>
    

    


<font size=-1>ON ENDOGENOUS GLUCOSE PRODUCTION.</font>

Insulin decreases or prevents net release of glucose from the liver,
and perhaps the kidney, by two mechanisms, direct and<SUP> </SUP>indirect.
</P>
Direct effects of insulin on liver and kidney are exerted by way of
insulin's actions on the insulin receptor, initiating<SUP> </SUP>transduction
cascades that lead to increased glycogen synthase<SUP> </SUP>activity and
decreased glycogenolysis (<A HREF="#B110">110</A>).
</P>
It was first observed in 1987,&nbsp;during studies of obese subjects, that
increased systemic insulin concentration, in the estimated<SUP> </SUP>absence of
increased portal venous insulin concentration, suppressed<SUP> </SUP>hepatic
glucose output (<A HREF="#B95">95</A>). The phenomenon was confirmed and<SUP> </SUP>demonstrated
convincingly in normal animals, including humans,<SUP> </SUP>by a series of
reports mainly from the laboratories of Giacca<SUP> </SUP>(McCall et al., 83),
Bergman (Mittleman et al., 86), and Cherrington<SUP> </SUP>(Sindelar et al., 108).
A contributory factor is insulin inhibition<SUP> </SUP>of glucagon release from
the<SUP> </SUP>pancreas.
</P>
There is general agreement that the major factor in insulin's indirect
suppression of endogenous glucose production is decreased<SUP> </SUP>plasma FFA
concentration, due to the antilipolytic effect of insulin<SUP> </SUP>on adipose
tissue. When fatty acid is infused during insulin administration<SUP> </SUP>so as
to maintain normal circulating FFA concentration, hepatic<SUP> </SUP>glucose
output is at least partly restored (<A HREF="#B78">78</A>, <A HREF="#B101">101</A>, <A HREF="#B109">109</A>).<SUP> </SUP>The mechanism by
which reduced FFA concentration suppresses hepatic<SUP> </SUP>glucose output is
unknown. Sindelar et al. (<A HREF="#B109">109</A>) report that<SUP> </SUP>increased peripheral insulin
concentration causes a small decrease<SUP> </SUP>in hepatic uptake of
gluconeogenic substrate, prevented by fatty<SUP> </SUP>acid infusion. This group
of investigators found increased intrahepatic<SUP> </SUP>lactate concentration
accompanying insulin-induced anti-lipolysis,<SUP> </SUP>and they propose that
decreased circulating FFA somehow suppress<SUP> </SUP>glucose-6-phosphatase
activity so that hepatic glycogenolysis<SUP> </SUP>results in increased lactate
production instead of the usual glucose<SUP> </SUP>production.
</P>
There is disagreement about the relative importance of the contribution
of the indirect effect of insulin in suppressing hepatic<SUP> </SUP>glucose
output. Bergman's group (<A HREF="#B86">86</A>) calculates that most of<SUP> </SUP>insulin-induced
suppression is indirect, whereas Cherrington's<SUP> </SUP>group (<A HREF="#B108">108</A>) calculates
that most of the effect is directly on<SUP> </SUP>the liver via the hepatic
insulin receptor. The two groups use<SUP> </SUP>different experimental designs.
Cherrington's design, including<SUP> </SUP>input-output measurements across the
portal circulation, glucose<SUP> </SUP>clamp, and pancreatic clamp (suppression of
insulin and glucagon<SUP> </SUP>secretion), provides more complete control of<SUP> </SUP>variables.
</P>


    


    


    




<BR CLEAR=ALL>
<A NAME="SEC6"><!-- null --></A>
<TABLE WIDTH=100% BGCOLOR=E1E1E1 CELLPADDING=0 CELLSPACING=0>
<TR>
<TD ALIGN=LEFT VALIGN=MIDDLE WIDTH=5% BGCOLOR=FFFFFF>&nbsp;<IMG WIDTH=10 HEIGHT=21 HSPACE=5 ALT="" SRC="/icons/toc/rarrow.gif"></TD>
<TH ALIGN=LEFT VALIGN=MIDDLE WIDTH=95%><FONT SIZE=+2>&nbsp;&nbsp;EXERCISE</FONT></TH>
</TR>
</TABLE>

<TABLE ALIGN=RIGHT CELLPADDING=5 BORDER NOWRAP><R>
<TH ALIGN=LEFT>
<FONT SIZE=-1>



<A HREF="#Top"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">Top</A>


<BR>
<A HREF="#Abstract"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">Abstract</A>


<BR>
<A HREF="#SEC1"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">SCOPE OF THE REVIEW</A>


<BR>
<A HREF="#SEC2"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">METHODS FOR STUDYING GLUCOSE...</A>


<BR>
<A HREF="#SEC3"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">GLUCOSE DISTRIBUTION AND...</A>


<BR>
<A HREF="#SEC4"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">GLUCOSE TRANSPORTERS:...</A>


<BR>
<A HREF="#SEC5"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">RELATION OF GLUCOSE METABOLISM...</A>


<BR><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/dot.gif"><FONT COLOR=46
4C53>EXERCISE</FONT>


<BR>
<A HREF="#SEC7"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/darrow.gif">HYPOXIA</A>


<BR>
<A HREF="#SEC8"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/darrow.gif">SUMMARY AND PROJECTION</A>


<BR>
<A HREF="#References"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/darrow.gif">References</A>
</FONT></TH>
</TR></TABLE>


    
    <P>In his century-old input-output studies of metabolism of the levator of
the upper lip of the horse, Chauveau caused exercise<SUP> </SUP>of that muscle by
feeding the horse oats (<A HREF="#B22">22</A>). He found increased<SUP> </SUP>blood flow, increased
glucose uptake, and, later, increased lipid<SUP> </SUP>uptake. Although there was
a lapse of about 70&nbsp;years before Chauveau's<SUP> </SUP>work was confirmed and
extended, it was well known in the 1940s<SUP> </SUP>that severe muscular work
caused a drop in blood glucose concentration<SUP> </SUP>(<A HREF="#B92">92</A>).
    </P>
    

    
    <P>Readers are referred to reviews for further details (<A HREF="#B49">49</A>, <A HREF="#B58">58</A>, <A HREF="#B122">122</A>).
During brief periods (e.g., ~20 min) of mild-to-moderate<SUP> </SUP>exercise,
glucose uptake increases but blood glucose concentration<SUP> </SUP>tends to
remain constant because endogenous glucose production<SUP> </SUP>matches the
increased uptake (<A HREF="#B54">54</A>, <A HREF="#B136">136</A>). During this period,<SUP> </SUP>insulin release is
inhibited, and glucagon and catecholamine releases<SUP> </SUP>are increased,
accounting for the increased hepatic glucose production.<SUP> </SUP>Despite
increased muscle glucose uptake, the RQ of exercising<SUP> </SUP>muscle, both leg
(<A HREF="#B54">54</A>) and forearm (<A HREF="#B136">136</A>) in humans, remains<SUP> </SUP>about the same as at rest,
between 0.68&nbsp;and 0.79,&nbsp;as does total<SUP> </SUP>body RQ, because FFA uptake is
also increased proportionately<SUP> </SUP>(<A HREF="#B136">136</A>). Despite increased muscle uptake,
plasma FFA levels rise<SUP> </SUP>during exercise (<A HREF="#B54">54</A>), perhaps due to decreased
plasma insulin<SUP> </SUP>with loss of its antilipolytic effect and to increased
circulating<SUP> </SUP>lipolytic agents (<A HREF="#B71">71</A>).
    </P>
    

    
    <P>It is difficult to study metabolism quantitatively during strenuous
exercise, because a steady state cannot be maintained<SUP> </SUP>for long. RQ at
the lungs is an invalid measure of the distribution<SUP> </SUP>of oxidized
substrate, because the lactic acidosis of exercise<SUP> </SUP>increases blood
CO<SUB>2</SUB>. Nevertheless, it is reported
that, during<SUP> </SUP>strenuous exercise, not only is glucose the major
substrate for<SUP> </SUP>oxygen consumption, but also that strenuous exercise is
not possible<SUP> </SUP>without adequate glycogen stores (<A HREF="#B58">58</A>). Although authors
write<SUP> </SUP>of metabolic effects of exercise or of muscle contractions, it<SUP> </SUP>should be noted that it has not been possible to measure metabolic<SUP> </SUP>responses during the period of exercise or of muscle contraction<SUP> </SUP>in
many experiments. For example, when muscles are stimulated<SUP> </SUP>to contract
in situ and then excised for metabolic studies in<SUP> </SUP>vitro, or excised
muscles are stimulated to contract and then<SUP> </SUP>submitted for metabolic
analysis, the observations necessarily<SUP> </SUP>include events occurring during
recovery from exercise. Similarly,<SUP> </SUP>when human subjects are exercised on
a bicycle ergometer, events<SUP> </SUP>concerning glucose metabolism have usually
been studied only on<SUP> </SUP>completion of the<SUP> </SUP>exercise.
    </P>
    

    
    <P>Increased muscle glucose uptake during or immediately after muscle
exercise is at least in part due to increased plasma membrane<SUP> </SUP>GLUT-4,
reported to be entirely in the membrane of T tubules;<SUP> </SUP>there is no
increase in plasma membrane GLUT-1 (<A HREF="#B35">35</A>). The increased<SUP> </SUP>plasma membrane
GLUT-4 is by a factor of only ~2, occasionally<SUP> </SUP>more, sometimes less,
small compared with the effect of insulin<SUP> </SUP>in vivo. As is the case for
insulin stimulation, in most reports<SUP> </SUP>the degree of increase in skeletal
muscle glucose uptake induced<SUP> </SUP>by exercise exceeds that in plasma
membrane GLUT, suggesting that<SUP> </SUP>there may be an exercise effect on
transport efficiency (<A HREF="#B72">72</A>).<SUP> </SUP>It has been suggested that the discrepancy
between increased glucose<SUP> </SUP>uptake and increased cell surface and T
tubule GLUT-4 can be accounted<SUP> </SUP>for by the fact that GLUT-4 is a more
efficient transporter than<SUP> </SUP>GLUT-1, but that argument is false. If
increased glucose uptake<SUP> </SUP>is to be accounted for entirely by
translocation of GLUT, the<SUP> </SUP>increase in GLUT-4 must actually be greater
than that of glucose<SUP> </SUP>uptake, as long as the increase in surface GLUT-1
is less than<SUP> </SUP>that of glucose uptake, no matter how much more efficient
GLUT-4<SUP> </SUP>is than GLUT-1 (<A HREF="#B131">131</A>).
    </P>
    

    
    <P>All but one (<A HREF="#B50">50</A>) of many studies report that combination of exercise
and insulin increases both membrane GLUT-4 and glucose<SUP> </SUP>uptake. These
increases have generally been found to be approximately<SUP> </SUP>additive or not
quite additive (<A HREF="#B19">19</A>), and, in one case, ~50%<SUP> </SUP>greater than purely
additive, so that synergism was claimed (<A HREF="#B32">32</A>).<SUP> </SUP>The bulk of these
observations suggest that exercise stimulates<SUP> </SUP>translocation from a pool
of GLUT-laden intracellular vesicles<SUP> </SUP>different from the pool stimulated
by insulin. The suggestion<SUP> </SUP>is strong if maximum effects of insulin and
exercise are additive,<SUP> </SUP>but not if the combined effects
are submaximal. If the hypothesis<SUP> </SUP>is correct, one should find that
exercise decreases GLUT from<SUP> </SUP>a different intracellular pool than that
decreased by insulin.<SUP> </SUP>This has been reported to be the case (<A HREF="#B36">36</A>).
Consistent with,<SUP> </SUP>but not unequivocally supporting, the hypothesis is
the observation<SUP> </SUP>that exercise increased glucose uptake in membrane
(combined sarcolemma<SUP> </SUP>and T tubules) vesicles in obese Zucker rats (who
do not respond<SUP> </SUP>to insulin) by at least as much as it does in matched
lean Zucker<SUP> </SUP>rats (<A HREF="#B71">71</A>). Two separate intracellular GLUT-4 pools have now<SUP> </SUP>been identified, one responding to insulin and the other to contraction<SUP> </SUP>(<A HREF="#B26">26</A>).
    </P>
    

    
    <P>How does exercise stimulate translocation of GLUT-4 to the T tubule?
How does it increase glucose transport efficiency? These<SUP> </SUP>questions have
several levels of answers. At the more immediate<SUP> </SUP>level, it is proposed,
on the basis of studies of isolated perfused<SUP> </SUP>rat hindlimb, that
increased muscle blood flow, by increasing<SUP> </SUP>glucose delivery, adds to
the effects of muscle contraction. At<SUP> </SUP>a more general level, more than
40&nbsp;years ago, studies from Levine's<SUP> </SUP>laboratory (Goldstein et al., 46a)
showed, in eviscerated-nephrectomized<SUP> </SUP>dogs and rats, that hindlimb
contractions against a load caused<SUP> </SUP>a generalized uptake of
nonmetabolizable glucose analogs to the<SUP> </SUP>same extent as did insulin,
even in dogs with low spinal cord<SUP> </SUP>section to eliminate neural pathways
from the exercising muscles.<SUP> </SUP>This suggested strongly that exercising
muscle produced a humoral<SUP> </SUP>factor that acted on all skeletal muscles,
even those that were<SUP> </SUP>at rest during exercise of hindlimbs. A few years
later, the same<SUP> </SUP>laboratory reported that, in parabiotic
eviscerated-nephrectomized<SUP> </SUP>dogs, exercise by one dog increased sugar
uptake by both dogs,<SUP> </SUP>increasing the likelihood that a humoral factor is
released from<SUP> </SUP>exercising muscle (<A HREF="#B46">46</A>). These intriguing observations
have not<SUP> </SUP>been adequately pursued, and the mechanism by which exercise
increases<SUP> </SUP>glucose uptake remains basically not understood. An
observation<SUP> </SUP>taken to deny that a substance is released from exercising
muscle<SUP> </SUP>to stimulate idle muscles to transport glucose comes from an
isolated<SUP> </SUP>perfused rat hindlimb preparation in which there was no
stimulation<SUP> </SUP>of glucose uptake in resting muscles perfused with a medium
used<SUP> </SUP>previously in the exercise experiment (<A HREF="#B13">13</A>). This report is less<SUP> </SUP>than crucial evidence against Levine's proposal that exercise<SUP> </SUP>causes
production or release into the circulation of a substance<SUP> </SUP>that
increases glucose uptake; failure to obtain glucose uptake<SUP> </SUP>by the old
perfusing medium may have been a dilution effect, or<SUP> </SUP>it may have been
that the insulinomimetic factor does not arise<SUP> </SUP>in the exercised muscle,
for<SUP> </SUP>example.
    </P>
    

    
    <P>Exercise has been reported to increase sensitivity to insulin; that is,
more glucose is transported for the same dose of insulin<SUP> </SUP>a few minutes
after exercise or muscle contractions (see Ref.<SUP> </SUP><A HREF="#B45">45</A> for earlier
references). It is reported that there is a factor<SUP> </SUP>in serum, probably a
protein, that interacts with exercise (although<SUP> </SUP>not demonstrated to
have been produced by exercise) in such a<SUP> </SUP>way as to increase glucose
uptake by excised rat muscle in response<SUP> </SUP>to insulin, compared with the
insulin response of the muscle when<SUP> </SUP>incubated in the absence of serum
(<A HREF="#B45">45</A>). With a regular program<SUP> </SUP>of heavy exercise, there is increased
GLUT-4 mRNA and protein,<SUP> </SUP>and in response to insulin there is a greater
translocation of<SUP> </SUP>GLUT-4 to the cell surface and greater glucose
transport. Because<SUP> </SUP>the ratio of glucose uptake to cell surface GLUT-4
in response<SUP> </SUP>to insulin is about the same (both responses being
increased by<SUP> </SUP>~50%) before and after exercise training, it is
suggested that<SUP> </SUP>the change in insulin-induced glucose uptake after
exercise training<SUP> </SUP>is "fully accounted for by the appearance of cell
surface GLUT-4"<SUP> </SUP>(<A HREF="#B102">102</A>); however, as pointed out earlier in discussion
of whether<SUP> </SUP>translocation of GLUTs to the cell surface fully accounted
for<SUP> </SUP>insulin-stimulated glucose uptake, the data are consistent with<SUP> </SUP>the
hypothesis that insulin-stimulated glucose uptake is accounted<SUP> </SUP>for in
part by an increase in GLUT density on the cell surface<SUP> </SUP>and in part by
increased effectiveness of GLUT (<A HREF="#B131">131</A>).
    </P>
    

    
    <P>There are no reports of an acute effect of exercise on adipocyte
glucose uptake and plasma membrane GLUT density, but exercise<SUP> </SUP>training
(wheel-cage exercise-trained rats) produces increased<SUP> </SUP>GLUT-4 both in
adipocyte microsomal fraction and in plasma membranes<SUP> </SUP>due to increased
adipocyte GLUT-4 synthesis; there was no change<SUP> </SUP>in GLUT-1 (<A HREF="#B56">56</A>), similar
to the increases in skeletal muscle.<SUP> </SUP>If acute exercise does produce a
humoral factor that stimulates<SUP> </SUP>skeletal muscle glucose uptake, it might
also stimulate adipocyte<SUP> </SUP>glucose<SUP> </SUP>uptake.
    </P>
    




<BR CLEAR=ALL>
<A NAME="SEC7"><!-- null --></A>
<TABLE WIDTH=100% BGCOLOR=E1E1E1 CELLPADDING=0 CELLSPACING=0>
<TR>
<TD ALIGN=LEFT VALIGN=MIDDLE WIDTH=5% BGCOLOR=FFFFFF>&nbsp;<IMG WIDTH=10 HEIGHT=21 HSPACE=5 ALT="" SRC="/icons/toc/rarrow.gif"></TD>
<TH ALIGN=LEFT VALIGN=MIDDLE WIDTH=95%><FONT SIZE=+2>&nbsp;&nbsp;HYPOXIA</FONT></TH>
</TR>
</TABLE>

<TABLE ALIGN=RIGHT CELLPADDING=5 BORDER NOWRAP><R>
<TH ALIGN=LEFT>
<FONT SIZE=-1>



<A HREF="#Top"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">Top</A>


<BR>
<A HREF="#Abstract"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">Abstract</A>


<BR>
<A HREF="#SEC1"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">SCOPE OF THE REVIEW</A>


<BR>
<A HREF="#SEC2"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">METHODS FOR STUDYING GLUCOSE...</A>


<BR>
<A HREF="#SEC3"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">GLUCOSE DISTRIBUTION AND...</A>


<BR>
<A HREF="#SEC4"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">GLUCOSE TRANSPORTERS:...</A>


<BR>
<A HREF="#SEC5"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">RELATION OF GLUCOSE METABOLISM...</A>


<BR>
<A HREF="#SEC6"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">EXERCISE</A>


<BR><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/dot.gif"><FONT COLOR=46
4C53>HYPOXIA</FONT>


<BR>
<A HREF="#SEC8"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/darrow.gif">SUMMARY AND PROJECTION</A>


<BR>
<A HREF="#References"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/darrow.gif">References</A>
</FONT></TH>
</TR></TABLE>


    
    <P>It has been known at least since 1958&nbsp;that hypoxia stimulates glucose
uptake by skeletal muscle (<A HREF="#B100">100</A>). Studies were resumed<SUP> </SUP>in 1991&nbsp;with an
important report from the laboratories of Holloszy<SUP> </SUP>and Klip (Cartee et
al., 21), who have continued to play a major<SUP> </SUP>role in the area of
skeletal muscle metabolism. Excised rat epitrochlearis<SUP> </SUP>muscles
increased glucose uptake by 6-fold when
N<SUB>2</SUB> was substituted<SUP> </SUP>for
O<SUB>2</SUB> in the chamber. Anoxia
increased GLUT-4 content of a plasma<SUP> </SUP>membrane fraction by 2.4-fold, far
less than it increased glucose<SUP> </SUP>transport, again raising the question of
whether there is also<SUP> </SUP>an anoxia-induced increase in GLUT efficiency.
Maximum effects<SUP> </SUP>of insulin and anoxia were additive, whereas effects of
anoxia<SUP> </SUP>and muscle contraction on glucose uptake were not additive,
suggesting<SUP> </SUP>that the exercise and anoxia stimulate translocation of the
same<SUP> </SUP>pool of intracellular vesicles containing GLUT-4 and that insulin<SUP> </SUP>stimulates a different pool. This suggestion is supported by
observation<SUP> </SUP>on muscle strips obtained by biopsy from insulin-resistant
obese<SUP> </SUP>or diabetic subjects in whom anoxia elicited the same glucose<SUP> </SUP>uptake response as seen in muscles from normal, lean subjects<SUP> </SUP>(<A HREF="#B7">7</A>).
    </P>
    

    
    <P>After 5&nbsp;days of severe exercise training of rats, excised skeletal
muscle has smaller responses to hypoxia with regard to<SUP> </SUP>both glucose
uptake and GLUT-4 translocation (<A HREF="#B102">102</A>). The authors<SUP> </SUP>propose that
increased muscle glycogen content, which accumulates<SUP> </SUP>with exercise
training, is responsible for decreased sensitivity<SUP> </SUP>to<SUP> </SUP>hypoxia.
    </P>
    




<BR CLEAR=ALL>
<A NAME="SEC8"><!-- null --></A>
<TABLE WIDTH=100% BGCOLOR=E1E1E1 CELLPADDING=0 CELLSPACING=0>
<TR>
<TD ALIGN=LEFT VALIGN=MIDDLE WIDTH=5% BGCOLOR=FFFFFF>&nbsp;<IMG WIDTH=10 HEIGHT=21 HSPACE=5 ALT="" SRC="/icons/toc/rarrow.gif"></TD>
<TH ALIGN=LEFT VALIGN=MIDDLE WIDTH=95%><FONT SIZE=+2>&nbsp;&nbsp;SUMMARY AND PROJECTION</FONT></TH>
</TR>
</TABLE>

<TABLE ALIGN=RIGHT CELLPADDING=5 BORDER NOWRAP><R>
<TH ALIGN=LEFT>
<FONT SIZE=-1>



<A HREF="#Top"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">Top</A>


<BR>
<A HREF="#Abstract"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">Abstract</A>


<BR>
<A HREF="#SEC1"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">SCOPE OF THE REVIEW</A>


<BR>
<A HREF="#SEC2"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">METHODS FOR STUDYING GLUCOSE...</A>


<BR>
<A HREF="#SEC3"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">GLUCOSE DISTRIBUTION AND...</A>


<BR>
<A HREF="#SEC4"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">GLUCOSE TRANSPORTERS:...</A>


<BR>
<A HREF="#SEC5"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">RELATION OF GLUCOSE METABOLISM...</A>


<BR>
<A HREF="#SEC6"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">EXERCISE</A>


<BR>
<A HREF="#SEC7"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">HYPOXIA</A>


<BR><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/dot.gif"><FONT COLOR=46
4C53>SUMMARY AND PROJECTION</FONT>


<BR>
<A HREF="#References"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/darrow.gif">References</A>
</FONT></TH>
</TR></TABLE>


    
    <P>Glucose is an important substrate for oxidative consumption by nearly
all cells; however, except for neurones, it is not the<SUP> </SUP>major substrate.
Glucose is distributed in a heterogeneous concentration<SUP> </SUP>throughout
extracellular fluid. Except for liver and kidney, although<SUP> </SUP>they produce
glucose and release it into their effluent blood,<SUP> </SUP>arterial glucose
concentration exceeds venous, and venous glucose<SUP> </SUP>concentration varies
among organs and tissues depending on rate<SUP> </SUP>of glucose uptake and rate
of blood flow. Among mammalian species,<SUP> </SUP>the ratio of glucose
concentration in erythrocyte water to that<SUP> </SUP>in plasma water varies from
0&nbsp;to 1.&nbsp;Erythrocyte glucose and glycogen<SUP> </SUP>serve to buffer plasma glucose
concentration. Interstitial glucose<SUP> </SUP>concentration varies; possibly it
is one-half that in arterial<SUP> </SUP>plasma water. Better and more rapidly
responding methods for measuring<SUP> </SUP>interstitial fluid glucose
concentration are<SUP> </SUP>needed.
    </P>
    

    
    <P>All cell uptake and output of glucose are mediated only via specific
glucose transporters, SGLT and GLUT. SGLTs transport<SUP> </SUP>glucose against a
concentration gradient. This active transport<SUP> </SUP>is said to be fueled by
coupling it to passive transport of
Na<SUP>+</SUP>, but although this conjecture
has been repeated for decades,<SUP> </SUP>details of the coupling mechanism remain
unknown. The family of<SUP> </SUP>transporters probably has varying affinities for
glucose and transport<SUP> </SUP>glucose with varying efficiency. We do not know
the details of<SUP> </SUP>the mechanism by which glucose passes between
interstitial fluid<SUP> </SUP>and cytoplasm via a glucose transporter. Is the
process one of<SUP> </SUP>iterative association and dissociation between a glucose
molecule<SUP> </SUP>and the transporter through the thickness of the membrane? How<SUP> </SUP>many glucose molecules are bound to a single transporter at any<SUP> </SUP>instant? Without such knowledge, we lack the correct model by<SUP> </SUP>which to
calculate transporter affinities. Although affinities<SUP> </SUP>have been
reported as Michaelis-Menten
<I>K</I><SUB>m</SUB> values, we do
not know<SUP> </SUP>that such calculations are<SUP> </SUP>correct.
    </P>
    

    
    <P>With a CHO meal, there is accelerated gastric emptying, cycling of SGLT
in small intestinal enterocytes to increase glucose<SUP> </SUP>absorption, with
release of incretins to stimulate insulin release,<SUP> </SUP>hyperinsulinemia,
recruitment of GLUT to cell surfaces of fat<SUP> </SUP>cells and skeletal and
cardiac muscle with increased glucose uptake<SUP> </SUP>by these tissues, perhaps
due also to activation of GLUT in the<SUP> </SUP>plasma membrane, and coordinated
blocking of hepatic and renal<SUP> </SUP>glycogenolysis and gluconeogenesis. At
the same time there may<SUP> </SUP>also be increased blood flow to skeletal
muscle, increasing glucose<SUP> </SUP>delivery, and increased storage of glucose
as glycogen in muscle,<SUP> </SUP>decreased lipolysis, and increased triglyceride
storage in adipocytes.<SUP> </SUP>With chronic increase in dietary CHO there is
increased synthesis<SUP> </SUP>of both SGLT and GLUT. CHO in the gut stimulates
release of intestinal<SUP> </SUP>incretins that, in turn, stimulate release of
insulin. As glucose<SUP> </SUP>is absorbed, circulating glucose concentration
rises; there follows<SUP> </SUP>a complex hormonal interplay between insulin,
which stimulates<SUP> </SUP>glucose uptake and tends to reduce circulating glucose
concentration,<SUP> </SUP>and a number of other hormones that tend to raise it,
either by<SUP> </SUP>opposing the action of insulin or by stimulating hepatic and
renal<SUP> </SUP>glycogenolysis and gluconeogenesis. Our
understanding of exactly<SUP> </SUP>how certain hormones oppose the action of
insulin on glucose uptake<SUP> </SUP>is<SUP> </SUP>incomplete.
    </P>
    

    
    <P>When insulin increases glucose uptake by adipose cells and skeletal and
cardiac muscle, there is an increase in GLUT in the<SUP> </SUP>plasma membrane due
to migration of intracellular vesicles to<SUP> </SUP>fuse with the plasma
membrane. GLUTs are laced in the wall of<SUP> </SUP>these intracellular vesicles.
There is an unresolved question<SUP> </SUP>as to whether this translocation of
intracellular GLUT to the<SUP> </SUP>cell surface membrane accounts for all of
insulin-stimulated glucose<SUP> </SUP>uptake. There are strong suggestions that
the increase in cell<SUP> </SUP>surface GLUT is inadequate to account for observed
glucose uptake.<SUP> </SUP>It is suggested that insulin also somehow increases
GLUT effectiveness<SUP> </SUP>or turnover number so that a GLUT molecule
transports more glucose<SUP> </SUP>molecules per unit time. We have some evidence,
as yet incomplete,<SUP> </SUP>about the chain of signals by which insulin leads to
translocation<SUP> </SUP>of GLUT-laden vesicles to the plasma membrane. If insulin
also<SUP> </SUP>increases GLUT turnover number, that mechanism is quite unknown.<SUP> </SUP>I
think of a possible mechanism as being related to one of the<SUP> </SUP>mechanisms
by which ion channels are gated; a change in configuration<SUP> </SUP>of the
transporter caused by some as-yet-unidentified mechanism,<SUP> </SUP>which may be,
for example, an altered transmembrane electrical<SUP> </SUP>field, flips the
transporter from an inactive or poorly active<SUP> </SUP>state to a more active<SUP> </SUP>state.
    </P>
    

    
    <P>With exercise, glycogenolysis and gluconeogenesis are stimulated by a
number of related factors, including particularly glucagon<SUP> </SUP>and
catecholamines. Glucose uptake is increased. There is GLUT<SUP> </SUP>recruitment
to the T tubular membrane in skeletal muscle from<SUP> </SUP>an intracellular pool
distinct from that drawn on by insulin.<SUP> </SUP>Again, there is a possibility
that GLUT intrinsic transport activity<SUP> </SUP>may be increased, and also that
increased muscle blood flow may<SUP> </SUP>increase glucose delivery to previously
underperfused fibers.<SUP> </SUP>Hypoxia has an effect similar to the acute effect
of exercise,<SUP> </SUP>apparently drawing on the same GLUT pool. With sustained
exercise<SUP> </SUP>training there is increased synthesis of GLUT in muscle and
fat<SUP> </SUP>cells. There is a strong suggestion that exercise or muscle
contraction<SUP> </SUP>produces a humoral factor that initiates GLUT recruitment
in skeletal<SUP> </SUP>muscle, even in unstimulated muscles. It is not known
whether<SUP> </SUP>the same acute effect occurs in adipocytes, but the effect of<SUP> </SUP>exercise training to increase the population of muscle GLUT, presumably<SUP> </SUP>by increased synthesis, is observed also in adipocytes. The stimulus<SUP> </SUP>observed with acute exercise may not be the same as that produced<SUP> </SUP>by
sustained exercise<SUP> </SUP>training.
    </P>
    

    
    <P>In vivo glucose uptake differs from in vitro in that
<I>1</I>) blood flow can determine the rate
of glucose delivery to an organ<SUP> </SUP>or tissue,
<I>2</I>) artifacts occurring in tissue
preparation that may<SUP> </SUP>affect such properties as cell surface GLUT
density are avoided,<SUP> </SUP><I>3</I>) unknown and
unrecognized factors not present in vitro may modify<SUP> </SUP>glucose uptake and
output, and <I>4</I>) in vivo experiments
have their<SUP> </SUP>own<SUP> </SUP>artifacts.
    </P>
    

    
    <P>Insulin can stimulate NO synthesis in arterioles. It is possible that
this is the mechanism by which insulin can increase<SUP> </SUP>blood flow, but the
story is complicated by the fact that direct<SUP> </SUP>intra-arterial insulin
infusion does not cause vasodilatation,<SUP> </SUP>at least not to the degree
reported when insulin is administered<SUP> </SUP>in a fashion capable of lowering
circulating glucose concentration.<SUP> </SUP>Nor is it proven that skeletal or
cardiac muscle glucose uptake<SUP> </SUP>must increase simply because of increased
blood flow; there is<SUP> </SUP>evidence that the two insulin effects are
unrelated. What, then,<SUP> </SUP>is the function of insulin-induced<SUP> </SUP>vasodilatation?
    </P>
    

    
    <P>Although some may argue otherwise, an ideal model of total body blood
glucose kinetics and distribution has yet to be produced.<SUP> </SUP>Such a model
ought to recognize the role of distribution of blood<SUP> </SUP>flow,
heterogeneity of glucose uptake and, hence, heterogeneity<SUP> </SUP>of
interstitial fluid and venous glucose concentrations, and mechanisms<SUP> </SUP>by
which SGLT and GLUT transport glucose. The model might consist<SUP> </SUP>of a
weighted number of parallel terms, perhaps each in the form<SUP> </SUP>of a
modified Michaelis-Menten expression, to allow for the different<SUP> </SUP>affinities of the GLUT isoforms and for the fact that each GLUT<SUP> </SUP>is
capable of transport in either direction. Weighting factors<SUP> </SUP>need to
include distributions of transit times through blood,<SUP> </SUP>across
capillaries, and through interstitial fluid to the GLUT<SUP> </SUP>surface.
    </P>
    



</TXT>




<!-- Stray figures and tables -->

<!-- Appendices -->

<!-- Notes -->

<!-- Acknowledgements -->


<!-- Footnotes -->



<A NAME="foo"><!-- comment for mosaic --></A>

<BR CLEAR=ALL>
<TABLE WIDTH=100% BGCOLOR=E1E1E1 CELLPADDING=0 CELLSPACING=0>
<TR>
<TD ALIGN=LEFT VALIGN=MIDDLE WIDTH=5% BGCOLOR=FFFFFF>&nbsp;<IMG WIDTH=10 HEIGHT=21 HSPACE=5 ALT="" SRC="/icons/toc/rarrow.gif"></TD>
<TH ALIGN=LEFT VALIGN=MIDDLE WIDTH=95%><FONT SIZE=+2>&nbsp;&nbsp;FOOTNOTES</FONT></TH>
</TR>
</TABLE>








<!-- Reprint -->

<A NAME="reprint"><!-- comment for mosaic --></A>
<P>Address reprint requests to K.&nbsp;Zierler.
</P>

<!-- Corresp. Address -->

<!-- Received & Accepted -->

<!-- Bibliography -->

<A NAME="ref"><!-- comment for mosaic --></A>



<BR CLEAR=ALL>
<A NAME="References"><!-- null --></A>
<TABLE WIDTH=100% BGCOLOR=E1E1E1 CELLPADDING=0 CELLSPACING=0>
<TR>
<TD ALIGN=LEFT VALIGN=MIDDLE WIDTH=5% BGCOLOR=FFFFFF>&nbsp;<IMG WIDTH=10 HEIGHT=21 HSPACE=5 ALT="" SRC="/icons/toc/rarrow.gif"></TD>
<TH ALIGN=LEFT VALIGN=MIDDLE WIDTH=95%><FONT SIZE=+2>&nbsp;&nbsp;REFERENCES</FONT></TH>
</TR>
</TABLE>

<TABLE ALIGN=RIGHT CELLPADDING=5 BORDER NOWRAP><R>
<TH ALIGN=LEFT>
<FONT SIZE=-1>



<A HREF="#Top"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">Top</A>


<BR>
<A HREF="#Abstract"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">Abstract</A>


<BR>
<A HREF="#SEC1"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">SCOPE OF THE REVIEW</A>


<BR>
<A HREF="#SEC2"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">METHODS FOR STUDYING GLUCOSE...</A>


<BR>
<A HREF="#SEC3"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">GLUCOSE DISTRIBUTION AND...</A>


<BR>
<A HREF="#SEC4"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">GLUCOSE TRANSPORTERS:...</A>


<BR>
<A HREF="#SEC5"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">RELATION OF GLUCOSE METABOLISM...</A>


<BR>
<A HREF="#SEC6"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">EXERCISE</A>


<BR>
<A HREF="#SEC7"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">HYPOXIA</A>


<BR>
<A HREF="#SEC8"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">SUMMARY AND PROJECTION</A>


<BR><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/dot.gif"><FONT COLOR=46
4C53>References</FONT>
</FONT></TH>
</TR></TABLE>

<P>
<a name="B1">1.</a>
    &nbsp;

<B>
Andreen-Svedberg, A.</B>
On the distribution of sugar between plasma and corpuscles in animal and human blood.
<I>Skand. Arch. Physiol.</I>
66:
13-190,
1933.<!-- HIGHWIRE ID="276:3:E409:1" --><!-- /HIGHWIRE --><BR><BR>
<a name="B2">2.</a>
    &nbsp;

<B>
Andres, R.,
M. A. Baltzan,
G. Cader,
and 
K. L. Zierler.</B>
Effect of insulin on carbohydrate metabolism and on potassium in the forearm of man.
<I>J. Clin. Invest.</I>
41:
108-115,
1962<!-- HIGHWIRE ID="276:3:E409:2" --><!-- /HIGHWIRE -->.<BR><BR>
<a name="B3">3.</a>
    &nbsp;

<B>
Andres, R.,
G. Cader,
and 
K. L. Zierler.</B>
The quantitatively minor role of carbohydrate in oxidative metabolism by skeletal muscle in intact man in the basal state. Measurements of oxygen and glucose uptake and carbon dioxide and lactate production.
<I>J. Clin. Invest.</I>
35:
671-682,
1956<!-- HIGHWIRE ID="276:3:E409:3" --><!-- /HIGHWIRE -->.<BR><BR>
<a name="B4">4.</a>
    &nbsp;

<B>
Andres, R.,
R. Swerdloff,
T. Pozefsky,
and 
D. Coleman.</B>

Manual feedback for the control of blood glucose concentration.
In: <I>Automation in Analytical Chemistry</I>, edited by L. T. Skegs, Jr.. New York: Medial, 1966, p. 486-491.<!-- HIGHWIRE ID="276:3:E409:4" --><!-- /HIGHWIRE --><BR><BR>
<a name="B5">5.</a>
    &nbsp;

<B>
Andres, R.,
and 
K. L. Zierler.</B>
Stability of glucose uptake by human forearm despite increased arterial glucose concentration (Abstract).
<I>Federation Proc.</I>
17:
4,
1958<!-- HIGHWIRE ID="276:3:E409:5" --><!-- /HIGHWIRE -->.<BR><BR>
<a name="B6">6.</a>
    &nbsp;

<B>
Avogaro, A.,
P. Vicini,
A. Valerio,
A. Caumo,
and 
C. Cobelli.</B>
The hot but not the cold minimal model allows precise assessment of insulin sensitivity in NIDDM subjects.
<I>Am. J.&nbsp;Physiol.</I>
270 (<I>Endocrinol. Metab.</I> 33):
E532-E540,
1996<!-- HIGHWIRE ID="276:3:E409:6" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=ajpendo&resid=270/3/E532" ><nobr>[Abstract/<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE -->.<BR><BR>
<a name="B7">7.</a>
    &nbsp;

<B>
Azevedo, J. L., Jr.,
J. O. Carey,
W. J. Pories,
P. G. Morris,
and 
G. L. Dohm.</B>
Hypoxia stimulates glucose transport in insulin-resistant human skeletal muscle.
<I>Diabetes</I>
44:
695-698,
1995<!-- HIGHWIRE ID="276:3:E409:7" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=diabetes&resid=44/6/695" >[Abstract]</A><!-- /HIGHWIRE -->.<BR><BR>
<a name="B8">8.</a>
    &nbsp;

<B>
Balon, T. W.,
and 
J. L. Nadler.</B>
Evidence that nitric oxide increases glucose transport in skeletal muscle.
<I>J. Appl. Physiol.</I>
82:
359-363,
1997<!-- HIGHWIRE ID="276:3:E409:8" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=jap&resid=82/1/359" ><nobr>[Abstract/<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE -->.<BR><BR>
<a name="B9">9.</a>
    &nbsp;

<B>
Baltzan, M. A.,
R. Andres,
G. Cader,
and 
K. L. Zierler.</B>
Heterogeneity of forearm metabolism with special reference to free fatty acids.
<I>J. Clin. Invest.</I>
41:
116-125,
1962<!-- HIGHWIRE ID="276:3:E409:9" --><!-- /HIGHWIRE -->.<BR><BR>
<a name="B10">10.</a>
    &nbsp;

<B>
Baron, A. D.</B>
Hemodynamic actions of insulin.
<I>Am. J.&nbsp;Physiol.</I>
267 (<I>Endocrinol. Metab.</I> 30):
E187-E202,
1994<!-- HIGHWIRE ID="276:3:E409:10" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=ajpendo&resid=267/2/E187" ><nobr>[Abstract/<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE -->.<BR><BR>
<a name="B11">11.</a>
    &nbsp;

<B>
Baron, A. D.,
G. Brechtel,
P. Wallace,
and 
S. V. Edelman.</B>
Rates and tissue sites of non-insulin- and insulin-mediated glucose uptake in humans.
<I>Am. J.&nbsp;Physiol.</I>
255 (<I>Endocrinol. Metab.</I> 18):
E769-E774,
1988<!-- HIGHWIRE ID="276:3:E409:11" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=ajpendo&resid=255/6/E769" ><nobr>[Abstract/<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE -->.<BR><BR>
<a name="B12">12.</a>
    &nbsp;

<B>
Baron, A. D.,
and 
M. G. Clark.</B>
Role of blood flow in the regulation of muscle glucose uptake.
<I>Annu. Rev. Nutr.</I>
17:
487-499,
1997<!-- HIGHWIRE ID="276:3:E409:12" --><A HREF="/cgi/external_ref?access_num=9240937&link_type=MED" >[Medline]</A><!-- /HIGHWIRE -->.<BR><BR>
<a name="B13">13.</a>
    &nbsp;

<B>
Berger, M.,
S. Hagg,
and 
N. H. Ruderman.</B>
Glucose metabolism in perfused skeletal muscle. Interactions of insulin and exercise in glucose uptake.
<I>Biochem. J.</I>
146:
231-238,
1975<!-- HIGHWIRE ID="276:3:E409:13" --><A HREF="/cgi/external_ref?access_num=807202&link_type=MED" >[Medline]</A><!-- /HIGHWIRE -->.<BR><BR>
<a name="B14">14.</a>
    &nbsp;

<B>
Bergman, R. N.,
Y. Z. Ider,
C. R. Bowden,
and 
C. Cobelli.</B>
Quantitative estimation of insulin sensitivity.
<I>Am. J.&nbsp;Physiol.</I>
236 (<I>Endocrinol. Metab. Gastrointest. Physiol.</I> 5):
E667-E677,
1979<!-- HIGHWIRE ID="276:3:E409:14" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=ajpendo&resid=236/6/E667" ><nobr>[Abstract/<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE -->.<BR><BR>
<a name="B15">15.</a>
    &nbsp;

<B>
Bergman, R. N.,
L. S. Philips,
and 
C. Cobelli.</B>
Physiologic evaluation of factors controlling glucose tolerance in man: measurement of insulin sensitivity and <IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">-cell glucose sensitivity from the response to intravenous glucose.
<I>J. Clin. Invest.</I>
68:
1456-1467,
1981<!-- HIGHWIRE ID="276:3:E409:15" --><A HREF="/cgi/external_ref?access_num=7033284&link_type=MED" >[Medline]</A><!-- /HIGHWIRE -->.<BR><BR>
<a name="B16">16.</a>
    &nbsp;

<B>
Best, J. D.,
S. E. Kahn,
M. Ader,
R. M. Watanabe,
T.-C. Ni,
and 
R. N. Bergman.</B>
Role of glucose effectiveness in the determination of glucose tolerance.
<I>Diabetes Care</I>
19:
1018-1030,
1996<!-- HIGHWIRE ID="276:3:E409:16" --><A HREF="/cgi/external_ref?access_num=8875104&link_type=MED" >[Medline]</A><!-- /HIGHWIRE -->.<BR><BR>
<a name="B17">17.</a>
    &nbsp;

<B>
Bing, R. J.,
A. Siegel,
I. Ungar,
and 
M. Gilbert.</B>
Metabolism of the human heart. II. Studies on fat, ketone and amino acid metabolism.
<I>Am. J.&nbsp;Med.</I>
16:
504-515,
1954<!-- HIGHWIRE ID="276:3:E409:17" --><!-- /HIGHWIRE -->.<BR><BR>
<a name="B18">18.</a>
    &nbsp;

<B>
Boden, G.,
X. Chen,
J. Ruiz,
and 
L. Rosetti.</B>
Mechanisms of fatty acid induced inhibition of glucose uptake.
<I>J. Clin. Invest.</I>
93:
238-246,
1994<!-- HIGHWIRE ID="276:3:E409:18" --><!-- /HIGHWIRE -->.<BR><BR>
<a name="B19">19.</a>
    &nbsp;

<B>
Brozinick, J. T., Jr.,
G. J. Etgen, Jr.,
B. B. Yaspelkis III,
and 
J. L. Ivy.</B>
The effects of muscle contraction and insulin on glucose-transported translocation in rat skeletal muscle.
<I>Biochem. J.</I>
297:
539-545,
1994<!-- HIGHWIRE ID="276:3:E409:19" --><A HREF="/cgi/external_ref?access_num=8110191&link_type=MED" >[Medline]</A><!-- /HIGHWIRE -->.<BR><BR>
<a name="B20">20.</a>
    &nbsp;

<B>
Calderhead, D. M.,
K. Kitagawa,
L. I. Tanner,
G. D. Holman,
and 
G. V. Lienhard.</B>
Insulin regulation of the two glucose transporters in 3T3-L1 adipocytes.
<I>J. Biol. Chem.</I>
265:
13800-13808,
1990<!-- HIGHWIRE ID="276:3:E409:20" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=jbc&resid=265/23/13800" ><nobr>[Abstract/<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE -->.<BR><BR>
<a name="B21">21.</a>
    &nbsp;

<B>
Cartee, G. D.,
A. G. Douen,
T. Ramlal,
A. Klip,
and 
J. O. Holloszy.</B>
Stimulation of glucose transport in skeletal muscle by hypoxia.
<I>J. Appl. Physiol.</I>
70:
1593-1600,
1991<!-- HIGHWIRE ID="276:3:E409:21" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=jap&resid=70/4/1593" ><nobr>[Abstract/<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE -->.<BR><BR>
<a name="B22">22.</a>
    &nbsp;

<B>
Chauveau, A.</B>
M&eacute;thode pour la d&eacute;termination de l'activit&eacute; sp&eacute;cifique des &eacute;changes intramusculares ou du coefficient de l'acitivit&eacute; nutritive et respiratoire des muscles en repos et en travail.
<I>C. R.&nbsp;Acad. Sci.</I>
104:
1409-1414,
1887.<!-- HIGHWIRE ID="276:3:E409:22" --><!-- /HIGHWIRE --><BR><BR>
<a name="B23">23.</a>
    &nbsp;

<B>
Cheeseman, C. I.,
and 
B. Harley.</B>
Adaptation of glucose transport across rat enterocyte basolateral membrane in response to altered dietary carbohydrate intake.
<I>J. Physiol. (Lond.)</I>
437:
563-575,
1991<!-- HIGHWIRE ID="276:3:E409:23" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=jphysiol&resid=437/1/563" >[Abstract]</A><!-- /HIGHWIRE -->.<BR><BR>
<a name="B24">24.</a>
    &nbsp;

<B>
Cheeseman, C. I.,
and 
D. D. Maenz.</B>
Rapid regulation of <font size=-1>D</font>-glucose transport in basolateral membrane of rat jejunum.
<I>Am. J.&nbsp;Physiol.</I>
256 (<I>Gastrointest. Liver Physiol.</I> 19):
G878-G883,
1989<!-- HIGHWIRE ID="276:3:E409:24" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=ajpgi&resid=256/5/G878" ><nobr>[Abstract/<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE -->.<BR><BR>
<a name="B25">25.</a>
    &nbsp;

<B>
Clark, A. E.,
and 
G. D. Holman.</B>
Exofacial photolabeling of the human erythrocyte glucose transporter with an azitrifluorobenzoyl-substituted bismannose.
<I>Biochem. J.</I>
269:
615-622,
1990<!-- HIGHWIRE ID="276:3:E409:25" --><A HREF="/cgi/external_ref?access_num=2390055&link_type=MED" >[Medline]</A><!-- /HIGHWIRE -->.<BR><BR>
<a name="B26">26.</a>
    &nbsp;

<B>
Coderre, L.,
K. V. Kandror,
G. Vallega,
and 
P. F. Pilch.</B>
Identification and characterization of an exercise-sensitive pool of glucose transporters in skeletal muscle.
<I>J. Biol. Chem.</I>
270:
27584-27588,
1995<!-- HIGHWIRE ID="276:3:E409:26" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=jbc&resid=270/46/27584" ><nobr>[Abstract/<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE -->.<BR><BR>
<a name="B27">27.</a>
    &nbsp;

<B>
Courtice, F. C.,
and 
C. G. Douglas.</B>
The effects of prolonged muscular exercise on the metabolism.
<I>Proc. Roy. Soc. (Lond.)</I>
119B:
381-439,
1935-36.<!-- HIGHWIRE ID="276:3:E409:27" --><!-- /HIGHWIRE --><BR><BR>
<a name="B28">28.</a>
    &nbsp;

<B>
Cryer, P. E.</B>
Glucose counterregulation: prevention and correction of hypoglycemia in humans.
<I>Am. J.&nbsp;Physiol.</I>
264 (<I>Endocrinol. Metab.</I> 27):
E149-E155,
1993<!-- HIGHWIRE ID="276:3:E409:28" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=ajpendo&resid=264/2/E149" ><nobr>[Abstract/<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE -->.<BR><BR>
<a name="B29">29.</a>
    &nbsp;

<B>
Cushman, S. W.,
and 
L. J. Wardzala.</B>
Potential mechanism of insulin action on glucose transport in the isolated adipose cell.
<I>J. Biol. Chem.</I>
255:
4758-4762,
1980<!-- HIGHWIRE ID="276:3:E409:29" --><A HREF="/cgi/ijlink?linkType=PDF&journalCode=jbc&resid=255/10/4758" ><nobr>[<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE -->.<BR><BR>
<a name="B30">30.</a>
    &nbsp;

<B>
Dallman, M. F.,
A. M. Strack,
S. F. Akana,
M. J. Bradbury,
E. S. Hanson,
K. A. Scribner,
and 
M. Smith.</B>
Feast and famine: critical role of glucocorticoids with insulin in daily energy flow.
<I>Front. Neuroendocrinol.</I>
14:
303-347,
1993<!-- HIGHWIRE ID="276:3:E409:30" --><A HREF="/cgi/external_ref?access_num=8258378&link_type=MED" >[Medline]</A><!-- /HIGHWIRE -->.<BR><BR>
<a name="B31">31.</a>
    &nbsp;

<B>
DeFronzo, R. A.,
R. Andres,
T. A. Bledsoe,
G. Boden,
G. A. Faloona,
and 
J. A. Tobin.</B>
A test of the hypothesis that the rate of fall in glucose concentration triggers counterregulatory hormonal responses in man.
<I>Diabetes</I>
26:
445-452,
1977<!-- HIGHWIRE ID="276:3:E409:31" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=diabetes&resid=26/5/445" >[Abstract]</A><!-- /HIGHWIRE -->.<BR><BR>
<a name="B32">32.</a>
    &nbsp;

<B>
DeFronzo, R. A.,
E. Ferrannini,
Y. Sato,
P. Felig,
and 
J. Wahren.</B>
Synergistic interaction between exercise and insulin on peripheral glucose uptake.
<I>J. Clin. Invest.</I>
68:
1469-1474,
1981<!-- HIGHWIRE ID="276:3:E409:32" --><!-- /HIGHWIRE -->.<BR><BR>
<a name="B33">33.</a>
    &nbsp;

<B>
Deussen, A.</B>
Local myocardial glucose uptake is proportional to, but not dependent on blood flow.
<I>Pfl&uuml;gers Arch.<IMG SRC="/math/12pt/normal/mdash.gif" ALIGN=BASELINE ALT="---">Eur. J.&nbsp;Physiol.</I>
433:
488-496,
1997<!-- HIGHWIRE ID="276:3:E409:33" --><A HREF="/cgi/external_ref?access_num=9000428&link_type=MED" >[Medline]</A><!-- /HIGHWIRE -->.<BR><BR>
<a name="B34">34.</a>
    &nbsp;

<B>
De Vos, A.,
H. Heimberg,
E. Quartier,
P. Huypens,
L. Bouwens,
D. Pipeleers,
and 
F. Schuit.</B>
Human and rat beta cells differ in glucose transporter but not in glucokinase gene expression.
<I>J. Clin. Invest.</I>
96:
2489-2495,
1995<!-- HIGHWIRE ID="276:3:E409:34" --><A HREF="/cgi/external_ref?access_num=7593639&link_type=MED" >[Medline]</A><!-- /HIGHWIRE -->.<BR><BR>
<a name="B35">35.</a>
    &nbsp;

<B>
Douen, A. G.,
T. Ramlal,
G. D. Carter,
and 
A. Klip.</B>
Exercise modulates the insulin-induced translocation of glucose transporters in rat skeletal muscle.
<I>FEBS Lett.</I>
261:
256-260,
1990<!-- HIGHWIRE ID="276:3:E409:35" --><A HREF="/cgi/external_ref?access_num=2178971&link_type=MED" >[Medline]</A><!-- /HIGHWIRE -->.<BR><BR>
<a name="B36">36.</a>
    &nbsp;

<B>
Douen, A. G.,
T. Ramlal,
S. Rastogi,
P. J. Bilan,
G. D. Carter,
M. Vranic,
J. O. Holloszy,
and 
A. Klip.</B>
Exercise induces recruitment of the "insulin-responsive glucose transporter." Evidence for distinct intracellular insulin and exercise recruitable transporter pools in skeletal muscle.
<I>J. Biol. Chem.</I>
265:
13427-13430,
1990<!-- HIGHWIRE ID="276:3:E409:36" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=jbc&resid=265/23/13427" ><nobr>[Abstract/<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE -->.<BR><BR>
<a name="B37">37.</a>
    &nbsp;

<B>
Drucker, D. J.</B>
Glucagon-like peptides.
<I>Diabetes</I>
47:
159-169,
1998<!-- HIGHWIRE ID="276:3:E409:37" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=diabetes&resid=47/2/159" >[Abstract]</A><!-- /HIGHWIRE -->.<BR><BR>
<a name="B38">38.</a>
    &nbsp;

<B>
Dudek, R. W.,
G. I. Dohm,
G. D. Holman,
S. W. Cushman,
and 
C. M. Wilson.</B>
Glucose transporter localization in rat skeletal muscle. Autoradiographic study using ATB-[2-<SUP>3</SUP>H]BMPA photolabel.
<I>FEBS Lett.</I>
339:
205-208,
1994<!-- HIGHWIRE ID="276:3:E409:38" --><A HREF="/cgi/external_ref?access_num=8112456&link_type=MED" >[Medline]</A><!-- /HIGHWIRE -->.<BR><BR>
<a name="B39">39.</a>
    &nbsp;

<B>
Dwyer, K. J.,
and 
W. M. Pardridge.</B>
Developmental modulation of blood-brain barrier and choroid plexus GLUT1 transporter messenger ribonucleic acid and immunoreactive protein in rabbits.
<I>Endocrinology</I>
132:
558-565,
1993<!-- HIGHWIRE ID="276:3:E409:39" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=endo&resid=132/2/558" >[Abstract]</A><!-- /HIGHWIRE -->.<BR><BR>
<a name="B40">40.</a>
    &nbsp;

<B>
Ferraris, R. P.,
and 
J. M. Diamond.</B>
Use of phlorizin binding to demonstrate induction of intestinal glucose transporters.
<I>J. Membr. Biol.</I>
94:
77-82,
1986<!-- HIGHWIRE ID="276:3:E409:40" --><A HREF="/cgi/external_ref?access_num=3806659&link_type=MED" >[Medline]</A><!-- /HIGHWIRE -->.<BR><BR>
<a name="B41">41.</a>
    &nbsp;

<B>
Ferraris, R. P.,
and 
J. Diamond.</B>
Regulation of intestinal sugar transport.
<I>Physiol. Rev.</I>
77:
257-301,
1997<!-- HIGHWIRE ID="276:3:E409:41" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=physrev&resid=77/1/257" ><nobr>[Abstract/<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE -->.<BR><BR>
<a name="B42">42.</a>
    &nbsp;

<B>
Friedman, J. F.,
R. W. Dudek,
D. S. Whitehead,
D. L. Downes,
J. F. Caro,
and 
G. L. Dohm.</B>
Immunolocalization of glucose transporter GLUT4 within human skeletal muscle.
<I>Diabetes</I>
40:
150-154,
1991<!-- HIGHWIRE ID="276:3:E409:42" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=diabetes&resid=40/1/150" >[Abstract]</A><!-- /HIGHWIRE -->.<BR><BR>
<a name="B43">43.</a>
    &nbsp;

<B>
Fuchi, T.,
H. Rosdahl,
R. C. Hickner,
U. Ungerstedt,
and 
H. Wallberg-Henricksson.</B>
Microdialysis of rat skeletal muscle and adipose tissue: dynamics of the interstitial glucose pool.
<I>Acta Physiol. Scand.</I>
151:
249-260,
1994<!-- HIGHWIRE ID="276:3:E409:43" --><A HREF="/cgi/external_ref?access_num=7942061&link_type=MED" >[Medline]</A><!-- /HIGHWIRE -->.<BR><BR>
<a name="B44">44.</a>
    &nbsp;

<B>
Galante, P.,
L. Mosthaf,
M. Kellerer,
L. Berti,
S. Tippner,
B. Bossenmaier,
T. Fujiwara,
A. Okuno,
H. Horikoshi,
and 
H. U. Haring.</B>
Acute hyperglycemia provides an insulin-independent inducer for GLUT4 translocation in C<SUB>2</SUB>C<SUB>12</SUB> myotubes and rat skeletal muscle.
<I>Diabetes</I>
44:
646-651,
1995<!-- HIGHWIRE ID="276:3:E409:44" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=diabetes&resid=44/6/646" >[Abstract]</A><!-- /HIGHWIRE -->.<BR><BR>
<a name="B45">45.</a>
    &nbsp;

<B>
Gao, J.,
E. A. Gulve,
and 
J. O. Holloszy.</B>
Contraction-induced increase in muscle insulin sensitivity: requirement for a serum factor.
<I>Am. J.&nbsp;Physiol.</I>
266 (<I>Endocrinol. Metab.</I> 29):
E186-E192,
1994<!-- HIGHWIRE ID="276:3:E409:45" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=ajpendo&resid=266/2/E186" ><nobr>[Abstract/<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE -->.<BR><BR>
<a name="B46">46.</a>
    &nbsp;

<B>
Goldstein, M. S.</B>
Humoral nature of hypoglycemia in muscular exercise.
<I>Am. J.&nbsp;Physiol.</I>
200:
67-70,
1961<!-- HIGHWIRE ID="276:3:E409:46" --><!-- /HIGHWIRE -->.<BR><BR>
<a name="B46a">46a.</a>
    &nbsp;

<B>
Goldstein, M. S.,
V. Mullick,
B. Huddleston,
and 
R. Levine.</B>
Action of muscular work on transfer of sugars across cell membranes: comparison with action of insulin.
<I>Am. J.&nbsp;Physiol.</I>
173:
212-216,
1953<!-- HIGHWIRE ID="276:3:E409:47" --><!-- /HIGHWIRE -->.<BR><BR>
<a name="B47">47.</a>
    &nbsp;

<B>
Goodwin, R. F.&nbsp;W.</B>
The distribution of sugar between red cells and plasma: variations associated with age and species.
<I>J. Physiol. (Lond.)</I>
134:
88-101,
1956<!-- HIGHWIRE ID="276:3:E409:48" --><!-- /HIGHWIRE -->.<BR><BR>
<a name="B48">48.</a>
    &nbsp;

<B>
Goodyear, L. J.,
M. F. Hirshman,
R. J. Smith,
and 
E. S. Horton.</B>
Glucose transporter number, activity, and isoform content in plasma membranes of red and white skeletal muscle.
<I>Am. J.&nbsp;Physiol.</I>
261 (<I>Endocrinol. Metab.</I> 24):
E556-E561,
1991<!-- HIGHWIRE ID="276:3:E409:49" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=ajpendo&resid=261/5/E556" ><nobr>[Abstract/<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE -->.<BR><BR>
<a name="B49">49.</a>
    &nbsp;

<B>
Goodyear, L. J.,
and 
B. B. Kahn.</B>
Exercise, glucose transport, and insulin sensitivity.
<I>Annu. Rev. Med.</I>
49:
235-261,
1998<!-- HIGHWIRE ID="276:3:E409:50" --><A HREF="/cgi/external_ref?access_num=9509261&link_type=MED" >[Medline]</A><!-- /HIGHWIRE -->.<BR><BR>
<a name="B50">50.</a>
    &nbsp;

<B>
Goodyear, L. J.,
P. A. King,
M. F. Hirshman,
C. M. Thompson,
E. D. Horton,
and 
E. S. Horton.</B>
Contractile activity increases plasma membrane glucose transporters in absence of insulin.
<I>Am. J.&nbsp;Physiol.</I>
258 (<I>Endocrinol. Metab.</I> 21):
E667-E672,
1990<!-- HIGHWIRE ID="276:3:E409:51" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=ajpendo&resid=258/4/E667" ><nobr>[Abstract/<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE -->.<BR><BR>
<a name="B51">51.</a>
    &nbsp;

<B>
Groop, L. C.,
R. C. Bonadonna,
S. DelPrato,
K. Ratheiser,
K. Zyck,
E. Ferrannini,
and 
R. A. DeFronzo.</B>
Glucose and free fatty acid metabolism in non-insulin-dependent diabetes mellitus.
<I>J. Clin. Invest.</I>
84:
205-213,
1989<!-- HIGHWIRE ID="276:3:E409:52" --><A HREF="/cgi/external_ref?access_num=2661589&link_type=MED" >[Medline]</A><!-- /HIGHWIRE -->.<BR><BR>
<a name="B52">52.</a>
    &nbsp;

<B>
Guarner, V.,
and 
R. Alvarez-Buylla.</B>
Erythrocytes and glucose homeostasis in rats.
<I>Diabetes</I>
38:
410-415,
1989<!-- HIGHWIRE ID="276:3:E409:53" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=diabetes&resid=38/4/410" >[Abstract]</A><!-- /HIGHWIRE -->.<BR><BR>
<a name="B53">53.</a>
    &nbsp;

<B>
Halama, J. R.,
S. J. Gatley,
T. R. DeGrado,
D. R. Bernstein,
C. K. Ng,
and 
J. E. Holden.</B>
Validation of 3-deoxy-3-fluoro-<font size=-1>D</font>-glucose as a glucose transport analogue in rat heart.
<I>Am. J.&nbsp;Physiol.</I>
247 (<I>Heart Circ. Physiol.</I> 16):
H754-H759,
1984<!-- HIGHWIRE ID="276:3:E409:54" --><A HREF="/cgi/external_ref?access_num=6496756&link_type=MED" >[Medline]</A><!-- /HIGHWIRE -->.<BR><BR>
<a name="B54">54.</a>
    &nbsp;

<B>
Havel, R. J.,
B. Pernow,
and 
N. L. Jones.</B>
Uptake and release of free fatty acids and other metabolites in the legs of exercising men.
<I>J. Appl. Physiol.</I>
23:
90-96,
1967<!-- HIGHWIRE ID="276:3:E409:55" --><A HREF="/cgi/ijlink?linkType=PDF&journalCode=jap&resid=23/1/90" ><nobr>[<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE -->.<BR><BR>
<a name="B55">55.</a>
    &nbsp;

<B>
Heim, J. W.,
and 
B. N. Berg.</B>
The sugar in blood and subcutaneous lymph following insulin administration.
<I>Am. J.&nbsp;Physiol.</I>
105:
674-677,
1933<!-- HIGHWIRE ID="276:3:E409:56" --><!-- /HIGHWIRE -->.<BR><BR>
<a name="B56">56.</a>
    &nbsp;

<B>
Hirshman, M. F.,
L. J. Goodyear,
E. D. Horton,
L. J. Wardzala,
and 
E. S. Horton.</B>
Exercise training increases GLUT-4 protein in rat adipose cells.
<I>Am. J.&nbsp;Physiol.</I>
264 (<I>Endocrinol. Metab.</I> 27):
E882-E889,
1993<!-- HIGHWIRE ID="276:3:E409:57" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=ajpendo&resid=264/6/E882" ><nobr>[Abstract/<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE -->.<BR><BR>
<a name="B57">57.</a>
    &nbsp;

<B>
Holman, G. D.,
I. J. Kozka,
A. E. Clark,
C. J. Flower,
J. Saltis,
A. D. Habberfield,
I. A. Simpson,
and 
S. W. Cushman.</B>
Cell surface labeling of glucose transporter isoform GLUT4 by bismannose photolabel. Correlation with stimulation of glucose transport in adipose cells by insulin and phorbolester.
<I>J. Biol. Chem.</I>
265:
18172-18179,
1990<!-- HIGHWIRE ID="276:3:E409:58" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=jbc&resid=265/30/18172" ><nobr>[Abstract/<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE -->.<BR><BR>
<a name="B58">58.</a>
    &nbsp;

<B>
Holloszy, J. O.,
and 
W. M. Kohrt.</B>
Regulation of carbohydrate and fat metabolism during and after exercise.
<I>Annu. Rev. Nutr.</I>
16:
121-138,
1996<!-- HIGHWIRE ID="276:3:E409:59" --><A HREF="/cgi/external_ref?access_num=8839922&link_type=MED" >[Medline]</A><!-- /HIGHWIRE -->.<BR><BR>
<a name="B59">59.</a>
    &nbsp;

<B>
Hother-Nielsen, O.,
and 
H. Beck-Nielsen.</B>
On the determination of basal glucose production rate in patients with type 2&nbsp;(non-insulin-dependent) diabetes mellitus using primed-continuous <SUP>3</SUP>H-glucose infusion.
<I>Diabetologia</I>
33:
603-610,
1990<!-- HIGHWIRE ID="276:3:E409:60" --><A HREF="/cgi/external_ref?access_num=2257997&link_type=MED" >[Medline]</A><!-- /HIGHWIRE -->.<BR><BR>
<a name="B60">60.</a>
    &nbsp;

<B>
Idstrom, J. P.,
M. J. Rennie,
T. Scherstein,
and 
A. C. Bylund-Fellenius.</B>
Membrane transport in relation to net uptake of glucose in the perfused rat hindlimb. Stimulatory effect of insulin, hypoxia and contractile activity.
<I>Biochem. J.</I>
233:
11-17,
1986<!-- HIGHWIRE ID="276:3:E409:61" --><!-- /HIGHWIRE -->.<BR><BR>
<a name="B61">61.</a>
    &nbsp;

<B>
<IMG SRC="/content/vol276/issue3/fulltext/E409/img001.gif" 
	 ALT="&Idot;">mery&uuml;z, N.,
B. &Ccedil;. Ye<IMG SRC="/math/12pt/normal/gbreve.gif" ALIGN=BASELINE ALT="g">en,
A. Bozkurt,
T. Co<IMG SRC="/math/12pt/normal/scedil.gif" ALIGN=BASELINE ALT="s">kun,
M. L. Villaneuva-Pe&ntilde;acarrillo,
and 
N. B. Ulusoy.</B>
Glucagon-like peptide-1 inhibits gastric emptying via vagal afferent-mediated central mechanisms.
<I>Am. J.&nbsp;Physiol.</I>
273 (<I>Gastrointest. Liver Physiol.</I> 36):
G920-G927,
1997<!-- HIGHWIRE ID="276:3:E409:62" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=ajpgi&resid=273/4/G920" ><nobr>[Abstract/<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE -->.<BR><BR>
<a name="B62">62.</a>
    &nbsp;

<B>
Insel, P. A.,
J. E. Liljenquist,
J. D. Tobin,
R. S. Sherwin,
P. Watkins,
R. Andres,
and 
M. Berman.</B>
Insulin control of glucose metabolism in man. A new kinetic analysis.
<I>J. Clin. Invest.</I>
55:
1057-1066,
1975<!-- HIGHWIRE ID="276:3:E409:63" --><!-- /HIGHWIRE -->.<BR><BR>
<a name="B63">63.</a>
    &nbsp;

<B>
Jacquez, J. A.</B>
Red blood cell as glucose carrier: significance for placental and cerebral glucose transfer.
<I>Am. J.&nbsp;Physiol.</I>
246 (<I>Regulatory Integrative Comp. Physiol.</I> 15):
R289-R298,
1984<!-- HIGHWIRE ID="276:3:E409:64" --><A HREF="/cgi/external_ref?access_num=6367491&link_type=MED" >[Medline]</A><!-- /HIGHWIRE -->.<BR><BR>
<a name="B64">64.</a>
    &nbsp;

<B>
Karasov, W. H.,
and 
J. M. Diamond.</B>
Adaptive regulation of sugar and amino acid transport by vertebrate intestine.
<I>Am. J.&nbsp;Physiol.</I>
245 (<I>Gastrointest. Liver Physiol.</I> 8):
G443-G462,
1983<!-- HIGHWIRE ID="276:3:E409:65" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=ajpgi&resid=245/4/G443" ><nobr>[Abstract/<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE -->.<BR><BR>
<a name="B65">65.</a>
    &nbsp;

<B>
Katz, A.,
B. L. Nyomba,
and 
C. Bogardus.</B>
No accumulation of glucose in human skeletal muscle during euglycemic hyperinsulinemia.
<I>Am. J.&nbsp;Physiol.</I>
255 (<I>Endocrinol. Metab.</I> 18):
E942-E945,
1988<!-- HIGHWIRE ID="276:3:E409:66" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=ajpendo&resid=255/6/E942" ><nobr>[Abstract/<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE -->.<BR><BR>
<a name="B66">66.</a>
    &nbsp;

<B>
Kelley, D. E.,
M. Mokan,
J.-A. Simoneau,
and 
L. Mandarino.</B>
Interaction between glucose and fatty acid metabolism in human skeletal muscle.
<I>J. Clin. Invest.</I>
92:
91-98,
1993<!-- HIGHWIRE ID="276:3:E409:67" --><A HREF="/cgi/external_ref?access_num=8326021&link_type=MED" >[Medline]</A><!-- /HIGHWIRE -->.<BR><BR>
<a name="B67">67.</a>
    &nbsp;

<B>
Kern, M.,
E. B. Tapscott,
R. D. Snider,
and 
G. L. Dohm.</B>
Differences in glucose transport rates between perfused and in vitro incubated muscles.
<I>Horm. Metab. Res.</I>
22:
366-368,
1990<!-- HIGHWIRE ID="276:3:E409:68" --><A HREF="/cgi/external_ref?access_num=2205555&link_type=MED" >[Medline]</A><!-- /HIGHWIRE -->.<BR><BR>
<a name="B68">68.</a>
    &nbsp;

<B>
Kim, Y.,
S. Iwashita,
T. Tamura,
K. Tokuyama,
and 
M. Suzuki.</B>
Effect of high-fat diet on the gene expression of pancreatic GLUT2 and glucokinase in rats.
<I>Biochem. Biophys. Res. Commun.</I>
208:
1092-1098,
1995<!-- HIGHWIRE ID="276:3:E409:69" --><A HREF="/cgi/external_ref?access_num=7702608&link_type=MED" >[Medline]</A><!-- /HIGHWIRE -->.<BR><BR>
<a name="B69">69.</a>
    &nbsp;

<B>
Kim, J. K.,
J. K. Wi,
and 
J. H. Youn.</B>
Plasma free fatty acids decrease insulin-stimulated skeletal muscle glucose uptake by suppressing glycolysis in conscious rats.
<I>Diabetes</I>
45:
446-453,
1996<!-- HIGHWIRE ID="276:3:E409:70" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=diabetes&resid=45/4/446" >[Abstract]</A><!-- /HIGHWIRE -->.<BR><BR>
<a name="B70">70.</a>
    &nbsp;

<B>
Kimmich, G. A.,
C. Carter-Su,
and 
J. Randles.</B>
Energetics of Na<SUP>+</SUP>-dependent sugar transport by isolated intestinal cells: evidence for a major role for membrane potentials.
<I>Am. J.&nbsp;Physiol.</I>
233 (<I>Endocrinol. Metab. Gastrointest. Physiol.</I> 2):
E357-E362,
1977<!-- HIGHWIRE ID="276:3:E409:71" --><A HREF="/cgi/external_ref?access_num=562624&link_type=MED" >[Medline]</A><!-- /HIGHWIRE -->.<BR><BR>
<a name="B71">71.</a>
    &nbsp;

<B>
King, P. A.,
J. J. Betts,
E. D. Horton,
and 
E. S. Horton.</B>
Exercise, unlike insulin, promotes glucose transporter translocation in obese Zucker rat muscle.
<I>Am. J.&nbsp;Physiol.</I>
265 (<I>Regulatory Integrative Comp. Physiol.</I> 34):
R447-R452,
1993<!-- HIGHWIRE ID="276:3:E409:72" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=ajpregu&resid=265/2/R447" ><nobr>[Abstract/<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE -->.<BR><BR>
<a name="B72">72.</a>
    &nbsp;

<B>
King, P. A.,
M. F. Hirshman,
E. D. Horton,
and 
E. S. Horton.</B>
Glucose transport in skeletal muscle membrane vesicles from control and exercised rats.
<I>Am. J.&nbsp;Physiol.</I>
257 (<I>Cell Physiol.</I> 26):
C1128-C1134,
1989<!-- HIGHWIRE ID="276:3:E409:73" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=ajpcell&resid=257/6/C1128" ><nobr>[Abstract/<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE -->.<BR><BR>
<a name="B73">73.</a>
    &nbsp;

<B>
Klip, A.,
and 
M. R. Piquet.</B>
Glucose transport and glucose transporters in muscle and their metabolic regulation.
<I>Diabetes Care</I>
13:
228-243,
1990<!-- HIGHWIRE ID="276:3:E409:74" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=diacare&resid=13/3/228" >[Abstract]</A><!-- /HIGHWIRE -->.<BR><BR>
<a name="B74">74.</a>
    &nbsp;

<B>
Klip, A.,
T. Ramial,
D. A. Young,
and 
J. O. Holloszy.</B>
Insulin-induced translocation of glucose transporters in rat hindlimb muscles.
<I>FEBS Lett.</I>
224:
224-230,
1987<!-- HIGHWIRE ID="276:3:E409:75" --><A HREF="/cgi/external_ref?access_num=2960560&link_type=MED" >[Medline]</A><!-- /HIGHWIRE -->.<BR><BR>
<a name="B75">75.</a>
    &nbsp;

<B>
Klip, A.,
A. Volchuk,
H. Lijing,
and 
T. Tsakiridis.</B>
The glucose transporters of skeletal muscle.
<I>Semin. Cell Dev. Biol.</I>
7:
229-237,
1996<!-- HIGHWIRE ID="276:3:E409:76" --><!-- /HIGHWIRE -->.<BR><BR>
<a name="B76">76.</a>
    &nbsp;

<B>
Kozka, I. J.,
A. E. Clark,
and 
G. D. Holman.</B>
Chronic treatment with insulin selectively down-regulates cell-surface GLUT4 transporters in 3T3-L1 adipocytes.
<I>J. Biol. Chem.</I>
266:
11726-11731,
1991<!-- HIGHWIRE ID="276:3:E409:77" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=jbc&resid=266/18/11726" ><nobr>[Abstract/<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE -->.<BR><BR>
<a name="B77">77.</a>
    &nbsp;

<B>
Laakso, M.,
S. V. Edelman,
G. Brechtel,
and 
A. D. Baron.</B>
Decreased effect of insulin to stimulate skeletal muscle blood flow in obese man.
<I>J. Clin. Invest.</I>
85:
1844-1852,
1990<!-- HIGHWIRE ID="276:3:E409:78" --><A HREF="/cgi/external_ref?access_num=2189893&link_type=MED" >[Medline]</A><!-- /HIGHWIRE -->.<BR><BR>
<a name="B78">78.</a>
    &nbsp;

<B>
Lewis, G. F.,
M. Vranic,
P. Harley,
and 
A. Giacca.</B>
Fatty acids mediate the acute extrahepatic effects of insulin on hepatic glucose production in humans.
<I>Diabetes</I>
46:
1111-1119,
1997<!-- HIGHWIRE ID="276:3:E409:79" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=diabetes&resid=46/7/1111" >[Abstract]</A><!-- /HIGHWIRE -->.<BR><BR>
<a name="B79">79.</a>
    &nbsp;

<B>
Maggs, D. G.,
R. Jacobs,
F. Rife,
S. Caprio,
W. V. Tamborlane,
and 
R. S. Sherwin.</B>
Counterregulation in peripheral tissues. Effect of systemic hypoglycemia on levels of substrates and catecholamines in human skeletal muscle and adipose tissue.
<I>Diabetes</I>
46:
70-76,
1997<!-- HIGHWIRE ID="276:3:E409:80" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=diabetes&resid=46/1/70" >[Abstract]</A><!-- /HIGHWIRE -->.<BR><BR>
<a name="B80">80.</a>
    &nbsp;

<B>
Magnan, C.,
M. Gilbert,
and 
B. B. Kahn.</B>
Chronic free fatty acid infusion in rats results in insulin resistance but no alteration in insulin-responsive glucose transporter levels in skeletal muscle.
<I>Lipids</I>
31:
1141-1149,
1995<!-- HIGHWIRE ID="276:3:E409:81" --><!-- /HIGHWIRE -->.<BR><BR>
<a name="B81">81.</a>
    &nbsp;

<B>
Marette, A.,
E. Burdett,
A. Douen,
M. Vranic,
and 
A. Klip.</B>
Insulin induces the translocation of GLUT4 from a unique intracellular organelle to transverse tubules in rat skeletal muscle.
<I>Diabetes</I>
41:
1562-1569,
1992<!-- HIGHWIRE ID="276:3:E409:82" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=diabetes&resid=41/12/1562" >[Abstract]</A><!-- /HIGHWIRE -->.<BR><BR>
<a name="B82">82.</a>
    &nbsp;

<B>
Mari, A.</B>
Determination of the single-pass impulse response of the body tissues with circulatory models.
<I>IEEE Trans. Biomed. Eng.</I>
42:
304-312,
1995<!-- HIGHWIRE ID="276:3:E409:83" --><A HREF="/cgi/external_ref?access_num=7698786&link_type=MED" >[Medline]</A><!-- /HIGHWIRE -->.<BR><BR>
<a name="B83">83.</a>
    &nbsp;

<B>
McCall, R. H.,
S. R. Wiesenthal,
Z. Q. Shi,
K. Polonsky,
and 
A. Giacca.</B>
Insulin acutely suppresses glucose production by both peripheral and hepatic effects in normal dogs.
<I>Am. J.&nbsp;Physiol.</I>
274 (<I>Endocrinol. Metab.</I> 37):
E346-E356,
1998<!-- HIGHWIRE ID="276:3:E409:84" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=ajpendo&resid=274/2/E346" ><nobr>[Abstract/<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE -->.<BR><BR>
<a name="B84">84.</a>
    &nbsp;

<B>
McKay, E. M.</B>
The distribution of glucose in human blood.
<I>J. Biol. Chem.</I>
97:
685-689,
1932<!-- HIGHWIRE ID="276:3:E409:85" --><A HREF="/cgi/ijlink?linkType=PDF&journalCode=jbc&resid=97/3/685" ><nobr>[<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE -->.<BR><BR>
<a name="B85">85.</a>
    &nbsp;

<B>
Mehboob, A. H.,
O. Schmitz,
and 
E. R. Froesch.</B>
Growth hormone, insulin, and insulin-like growth factor 1: revisiting the food and famine theory.
<I>News Physiol. Sci.</I>
10:
81-86,
1995.<!-- HIGHWIRE ID="276:3:E409:86" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=nips&resid=10/2/81" ><nobr>[Abstract/<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE --><BR><BR>
<a name="B86">86.</a>
    &nbsp;

<B>
Mittleman, S. D.,
Y.-Y. Fu,
K. Rebin,
G. Steil,
and 
R. N. Bergman.</B>
Indirect effect of insulin to suppress endogenous glucose production is dominant, even with hyperglucagonemia.
<I>J. Clin. Invest.</I>
100:
3121-3130,
1997<!-- HIGHWIRE ID="276:3:E409:87" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=jci&resid=100/12/3121" ><nobr>[Abstract/<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE -->.<BR><BR>
<a name="B87">87.</a>
    &nbsp;

<B>
Mueckler, M.</B>
Facilitative glucose transporters.
<I>Eur. J.&nbsp;Biochem.</I>
219:
713-725,
1994<!-- HIGHWIRE ID="276:3:E409:88" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=ejbiochem&resid=219/3/713" >[Abstract]</A><!-- /HIGHWIRE -->.<BR><BR>
<a name="B88">88.</a>
    &nbsp;

<B>
Myers, J. D.</B>
Net splanchnic glucose production in normal man and in various disease states.
<I>J. Clin. Invest.</I>
29:
1421-1429,
1950<!-- HIGHWIRE ID="276:3:E409:89" --><!-- /HIGHWIRE -->.<BR><BR>
<a name="B89">89.</a>
    &nbsp;

<B>
Natali, A.,
R. Bonadonna,
D. Santoro,
A. Q. Galvin,
S. Baldi,
S. Frascerra,
C. Palombo,
S. Ghione,
and 
E. Ferrannini.</B>
Insulin resistance and vasodilation in hypertension. Studies with adenosine.
<I>J. Clin. Invest.</I>
94:
1570-1576,
1994<!-- HIGHWIRE ID="276:3:E409:90" --><A HREF="/cgi/external_ref?access_num=7929833&link_type=MED" >[Medline]</A><!-- /HIGHWIRE -->.<BR><BR>
<a name="B90">90.</a>
    &nbsp;

<B>
Natali, A.,
A. Quinones Galvan,
N. Pecon,
G. Sanna,
E. Toschi,
and 
E. Ferrannini.</B>
Vasodilation with sodium nitroprusside does not improve insulin action in essential hypertension.
<I>Hypertension</I>
31:
632-636,
1998<!-- HIGHWIRE ID="276:3:E409:91" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=hypertensionaha&resid=31/2/632" ><nobr>[Abstract/<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE -->.<BR><BR>
<a name="B91">91.</a>
    &nbsp;

<B>
Olson, A. L.,
and 
J. E. Pessin.</B>
Structure, function, and regulation of the mammalian facilitated diffusion transporter gene family.
<I>Annu. Rev. Nutr.</I>
16:
236-256,
1996<!-- HIGHWIRE ID="276:3:E409:92" --><!-- /HIGHWIRE -->.<BR><BR>
<a name="B92">92.</a>
    &nbsp;

<B>
Peters, J. P.,
and 
D. D. Van Slyke.</B>


<I>Quantitative Clinical Chemistry</I> (2nd ed.). Baltimore, MD: Williams &amp;&nbsp;Wilkins, 1946, vol. I, p. 166-167.<!-- HIGHWIRE ID="276:3:E409:93" --><!-- /HIGHWIRE --><BR><BR>
<a name="B93">93.</a>
    &nbsp;

<B>
Philpott, D. J.,
J. D. Butzner,
and 
J. B. Meddings.</B>
Regulation of intestinal glucose transport.
<I>Can. J.&nbsp;Physiol. Pharmacol.</I>
70:
1201-1207,
1992<!-- HIGHWIRE ID="276:3:E409:94" --><A HREF="/cgi/external_ref?access_num=1493588&link_type=MED" >[Medline]</A><!-- /HIGHWIRE -->.<BR><BR>
<a name="B94">94.</a>
    &nbsp;

<B>
Pickup, J. C.,
G. W. Shaw,
and 
D. J. Claremont.</B>
In vivo molecular sensing in diabetes mellitus; an implantable glucose sensor with direct electron transfer.
<I>Diabetologia</I>
32:
213-217,
1989<!-- HIGHWIRE ID="276:3:E409:95" --><A HREF="/cgi/external_ref?access_num=2666212&link_type=MED" >[Medline]</A><!-- /HIGHWIRE -->.<BR><BR>
<a name="B95">95.</a>
    &nbsp;

<B>
Prager, R.,
P. Wallace,
and 
J. M. Olefsky.</B>
Direct and indirect effects of insulin to inhibit hepatic glucose output in obese subjects.
<I>Diabetes</I>
36:
607-611,
1987<!-- HIGHWIRE ID="276:3:E409:96" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=diabetes&resid=36/5/607" >[Abstract]</A><!-- /HIGHWIRE -->.<BR><BR>
<a name="B96">96.</a>
    &nbsp;

<B>
Rabinowitz, D.,
and 
K. L. Zierler.</B>
A metabolic regulating device based on the actions of human growth hormone and of insulin, singly and together, on the human forearm.
<I>Nature</I>
199:
913-915,
1963<!-- HIGHWIRE ID="276:3:E409:97" --><!-- /HIGHWIRE -->.<BR><BR>
<a name="B97">97.</a>
    &nbsp;

<B>
Radziuk, J.,
and 
H. L. Lickley.</B>
The metabolic clearance of glucose: measurement and meaning.
<I>Diabetologia</I>
28:
315-322,
1985<!-- HIGHWIRE ID="276:3:E409:98" --><A HREF="/cgi/external_ref?access_num=3899817&link_type=MED" >[Medline]</A><!-- /HIGHWIRE -->.<BR><BR>
<a name="B98">98.</a>
    &nbsp;

<B>
Raitakari, M.,
P. Nuutila,
U. Ruotsalainen,
H. Laine,
M. Teras,
H. Iida,
S. Makimattila,
T. Utriainen,
V. Oikonen,
H. Sipila,
M. Haaparanta,
O. Solin,
U. Wegelius,
J. Knuuti,
and 
H. Yki-Jarvinen.</B>
Evidence for dissociation of insulin stimulation of blood flow and glucose uptake in human skeletal muscle: studies using [<SUP>15</SUP>O]H<SUB>2</SUB>O, [F]fluoro-2-<font size=-1>D</font>-glucose, and positron emission tomography.
<I>Diabetes</I>
45:
1471-1477,
1996<!-- HIGHWIRE ID="276:3:E409:99" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=diabetes&resid=45/11/1471" >[Abstract]</A><!-- /HIGHWIRE -->.<BR><BR>
<a name="B99">99.</a>
    &nbsp;

<B>
Randle, P. J.,
P. B. Garland,
C. N. Hales,
and 
E. A. Newsholme.</B>
The glucose fatty acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus.
<I>Lancet</I>
i:
785-789,
1963<!-- HIGHWIRE ID="276:3:E409:100" --><!-- /HIGHWIRE -->.<BR><BR>
<a name="B100">100.</a>
    &nbsp;

<B>
Randle, P. J.,
and 
G. H. Smith.</B>
Regulation of glucose uptake by muscle. 1.&nbsp;The effects of insulin, anaerobiosis and cell poisons on uptake of glucose and release of potassium by isolated rat diaphragm.
<I>Biochem. J.</I>
70:
490-508,
1958<!-- HIGHWIRE ID="276:3:E409:101" --><!-- /HIGHWIRE -->.<BR><BR>
<a name="B101">101.</a>
    &nbsp;

<B>
Rebrin, K.,
G. M. Stell,
S. D. Mittelman,
and 
R. N. Bergman.</B>
Causal linkage between insulin suppression of lipolysis and suppression of liver glucose output on dogs.
<I>J. Clin. Invest.</I>
98:
741-749,
1996<!-- HIGHWIRE ID="276:3:E409:102" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=jci&resid=98/3/741" ><nobr>[Abstract/<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE -->.<BR><BR>
<a name="B102">102.</a>
    &nbsp;

<B>
Reynolds, T. H., IV,
J. T. Brozinick, Jr.,
M. A. Rogers,
and 
S. W. Cushman.</B>
Effects of exercise training on glucose transport and cell surface GLUT-4 in isolated rat epitrochlearis muscle.
<I>Am. J.&nbsp;Physiol.</I>
272 (<I>Endocrinol. Metab.</I> 35):
E320-E325,
1997<!-- HIGHWIRE ID="276:3:E409:103" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=ajpendo&resid=272/2/E320" ><nobr>[Abstract/<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE -->.<BR><BR>
<a name="B103">103.</a>
    &nbsp;

<B>
Rosholt, M. N.,
P. A. King,
and 
E. S. Horton.</B>
High-fat diet reduces glucose transporter responses to both insulin and exercise.
<I>Am. J.&nbsp;Physiol.</I>
266 (<I>Regulatory Integrative Comp. Physiol.</I> 35):
R95-R101,
1994<!-- HIGHWIRE ID="276:3:E409:104" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=ajpregu&resid=266/1/R95" ><nobr>[Abstract/<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE -->.<BR><BR>
<a name="B104">104.</a>
    &nbsp;

<B>
Scheinberg, P.,
and 
E. A. Stead, Jr.</B>
The cerebral blood flow in male subjects as measured by the nitrous oxide technique. Normal values for blood flow, oxygen utilization, glucose utilization, and peripheral resistance, with observations on the effects of tilting and anxiety.
<I>J. Clin. Invest.</I>
28:
1163-1171,
1949<!-- HIGHWIRE ID="276:3:E409:105" --><!-- /HIGHWIRE -->.<BR><BR>
<a name="B105">105.</a>
    &nbsp;

<B>
Scherrer, U.,
D. Randin,
P. Vollender,
L. Vollender,
and 
P. Nicod.</B>
Nitric oxide release accounts for insulin's vascular effects in humans.
<I>J. Clin. Invest.</I>
94:
2511-2515,
1994<!-- HIGHWIRE ID="276:3:E409:106" --><A HREF="/cgi/external_ref?access_num=7989610&link_type=MED" >[Medline]</A><!-- /HIGHWIRE -->.<BR><BR>
<a name="B106">106.</a>
    &nbsp;

<B>
Schmidt, F. J.,
W. J. Slutter,
and 
A. J.&nbsp;M. Schooner.</B>
Glucose concentration in subcutaneous extracellular space.
<I>Diabetes Care</I>
16:
695-700,
1993<!-- HIGHWIRE ID="276:3:E409:107" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=diacare&resid=16/5/695" >[Abstract]</A><!-- /HIGHWIRE -->.<BR><BR>
<a name="B107">107.</a>
    &nbsp;

<B>
Shulman, G. I.,
D. L. Rothman,
T. Jue,
P. Stein,
R. A. DeFronzo,
and 
R. G. Shulman.</B>
Quantitation of muscle glycogen synthesis in normal subjects and subjects with non-insulin dependent diabetes by <SUP>13</SUP>C nuclear magnetic resonance spectroscopy.
<I>N. Engl. J.&nbsp;Med.</I>
322:
223-228,
1990<!-- HIGHWIRE ID="276:3:E409:108" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=nejm&resid=322/4/223" >[Abstract]</A><!-- /HIGHWIRE -->.<BR><BR>
<a name="B108">108.</a>
    &nbsp;

<B>
Sindelar, D. K.,
C. A. Chu,
D. W. Neal,
and 
A. D. Cherrington.</B>
Interaction of equal increments in arterial and portal vein insulin on hepatic glucose production in the dog.
<I>Am. J.&nbsp;Physiol.</I>
273 (<I>Endocrinol. Metab.</I> 36):
E972-E980,
1997<!-- HIGHWIRE ID="276:3:E409:109" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=ajpendo&resid=273/5/E972" ><nobr>[Abstract/<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE -->.<BR><BR>
<a name="B109">109.</a>
    &nbsp;

<B>
Sindelar, D. K.,
C. A. Chu,
M. Rohlie,
D. W. Neal,
L. L. Swift,
and 
A. D. Cherrington.</B>
The role of fatty acids in mediating the effects of peripheral insulin on hepatic glucose production in the conscious dog.
<I>Diabetes</I>
46:
187-196,
1997<!-- HIGHWIRE ID="276:3:E409:110" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=diabetes&resid=46/2/187" >[Abstract]</A><!-- /HIGHWIRE -->.<BR><BR>
<a name="B110">110.</a>
    &nbsp;

<B>
Sindelar, D. K.,
C. A. Chu,
P. Venson,
P. Donahue,
D. W. Neal,
and 
A. D. Cherrington.</B>
Basal hepatic glucose production is regulated by the portal vein insulin concentration.
<I>Diabetes</I>
47:
523-529,
1998<!-- HIGHWIRE ID="276:3:E409:111" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=diabetes&resid=47/4/523" >[Abstract]</A><!-- /HIGHWIRE -->.<BR><BR>
<a name="B111">111.</a>
    &nbsp;

<B>
Somogyi, M.</B>
Studies of arteriovenous differences in blood sugar. I.&nbsp;Effect of alimentary hyperglycemia on the rate of extrahepatic glucose assimilation.
<I>J. Biol. Chem.</I>
174:
189-200,
1948<!-- HIGHWIRE ID="276:3:E409:112" --><A HREF="/cgi/ijlink?linkType=PDF&journalCode=jbc&resid=174/1/189" ><nobr>[<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE -->.<BR><BR>
<a name="B112">112.</a>
    &nbsp;

<B>
Steinberg, H. O.,
G. Brechtel,
A. Johnson,
N. Fineberg,
and 
A. D. Baron.</B>
Insulin-mediated skeletal muscle vasodilation is nitric oxide dependent. A novel action of insulin to increase nitric oxide release.
<I>J. Clin. Invest.</I>
94:
1172-1179,
1994<!-- HIGHWIRE ID="276:3:E409:113" --><A HREF="/cgi/external_ref?access_num=8083357&link_type=MED" >[Medline]</A><!-- /HIGHWIRE -->.<BR><BR>
<a name="B113">113.</a>
    &nbsp;

<B>
Stumvoll, M.,
U. Chintalapudi,
G. Perriello,
S. Wells,
O. Gutierrez,
and 
J. Sarich.</B>
Uptake and release of glucose by the human kidney. Postabsorptive rates and responses to epinephrine.
<I>J. Clin. Invest.</I>
96:
2528-2533,
1955<!-- HIGHWIRE ID="276:3:E409:114" --><!-- /HIGHWIRE -->.<BR><BR>
<a name="B114">114.</a>
    &nbsp;

<B>
Suzuki, K.,
and 
T. Kono.</B>
Evidence that insulin causes translocation of glucose transport activity to the plasma membrane from an intracellular storage site.
<I>Proc. Natl. Acad. Sci. USA</I>
77:
2542-2545,
1980<!-- HIGHWIRE ID="276:3:E409:115" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=pnas&resid=77/5/2542" >[Abstract]</A><!-- /HIGHWIRE -->.<BR><BR>
<a name="B115">115.</a>
    &nbsp;

<B>
Ueda, S.,
J. R. Petrie,
S. J. Cleland,
H. L. Elliott,
and 
J. M. Connell.</B>
The vasodilating effect of insulin is dependent on local glucose uptake: a double blind, placebo-controlled study.
<I>J. Clin. Endocrinol. Metab.</I>
83:
2126-2131,
1997<!-- HIGHWIRE ID="276:3:E409:116" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=jcem&resid=83/6/2126" ><nobr>[Abstract/<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE -->.<BR><BR>
<a name="B116">116.</a>
    &nbsp;

<B>
Ungar, I.,
M. Gilbert,
A. Siegel,
J. M. Blain,
and 
R. J. Bing.</B>
Studies in myocardial metabolism. IV. Myocardial metabolism in diabetes.
<I>Am. J.&nbsp;Med.</I>
18:
385-396,
1955<!-- HIGHWIRE ID="276:3:E409:117" --><!-- /HIGHWIRE -->.<BR><BR>
<a name="B117">117.</a>
    &nbsp;

<B>
Utriainen, T.,
P. Nuutila,
T. Takala,
P. Vicini,
U. Ruotsalainen,
T. Ronnemaa,
T. Tolvanen,
M. Raitakari,
M. Haaparanta,
O. Kirvela,
C. Cobelli,
and 
H. Yki-Jarvinen.</B>
Intact insulin stimulation of skeletal muscle blood flow, its heterogeneity and redistribution, but not of glucose uptake in non-insulin-dependent diabetes mellitus.
<I>J. Clin. Invest.</I>
100:
777-785,
1997<!-- HIGHWIRE ID="276:3:E409:118" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=jci&resid=100/4/777" ><nobr>[Abstract/<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE -->.<BR><BR>
<a name="B118">118.</a>
    &nbsp;

<B>
Vicini, P.,
R. C. Bonadonna,
T. Utriainen,
P. Nuutila,
M. Raitakari,
H. Yki-Jarvinen,
and 
C. Cobelli.</B>
Estimation of blood flow heterogeneity distribution in human skeletal muscle from positron emission tomography data.
<I>Ann. Biomed. Eng.</I>
25:
906-910,
1997<!-- HIGHWIRE ID="276:3:E409:119" --><A HREF="/cgi/external_ref?access_num=9300115&link_type=MED" >[Medline]</A><!-- /HIGHWIRE -->.<BR><BR>
<a name="B119">119.</a>
    &nbsp;

<B>
Waddell, I. D.,
A. G. Zomerschoe,
M. W. Voice,
and 
A. Burchell.</B>
Cloning and expression of a hepatic microsomal glucose transport protein.
<I>Biochem. J.</I>
286:
173-177,
1992<!-- HIGHWIRE ID="276:3:E409:120" --><A HREF="/cgi/external_ref?access_num=1520266&link_type=MED" >[Medline]</A><!-- /HIGHWIRE -->.<BR><BR>
<a name="B120">120.</a>
    &nbsp;

<B>
Wallberg-Henriksson, H.,
S. H. Constable,
D. A. Young,
and 
J. O. Holloszy.</B>
Glucose transport into rat skeletal muscle: interaction between exercise and insulin.
<I>J. Appl. Physiol.</I>
65:
909-913,
1988<!-- HIGHWIRE ID="276:3:E409:121" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=jap&resid=65/2/909" ><nobr>[Abstract/<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE -->.<BR><BR>
<a name="B121">121.</a>
    &nbsp;

<B>
Wang, Z.,
R. M. Wang,
A. A. Owji,
D. M. Smith,
M. A. Ghatei,
and 
S. R. Bloom.</B>
Glucagon-like peptide is a physiological incretin in the rat.
<I>J. Clin. Invest.</I>
95:
417-421,
1995<!-- HIGHWIRE ID="276:3:E409:122" --><A HREF="/cgi/external_ref?access_num=7814643&link_type=MED" >[Medline]</A><!-- /HIGHWIRE -->.<BR><BR>
<a name="B122">122.</a>
    &nbsp;

<B>
Wasserman, D. H.</B>
Regulation of glucose fluxes during exercise in the postabsorptive state.
<I>Annu. Rev. Physiol.</I>
57:
191-218,
1995<!-- HIGHWIRE ID="276:3:E409:123" --><A HREF="/cgi/external_ref?access_num=7778865&link_type=MED" >[Medline]</A><!-- /HIGHWIRE -->.<BR><BR>
<a name="B123">123.</a>
    &nbsp;

<B>
Wettergren, A.,
B. Schjoldager,
P. E. Mortensen,
J. Myhre,
J. Christiansen,
and 
J. Holst.</B>
Truncated GLP-1 (proglucagon&nbsp;78<IMG SRC="/math/12pt/normal/mdash.gif" ALIGN=BASELINE ALT="---">107-amide) inhibits gastric and pancreatic functions in man.
<I>Dig. Dis. Sci.</I>
38:
665-673,
1993<!-- HIGHWIRE ID="276:3:E409:124" --><A HREF="/cgi/external_ref?access_num=8462365&link_type=MED" >[Medline]</A><!-- /HIGHWIRE -->.<BR><BR>
<a name="B124">124.</a>
    &nbsp;

<B>
Wright, E. M.,
J. R. Hirsch,
D. D.&nbsp;F. Loo,
and 
G. A. Zampighi.</B>
Regulation of Na<SUP>+</SUP>/glucose cotransporters.
<I>J. Exp. Biol.</I>
200:
287-293,
1997<!-- HIGHWIRE ID="276:3:E409:125" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=jexbio&resid=200/2/287" ><nobr>[Abstract/<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE -->.<BR><BR>
<a name="B125">125.</a>
    &nbsp;

<B>
Yki-Jarvinen, H.,
and 
Y. Utriainen.</B>
Insulin-induced vasodilatation: physiology or pharmacology?
<I>Diabetologia</I>
41:
369-379,
1998<!-- HIGHWIRE ID="276:3:E409:126" --><A HREF="/cgi/external_ref?access_num=9562340&link_type=MED" >[Medline]</A><!-- /HIGHWIRE -->.<BR><BR>
<a name="B126">126.</a>
    &nbsp;

<B>
Youn, J. H.,
J. K. Kim,
and 
G. M. Steil.</B>
Assessment of extracellular glucose distribution and glucose transport activity in conscious rats.
<I>Am. J.&nbsp;Physiol.</I>
268 (<I>Endocrinol. Metab.</I> 31):
E712-E721,
1995<!-- HIGHWIRE ID="276:3:E409:127" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=ajpendo&resid=268/4/E712" ><nobr>[Abstract/<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE -->.<BR><BR>
<a name="B127">127.</a>
    &nbsp;

<B>
Young, A. A.,
B. Gedulin,
W. Vine,
A. Percy,
and 
T. J. Rink.</B>
Gastric emptying is accelerated in diabetic BB rats and is slowed by subcutaneous injections of amylin.
<I>Diabetologia</I>
38:
642-648,
1995<!-- HIGHWIRE ID="276:3:E409:128" --><A HREF="/cgi/external_ref?access_num=7672483&link_type=MED" >[Medline]</A><!-- /HIGHWIRE -->.<BR><BR>
<a name="B128">128.</a>
    &nbsp;

<B>
Young, M. E.,
G. K. Radda,
and 
B. Leighton.</B>
Nitric oxide stimulates glucose transport in rat skeletal muscle in vitro.
<I>Biochem. J.</I>
322:
223-228,
1997<!-- HIGHWIRE ID="276:3:E409:129" --><A HREF="/cgi/external_ref?access_num=9078265&link_type=MED" >[Medline]</A><!-- /HIGHWIRE -->.<BR><BR>
<a name="B129">129.</a>
    &nbsp;

<B>
Zampighi, G. A.,
M. Kremen,
K. J. Boorer,
D. D. Loo,
F. Bezanilla,
G. Chando,
J. E. Hall,
and 
E. M. Wright.</B>
A new method for determining the unitary functional capacity of cloned channels and transporters.
<I>J. Membr. Biol.</I>
148:
65-78,
1995<!-- HIGHWIRE ID="276:3:E409:130" --><A HREF="/cgi/external_ref?access_num=8558603&link_type=MED" >[Medline]</A><!-- /HIGHWIRE -->.<BR><BR>
<a name="B130">130.</a>
    &nbsp;

<B>
Ziel, F. H.,
N. Venkatesan,
and 
M. B. Davidson.</B>
Glucose transport is rate limiting for skeletal muscle glucose metabolism in normal and STZ-induced diabetic rats.
<I>Diabetes</I>
37:
885-890,
1988<!-- HIGHWIRE ID="276:3:E409:131" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=diabetes&resid=37/7/885" >[Abstract]</A><!-- /HIGHWIRE -->.<BR><BR>
<a name="B131">131.</a>
    &nbsp;

<B>
Zierler, K.</B>
Does insulin-induced increase in the amount of plasma membrane GLUTs account quantitatively for insulin-induced increase in glucose uptake?
<I>Diabetologia</I>
41:
724-730,
1998<!-- HIGHWIRE ID="276:3:E409:132" --><A HREF="/cgi/external_ref?access_num=9662057&link_type=MED" >[Medline]</A><!-- /HIGHWIRE -->.<BR><BR>
<a name="B132">132.</a>
    &nbsp;

<B>
Zierler, K.,
and 
E. M. Rogus.</B>
Hyperpolarization as a mediator of insulin action: increased muscle glucose uptake induced electrically.
<I>Am. J.&nbsp;Physiol.</I>
239 (<I>Endocrinol. Metab.</I> 2):
E21-E29,
1980<!-- HIGHWIRE ID="276:3:E409:133" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=ajpendo&resid=239/1/E21" ><nobr>[Abstract/<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE -->.<BR><BR>
<a name="B133">133.</a>
    &nbsp;

<B>
Zierler, K. L.</B>
Theory of the use of arteriovenous concentration differences for measuring metabolism in steady and non-steady states.
<I>J. Clin. Invest.</I>
40:
2111-2125,
1961<!-- HIGHWIRE ID="276:3:E409:134" --><!-- /HIGHWIRE -->.<BR><BR>
<a name="B134">134.</a>
    &nbsp;

<B>
Zierler, K. L.,
and 
D. Rabinowitz.</B>
Roles of insulin and growth hormone based on studies of forearm metabolism in man.
<I>Medicine</I>
42:
385-402,
1963<!-- HIGHWIRE ID="276:3:E409:135" --><!-- /HIGHWIRE -->.<BR><BR>
<a name="B135">135.</a>
    &nbsp;

<B>
Zierler, K. L.,
and 
D. Rabinowitz.</B>
Effect of very small concentration of insulin on forearm metabolism. Persistence of its action on potassium and free fatty acids without its effect on glucose.
<I>J. Clin. Invest.</I>
43:
950-962,
1964<!-- HIGHWIRE ID="276:3:E409:136" --><!-- /HIGHWIRE -->.<BR><BR>
<a name="B136">136.</a>
    &nbsp;

<B>
Zierler, K. L.,
A. Maseri,
G. Klassen,
D. Rabinowitz,
and 
J. Burgess.</B>
Muscle metabolism during exercise in man.
<I>Trans. Assoc. Am. Phys.</I>
81:
266-272,
1968<!-- HIGHWIRE ID="276:3:E409:137" --><A HREF="/cgi/external_ref?access_num=5721405&link_type=MED" >[Medline]</A><!-- /HIGHWIRE -->.<BR><BR>
<a name="B137">137.</a>
    &nbsp;

<B>
Zorzano, A.,
W. Wilkinson,
N. Kotliar,
G. Thoidis,
B. E. Wadzinski,
A. Ruoho,
and 
P. E. Pilch.</B>
Insulin-regulated glucose uptake in rat adipocytes is regulated by two transporter isoforms present in at least two vesicle populations.
<I>J. Biol. Chem.</I>
264:
12358-12363,
1989<!-- HIGHWIRE ID="276:3:E409:138" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=jbc&resid=264/21/12358" ><nobr>[Abstract/<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE -->.<BR><BR>











<P><HR>
<FONT SIZE=-1>Am J Physiol Endocrinol Metab 276(3):E409-E426<BR>

0002-9513/99 $5.00
<A HREF="/misc/terms.shtml"><B>Copyright &#169; 1999 the American Physiological Society</B></A><BR>





<!-- /COPYRIGHT -->
<!--

   Pages created by the Electronic Press Engine from

		Atypon Systems, Inc.

   Visit http://www.atypon.com/

-->


</vardef>

		
        
        
	
	
	
	
	





 






<BR CLEAR=ALL>




  <FONT FACE="">
  
  </FONT>
<BR CLEAR=ALL>
<BR CLEAR=ALL>



<A NAME="otherarticles"><!-- null --></A>

<P>
</body></html>